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roles	 in	 nutrient	 acquisition	 and	 biofilm	 formation	 but	 are	 also	 important	
biochemical	 mediators	 in	 bacterial	 virulence,	 facilitating	 host	 invasion.	
Microorganisms	 within	 chronic	 wounds	 have	 been	 hypothesised	 to	 form	 biofilms,	





It	 is	 therefore	 the	 primary	 research	 aim	 of	 this	 thesis	 is	 to	 assess	 the	 proteolytic	
activity	of	Pseudomonas	aeruginosa	and	Staphylococcus	aureus	isolated	from	equine	
and	human	chronic	wounds	and	determine	whether	there	 is	a	difference	in	activity	
between	 planktonic-conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	 medium	
(BCM).	 The	 next	 aim	 will	 be	 to	 identify	 these	 bacterial-derived	 proteases	 using	
zymography	and	mass	spectrometry,	and	determine	whether	these	proteases	reduce	





zymography	 will	 be	 utilised	 to	 determine	 the	 release	 of	 host-derived	 matrix	
metalloproteases	(MMPs).		
In	 this	 thesis	 I	 have	 identified,	 for	 the	 first	 time,	 high	 protease	 activity	 in	 equine	





protease	 activity	 specific	 to	 P.	 aeruginosa	 BCM	 but	 not	 PCM	 (P	 <0.0001)	 was	
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determined.	P.	aeruginosa	BCM	significantly	reduced	the	wound	closure	of	HDFs	(P	
<0.0001)	 and	 cell	 viability	 (P	 <0.0001),	 and	 further	 induced	 the	 release	 of	
metalloproteases	 from	 HDFs.	 P.	 aeruginosa	 in	 biofilm	 form	 secreted	 62kDa	 and	
52kDa	proteases,	however,	through	the	partial	purification	of	these	proteases,	it	was	
determined	 that	 these	 proteases	 did	 not	 play	 a	 role	 in	 the	 reduction	 of	 wound	
closure	 in	HDFs.	The	P.	aeruginosa-derived	partially	purified	proteases	did	however	
reduce	HDF	cell	viability	(P	<0.05).	
The	 results	 in	 this	 thesis	 support	 the	 theory	 that	 bacterial-derived	 proteases	may	
contribute	 to	 the	 emphasised	 proteolytic	 environment	 of	 human	 chronic	 wounds.	
Furthermore,	 the	presence	of	bacterial	biofilms	within	chronic	wounds	may	 induce	
the	 release	 of	 host-derived	 proteases.	 However	 the	 role	 of	 these	 specific	 P.	






































in	 terms	 of	 the	 cellular	 mechanisms	 that	 take	 us	 from	 initial	 tissue	 injury	 to	
granulation	 tissue	 formation,	 successful	 tissue	 remodelling	 and	 re-epithelialisation.	
Despite	 this,	 the	mechanisms	 involved	 in	 the	 development	 of	 chronic,	 non-healing	
wounds	have	not	been	fully	elucidated.	A	wound	that	fails	to	heal	in	a	timely	manner	
or	results	in	compromised	tissue	integrity	is	defined	as	a	chronic	wound	(Stadelmann	
et	 al.	 1998).	 Common	 examples	 of	 chronic	 wounds	 in	 humans	 include	 pressure	
ulcers,	venous	ulcers	and	diabetic	 foot	ulcers,	which	pose	a	considerable	economic	
burden,	costing	the	National	Health	Service	(NHS)	an	estimated	£2.3-£3.1	billion	per	
year	 (Posnett	 and	 Franks	 2008).	 The	 physiological	 processes	 of	 tissue	 repair	 in	
chronic,	 non-healing	 wounds	 are	 disturbed	 and	 are	 halted	 in	 the	 inflammatory	
phase,	 manifesting	 clinically	 as	 persistent	 inflammation,	 increased	 tissue	
degradation,	and	excessive	exudate	and	malodour	(Gardner	et	al.	2001).	Whilst	there	
are	a	number	of	physical	 factors	 that	are	 thought	 to	 lead	 to	 the	development	of	a	
chronic	wound,	 including	 reduced	blood	 flow	 in	the	elderly	and	diabetic,	vasculitis,	
mechanical	 pressure	 and	 burns;	 evidence	 of	 localised	 imbalances	 in	 protease	
production	 is	 thought	 to	be	one	 theory	as	 to	why	wounds	 fail	 to	heal	within	 these	





The	 recognition	 of	 microbial	 biofilms	 in	 the	 context	 of	 the	 healthcare-associated	
infections	 has	 come	 to	 the	 forefront	 in	 recent	 years	 due	 to	 its	 association	 with	
increased	 antimicrobial	 resistance	 (Donlan	 2001).	 Biofilms	 can	 be	 described	 as	
complex	 communities	 of	 microorganisms	 that	 can	 attach	 to	 each	 other	 and	 both	
biotic	and	abiotic	surfaces,	and	reside	within	extracellular	polysaccharide	substances	










The	 aim	 of	 this	 chapter	 was	 to	 summarise	 mammalian	 wound	 healing,	 drawing	
attention	to	the	similarities	and	differences	between	chronic	wounds	in	both	humans	
and	 horses.	 Furthermore,	 the	 role	 of	 endogenous	 MMPs	 in	 physiological	 and	







occur	 in	 order	 to	 clear	 contaminating	 bacteria	 and	 cellular	 debris	 and	 to	 produce	
new,	vascularised,	granulation	tissue	and	a	protective	epithelial	barrier.	The	wound	







within	 the	 clot	 results	 in	 the	 release	 of	 alpha	 granules	 (α-granules),	which	 secrete	
growth	 factors	 such	 as	 platelet-derived	 growth	 factor	 (PDGF),	 insulin-like	 growth	
factor-1	 (IGF-1),	 epidermal	 growth	 factor	 (EGF),	 transforming	 growth	 factor-beta	
(TGF-β),	and	platelet	factor-IV.	The	release	of	these	growth	factors	not	only	initiates	
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the	 coagulation	 pathways	 leading	 to	 fibrin	 clot	 formation,	 but	 also	 initiates	 the	
inflammatory	 phase	 of	 tissue	 repair	 through	 the	 recruitment	 of	 several	 cellular	
mediators	(Stadelmann	et	al.	1998).		
Within	 the	 early	 phase	 of	 inflammation,	 within	 24-36	 hours	 of	 tissue	 injury,	
neutrophils	 are	 the	 first	 cells	 to	 infiltrate	 the	 wound	 site	 through	 a	 number	 of	
chemoattractants	 including	cleaved	ECM	components,	TGF-β,	complement	proteins	
and	 bacterial-derived	 formyl-methionyl	 peptide	 products	 (Velnar	 et	 al.	 2009).	 The	
primary	role	of	neutrophils	in	the	wound	site	is	to	phagocytose	invading	bacteria	and	




The	 later	 stages	 of	 inflammation,	 within	 48-72	 hours,	 are	 characterised	 by	 the	
recruitment	of	monocytes	in	response	to	cytokines	and	growth	factors	including	TGF-
β,	 PDGF	 and	platelet	 factor	 IV,	 but	 also	 cleaved	 fragments	 of	 collagen	 and	 elastin.	
The	monocytes	soon	differentiate	into	tissue	macrophages.	These	macrophages	then	
dominate	 this	phase	of	wound	 repair,	phagocytosing	 invading	bacteria	and	causing	
local	debridement	 (Leibovich	and	Ross	1975).	 Interestingly,	 research	by	Martin	and	
colleagues	 (2003)	has	 since	shown	that	 the	 infiltration	of	 inflammatory	neutrophils	
and	 macrophages	 is	 not	 essential	 for	 wound	 healing.	 This	 study	 showed	 scarless	
wound	 healing	 in	 the	 PU.1	 null	 mouse,	 a	 model	 lacking	 both	 neutrophils	 and	
macrophages,	 in	 which	 wound	 healing	 was	 comparable	 to	 wild-type	 siblings	 and	
cellular	debris	was	alternatively	engulfed	by	fibroblasts	(Martin	et	al.	2003).	
Following	haemostasis	and	an	appropriate	host	immune	response,	the	wound	enters	
the	 proliferative	 phase	 of	 tissue	 repair.	 The	 proliferative	 stage	 of	 wound	 healing,	
occurring	 between	 day	 3	 and	 week	 2,	 is	 predominated	 by	 the	 fibroblast-driven	
deposition	of	ECM	and	the	subsequent	generation	of	granulation	tissue	(Velnar	et	al.	
2009).	Fibroblasts	are	recruited	to	the	wound	due	to	the	presence	of	factors	such	as	
TGF-β	 and	 PDGF,	 whereby	 they	 then	 proliferate	 and	 produce	 matrix	 proteins	
including	 fibronectin,	 hyaluronan,	 collagens	 and	 proteoglycans.	 The	 production	 of	














wound	 healing,	 increased	 patient	 discomfort,	 increased	 rates	 of	 morbidity	 and	
mortality	 and	 increased	 costs	 of	 treatment	 (Reynolds	 and	 Chow	 2013).	 In	 chronic,	
non-healing	 wounds,	 the	 normal	 responses	 to	 tissue	 damage	 are	 impaired	 and,	
wound	 healing	 is	 thought	 to	 be	 halted	 in	 the	 inflammatory	 phase,	 therefore	 a	
persistent	 state	 of	 inflammation	 is	 observed	 (Enoch	 and	 Price	 2004).	 The	
mechanisms	behind	why	some	wounds	fail	to	heal	or	take	excessively	long	periods	of	
time	to	heal	 is	still	unclear,	however	 in	humans,	 factors	such	as	smoking,	 infection,	
reduced	mobility,	diabetes	mellitus	and	nutrient	deficiency	are	 thought	 to	 increase	
the	risk	of	developing	a	chronic	wound	(Guo	and	DiPietro	2010).		
A	 number	 of	 cellular	 mechanisms	 have	 been	 described	 in	 the	 pathophysiology	 of	
chronic	wounds.	 Firstly,	 the	 cellular	 activity	 of	 chronic	wounds	differs	 greatly	 from	
that	 of	 acute	 wounds.	 A	 common	 feature	 of	 chronic	 wounds	 is	 the	 failure	 of	








cultured	 fibroblasts	 isolated	 from	 human	 diabetic	 foot	 ulcers	 was	 greatly	 reduced	




reduced	 in	 chronic	diabetic	 and	 venous	ulcers	when	 compared	 to	 an	acute	wound	
model.	Furthermore,	CD20+	B-cells,	CD79a+	plasma	cells	and	CD68+	macrophages	are	
found	 at	 higher	 levels	 in	 chronic	 diabetic	 and	 venous	 wounds	 than	 acute	 wounds	
(Loots	et	al.	1998).	A	characteristic	influx	of	neutrophils	has	been	observed	in	chronic	
pressure	ulcers,	which	 leads	 to	 the	release	of	neutrophil-derived	proteases	such	as	
elastase	 and	 MMPs,	 contributing	 to	 ECM	 degradation	 (Nwomeh	 et	 al.	 1999).	 For	
instance,	neutrophil-derived	elastase	 is	 known	 to	degrade	growth	 factors	 including	
PDGF	and	TGF-β,	both	beneficial	growth	factors	for	the	release	of	ECM	components	
from	resident	fibroblasts	(Eming	et	al.	2007).	Indeed,	imbalances	in	the	secretion	of	
extracellular	 matrix	 (ECM)	 degrading	 proteases	 and	 the	 counteracting	 release	 of	
their	 inhibitors	within	chronic	wounds	has	been	well	published	(Menke	et	al.	2007,	
Widgerow	 2011)	 and	 will	 be	 discussed	 in	 more	 detail	 in	 the	 next	 section	 of	 this	
introductory	chapter.		
Finally,	the	presence	of	bacteria	within	a	chronic	wound	is	thought	to	be	a	potential	
reason	 as	 to	 why	 chronic	 wounds	 will	 not	 heal.	 Bjarnsholt	 and	 colleagues	 (2008)	
hypothesised	 that	 it	was	 the	 bacterial	 burden	 of	 a	wound	 that	 prevents	 a	 chronic	
wound	 from	 healing,	 in	 particular	 the	 Gram-negative	 bacteria	 Pseudomonas	
aeruginosa.	More	specifically,	 they	hypothesised	 that	 this	was	due	 to	 the	ability	of	
this	microorganism	to	form	a	biofilm	within	the	wound,	which	effectively	 is	able	to	





Studies	 into	wound	 healing	 and	 aberrant	 wound	 healing	 generally	 use	 laboratory-
bred	 models	 such	 as	 rabbits	 or	 mice,	 however	 there	 are	 considered	 to	 be	 great	
differences	 in	 these	 models	 when	 compared	 to	 wound	 healing	 in	 humans	
(Greenhalgh	2005).	For	example,	commonly	used	mouse	models	have	been	heavily	
criticised	 as	wound	healing	predominantly	 relies	 on	muscle	 contraction	due	 to	 the	
presence	 of	 the	 panniculus	 carnosus	muscle	 in	 the	 subcutaneous	 tissue,	 unlike	 in	
humans,	which	 lack	this	muscle	and	therefore	wound	healing	 is	primarily	driven	by	
epithelialisation.	Wound	repair	in	the	horse	however,	is	steadily	being	acknowledged	
as	 a	more	physiologically	 relevant	model	 for	wound	healing	 research	 (Theoret	 and	
Wilmink	2013).	
Physiological	wound	repair	 in	 the	horse	 is	 similar	 to	 that	of	human	wound	healing,	
consisting	 of	 an	 inflammatory	 phase,	 proliferative	 phase	 and	 a	 maturation	 phase	
(Stashak	 and	 Theoret	 2009).	Wounds	 on	 the	 trunk	 of	 the	 horse	 heal	more	 rapidly	
through	 contraction	 than	 wounds	 on	 the	 lower	 limb,	 which	 rely	 more	 heavily	 on	
epithelialisation,	resulting	in	slow-to-heal	wounds	and	therefore	drawing	similarities	
to	 human	 chronic	 wounds	 (Knottenbelt	 1997).	 Furthermore,	 equine	 lower-limb	
wounds	 can	 develop	 fibroproliferative	 complications	 as	 seen	 in	 humans.	 For	
instance,	 the	 spontaneous	 over-production	 of	 granulation	 tissue	 (exuberant	






Human	 chronic	 lower-leg	 wound	 (A)	 shows	 characteristic	 presence	 of	 slough,	
indicated	by	 the	black	 arrow,	 and	 the	 chronic	 equine	 lower-limb	wound	 (B)	 shows	





Proteases	 are	 enzymes	 that	 are	 able	 to	 break	 down	 proteins	 and	 peptides	 and,	
depending	 on	 their	 activity,	 can	 be	 classified	 as	 either	 exoproteases	 or	
endoproteases.	An	exoprotease	generally	cleaves	a	peptide	near	the	end	of	the	N-	or	
C-termini	 of	 the	 polypeptide	 chain	 and	 can	 be	 classified	 as	 amino-	 or	
carboxyproteases.	 An	 endoprotease,	 or	 proteinase,	 can	 cleave	 internal	 peptide	
bonds	 and	 are	 grouped	 into	metallo-,	 serine-,	 aspartic-	 or	 threonine-proteases.	 To	
date,	 there	 are	 569	 known	 human	 proteases,	 the	 most	 abundant	 of	 which	 are	
metalloproteases,	or	matrixins,	which	account	 for	194	proteins,	closely	 followed	by	
	 30	
serine	 proteases	 which	make	 up	 176	 of	 these	 proteins	 (Moali	 and	 Hulmes	 2009).	
Matrix	metalloproteases	 (MMPs)	 are	a	matrixin	 subfamily	of	 zinc	metalloproteases	
belonging	 to	 the	 M10	 family	 of	 peptidases	 according	 to	 the	 MEROPS	 peptidase	





MMPs	 belong	 to	 a	 group	 of	 peptidases	 known	 as	 ‘metzincins’,	 named	 after	 a	
conserved	methionine	C-terminal	 to	 the	 zinc	 ligands,	 known	as	a	 ‘Metturn’.	MMPs	
are	grouped	into	gelatinases,	collagenases,	membrane-type	(MT)-MMPs,	matrilysins,	
stromelysins	 and	 others,	 based	 on	 their	 domain	 arrangement	 and	 substrate	
preference.	 MMPs	 all	 have	 a	 similar	 basic	 structure	 in	 that	 they	 all	 have	 a	 signal	
peptide,	a	pro-peptide	and	a	catalytic	domain.	However	they	differ	in	the	presence	of	
fibronectin-type	II	repeats	in	the	catalytic	domain,	as	seen	in	the	gelatinases	MMP-2	











Figure	 1.2	 Schematic	 domain	 structure	 of	 human	 matrix	 metalloproteinases	
(MMPs)	
MMPs	generally	consist	of	three	domains,	the	pro-peptide,	catalytic	and	a	C-terminal	
haemapexin-like	domain.	 The	 figure	 represents	 the	 inactive	MMP	precursor	with	a	












removal	of	 the	pro-peptide	 is	carried	out	by	other	MMPs	or	 through	auto-catalytic	
cleavage,	thus	resulting	in	an	active	MMP.	Some	MMPs	are	activated	intracellularly,	
whereby	 the	 inactive	 pro-MMP	 is	 proteolytically	 cleaved	 in	 the	 Golgi	 apparatus,	
resulting	 in	 an	 active	 peptide	 that	 can	 then	 be	 secreted.	 MMP	 activity	 can	 be	
regulated	by	Tissue	Inhibitors	of	MMPs	(TIMPs)	-1,	-2,	-3	and	-4,	to	variable	extents.	
TIMPs	 are	 endogenous	 inhibitors	 belonging	 to	 the	 family	 I35	 according	 to	 the	
MEROPS	 database	 (Rawlings	 et	 al.	 2012),	 which	 can	 inhibit	 MMPs	 in	 a	 1:1	
stoichiometry,	 playing	 an	 important	 physiological	 role	 in	 tissue	 remodelling	 (Visse	
and	Nagase	2003).	TIMPs	are	able	to	bind	to	the	zinc	ion	within	the	catalytic	domain	





elastin	 and	 proteoglycans	 (see	 Table	 1.1),	 mediating	 processes	 such	 as	 tissue	
remodelling	and	facilitating	cell	migration.	However	it	has	been	recognised	that	the	
breakdown	 of	 ECM	 by	 MMPs	 also	 releases	 growth	 factors	 bound	 to	 the	 matrix,	
increasing	growth	factor	availability	to	receptors.	Furthermore,	MMPs	play	a	role	in	
in	 other,	 equally	 as	 important	 biological	 processes	 through	 the	 cleavage	 of	 other	
substrates	(Nagase	et	al.	2006).	For	instance,	macrophage-derived	MMP-9	has	been	
shown	 to	 cleave	 the	 chemokine	 CXCL12	 or	 stromal	 cell-derived	 factor	 1	 (SDF-1),	
which	inhibits	the	recruitment	of	endothelial	progenitor	cells	(EPCs),	a	key	player	in	


















Stromelysin	1	 MMP-3	 Collagen	 II,	 IV,	 IX,	 X,	 XI,	 gelatin,	 elastin,	
aggrecan,		
Stromelysin	2	 MMP-10	 Collagen	 IV,	 elastin,	 aggrecan,	 laminin,	
fibronectin	



























MMPs	 play	 a	 role	 in	 physiological	 wound	 repair	 as	 early	 as	 the	 first	 phase	 of	
haemostasis	 and	 inflammation.	 Infiltrating	 neutrophils	 at	 the	 wound	 site	 release	
MMP-8	 (neutrophil	 collagenase),	 which	 is	 thought	 to	 be	 essential	 in	 physiological	
wound	 repair	 by	 regulating	 the	 inflammatory	 response	 (Gutiérrez-Fernández	 et	 al.	
2007).	MMP-8	plays	a	role	in	neutrophil	migration	through	collagen	degradation	and	
the	 production	 of	 the	 chemotactic	 peptide	 Pro-Gly-Pro	 in	 a	 murine	 model	 of	




from	 the	 ECM	 by	 a	 variety	 of	MMPs.	 For	 instance,	MMP-2	 (gelatinase	 A),	MMP-3	
(stromelysin-1)	and	MMP-7	(matrilysin-1),	have	been	shown	to	cleave	a	decorin-TGF-
β1	 complex	 into	 several	 fragments,	 releasing	 TGF-β1	 in	 vitro	 (Imai	 et	 al.	 1997).	
Further	work	 in	this	area	revealed	that	the	release	of	TGF-β1	complexes	from	ECM	
occurred	 by	 the	 degradation	 of	 latent	 TGF-β	 by	 membrane	 type	 1	 matrix	
metalloprotease	 (MT1-MMP)	 (Tatti	 et	 al.	 2008).	 Belotti	 and	 colleagues	 (2003)	
discovered	a	positive	correlation	with	the	amount	of	MMP-9	(pro-enzyme	and	active	
enzyme)	and	MMP-2	(pro-enzyme)	and	the	release	of	the	angiogenic	growth	factor	
vascular	 endothelial	 growth	 factor	 (VEGF)	 in	 a	 human-derived	 ovarian	 carcinoma	
xenograft	mouse	model.	The	authors	 then	determined	 that	MMP-9	and	 to	a	 lesser	
extent	MMP-2,	 increased	 levels	 of	 VEGF	 in	 the	 human	 ovarian	 carcinoma	 cell	 line	
SKOV3	 in	 vitro,	 leading	 to	 endothelial	 cell	motility.	 This	 cell	motility	was	 then	 fully	
inhibited	by	the	VEGF	inhibitor	SU5416	(Belotti	et	al.	2003).		




wounding	 and	 a	 high	 expression	 of	MMP-9	 in	 the	wound	 fluid	 of	 2	 and	 4	 day-old	
secretions	 post-wounding.	 The	 expression	 of	 MMP-2	 remained	 constant	 in	
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fibroblasts	alone	(Salo	et	al.	1994).	Subsequent	studies	by	a	different	research	group	
in	 1998	 supported	 the	 involvement	 of	 MMP-9	 in	 re-epithelialisation,	 but	 also	
demonstrated	collagenase	and	stromelysins-1	and	-2	in	populations	of	keratinocytes	
at	the	migrating	wound	edge	(Madlener	et	al.	1998).		
Various	 mouse	 studies	 have	 demonstrated	 the	 importance	 of	 MMPs	 and	 other	
proteases	in	wound	closure.	Plasminogen,	a	serine	protease,	was	first	demonstrated	
to	 play	 a	 role	 in	wound	 healing	when	wound	 closure	was	 significantly	 impaired	 in	
plasminogen	 deficient	mice	 (Rømer	 et	 al.	 1996).	 Lund	 and	 co-workers	 (1999)	 then	
went	on	 to	 show	 the	effects	 of	 the	metalloprotease	 inhibitor	 galardin	 in	wounded	
plasminogen-deficient	 mice,	 which	 resulted	 in	 delayed	 wound	 closure,	






gelatinases	MMP-2	and	MMP-9	 in	 the	wound	 fluid	of	patients	with	pressure	ulcers	
when	 compared	 to	 healing	 wounds.	 Furthermore,	 collagenase	 was	 significantly	
increased	in	pressure	ulcers	compared	to	acute	surgical	wounds	(Yager	et	al.	1996).	
The	collagenase	MMP-8	(neutrophil	collagenase)	has	also	been	shown	to	be	one	of	
the	 predominant	 MMPs	 in	 both	 normal,	 healing	 wounds	 and	 non-healing	 chronic	
ulcers,	 with	 active	 forms	 of	MMP-8	 almost	 exclusively	 present	 in	 chronic	wounds.	
Furthermore,	reduced	levels	of	the	inhibitor	TIMP-1	in	chronic	wounds	and	elevated	
MMP-8	 has	 also	 been	 recorded	 (Nwomeh	 et	 al.	 1999),	 demonstrating	MMP:TIMP	
imbalances.	Liu	and	colleagues	(2009)	showed	an	inverse	correlation	between	MMP-
9	and	MMP9:	TIMP-1	ratio	to	healing	rates	in	the	patients	with	diabetic	foot	ulcers,	
with	 the	 authors	 stating	 that	 increases	 in	 MMP-9	 could	 be	 used	 to	 predict	 poor	
wound	healing	(Liu	et	al.	2009).	Furthermore,	various	levels	of	the	pro-enzyme	state	















may	be	observed.	 The	 first	 state	 is	 the	 contamination	of	 the	wound	area	with	 the	






colonisation	 is	 not	 thought	 to	 cause	 a	 host	 immune	 response	 or	 affect	 wound	
closure.	 The	 third	 state	 is	 ‘critical	 colonisation’	 and	 is	 a	 term	 coined	 to	 describe	 a	
delay	 in	wound	 healing	without	 clinical	 signs	 of	 inflammation.	 Here,	 bacteria	 have	
not	managed	to	invade	local	tissues,	however	they	are	thought	to	secrete	toxins	and	
virulence	 factors	 that	 impair	wound	closure	without	eliciting	an	 immune	 response.	
Critical	 colonisation	 is	 considered	 to	 be	 the	 point	 at	 which	 the	 wound	 can	 either	
improve	 following	appropriate	 treatment,	 remain	 in	a	 critical	 colonisation	 state,	or	
deteriorate	to	clinical	infection	(White	and	Cutting	2006).	However	it	is	important	to	
note	that	critical	colonisation	is	indeed,	a	theory.	The	final	state	is	known	as	bacterial	
infection	 and	 is	 characterised	 by	 the	 presence	 of	 proliferating	 bacteria	 that	 have	
invaded	 viable	 tissues	 and	 therefore	 initiate	 an	 immune	 response.	 Clinical	
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characteristics	 of	 bacterial	 infection	 include,	 tissue	 redness	 (erythema),	 pain,	 heat,	
swelling	 and	 excessive	 exudate	 at	 the	 site.	 This	 type	 of	 bacterial	 infection	 is	







within	 the	 slime	 located	on	 the	 surface	of	mountain	 streams	 (Geesey	 et	 al.	 1977).	
Biofilms	 can	 be	 described	 as	 communities	 of	 microorganisms	 that	 can	 attach	 to	
either	abiotic	(non-living	surfaces	such	as	metallic	implants)	or	biotic	surfaces	(living	





stages	 involving	 reversible	 and	 irreversible	 attachment,	 colonisation	 and	 dispersal	
(see	 Figure	 1.3).	 The	 physiological	 processes	 of	 a	 biofilm	 such	 as	 the	 secretion	 of	
virulence	 factors	 or	 motility	 of	 individual	 microorganisms,	 is	 controlled	 by	
intercellular	 communication	 known	 as	 quorum	 sensing.	 Bacteria	 within	 the	
developing	 biofilm	 release	 chemical	 signals	 known	 as	 autoinducers,	 which	 are	
constitutively	 released	 from	 bacteria,	 therefore	 as	 the	 biofilm	 grows,	 the	
concentration	 of	 autoinducers	 increases.	 As	 the	 concentration	 of	 autoinducers	
reaches	 a	 critical	 threshold,	 a	 change	 in	 gene	 expression	 occurs,	 resulting	 in	 a	
physiological	response,	such	as	the	release	of	virulence	factors	(Lindsay	and	Von	Holy	
2006,	 Mangwani	 et	 al.	 2012).	 Both	 Gram-negative	 and	 Gram-positive	 bacteria	
secrete	 autoinducers.	 In	 brief,	 Gram-negative	 bacteria	 secrete	 acyl-homoserine	
lactones	 and	 Gram-positive	 bacteria	 release	 oligo-peptide	 molecules	 (Lindsay	 and	
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Von	Holy	2006).	 The	Gram-negative	bacterium	P.	aeruginosa	has	been	 reported	 to	
secrete	 the	 quorum	 sensing	 molecule	 N-(3-oxo-dodecanoyl)-L-homoserine,	 which	
has	 been	 shown	 to	 enhance	 P.	 aeruginosa	 biofilm	 virulence	 and	 repress	 host	
immune	responses	(Driscoll	et	al.	2007).	Indeed,	P.	aeruginosa	has	been	implicated	in	
a	 number	 of	 infectious	 diseases	 including	 chronic	 lung	 infections	 such	 as	 cystic	
fibrosis,	thus	research	into	the	viability	of	targeting	these	quorum	sensing	molecules	





chronic	 lung	 infections,	 periodontitis,	 endocarditis,	 osteomyelitis	 and	 chronic	
wounds	(Singh	et	al.	2000,	Distel	et	al.	2002,	Gristina	et	al.	1985a,	James	et	al.	2008,	
Mohamed	et	al.	2004).	Furthermore,	biofilms	have	been	associated	with	the	use	of	
biomaterials,	 implants	 and	 devices,	 from	 urinary	 catheters,	 intravenous	 lines	 and	
prosthetics,	which	can	ultimately	lead	to	systemic	infection.	The	presence	of	biofilms	
in	 the	 healthcare	 setting	was	 recognised	 as	 a	 potential	 impact	 to	 health	 from	 the	
mid-1980’s	when	microorganisms	encased	 in	an	extracellular	matrix	on	the	sutures	
of	 surgical	 wounds	 were	 identified	 (Gristina	 et	 al.	 1985b).	 Subsequent	 to	 this,	 it	
appeared	 that	 bacteria	 growing	 within	 the	 biofilm	 state	 were	 more	 resistant	 to	
antibiotics	 and	 that	 biomaterial	 substrata	 acted	 as	 sites	 of	 colonisation	 and	
potentially	facilitated	bacterial	virulence	(Gristina	et	al.	1987).		
There	are	many	 theories	 involving	 the	potential	mechanisms	by	which	biofilms	are	
considered	 able	 to	 confer	 resistance.	 It	 is	 thought	 that	 the	 presence	 of	 EPS	 that	
encases	the	microorganisms,	results	in	the	incomplete	penetration	of	antimicrobials	
through	 the	 surface	 layers	 of	 the	 biofilm	 (Francolini	 and	 Donelli	 2010).	 Another	
theory	involves	the	slow	growth	rate	within	areas	of	the	biofilm	with	reduced	oxygen	
and	nutrients,	which	 is	 thought	 to	hamper	 the	actions	of	many	antimicrobials	 that	
require	 a	 certain	 degree	 of	 cellular	 metabolic	 activity	 in	 order	 to	 function	 (Hall-
Stoodley	 et	 al.	 2004).	 Phenotypic	 variants	 that	 are	 considered	 to	 demonstrate	 a	
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highly	 resistant	 phenotype	 when	 compared	 to	 other	 microorganisms	 within	 the	
biofilm,	commonly	referred	to	as	'persister	cells’,	confer	resistance	within	the	biofilm	
due	to	their	slow	rate	of	growth.	Although	these	persister	cells	lack	the	genetic	traits	
that	 resemble	 that	 of	 antibiotic	 resistance,	 they	 show	 high	 levels	 of	 multi-drug	
tolerance.	 (Hall-Stoodley	 et	 al.	 2004,	 Spoering	 and	 Lewis	 2001,	 Lewis	 2008,	 Lewis	


















The	 most	 commonly	 isolated	 bacteria	 in	 human	 chronic	 wounds	 include	
Staphylococcus	aureus	(93.5%),	Enterococcus	faecalis	(71.1%),	P.	aeruginosa	(52.2%)	
and	 coagulase	 negative	 Staphylococci	 (CoNS)	 (45.7%)	 (Gjødsbøl	 et	 al.	 2006).	Other	
research	 groups	 have	 extended	 this	 research	 in	 an	 attempt	 to	 gain	 a	 more	
comprehensive	understanding	of	 the	microbial	profile	of	wounds.	The	technique	of	
16S	 rDNA	 amplification	 followed	 by	 pyrosequencing,	 denaturing	 gradient	 gel	
electrophoresis	 (DGGE)	 and	 full	 ribosome	 shotgun	 sequencing	 has	 been	 used	 to	
determine	the	major	microbial	populations	in	diabetic	foot	ulcers,	venous	leg	ulcers	
and	 pressure	 ulcers,	 whereby	 the	 most	 common	 wound	 isolates	 included	
Staphylococcus,	 Pseudomonas,	 Peptoniphilus,	 Enterobacter,	 Stenotrophomonas,	
Finegoldia	and	Serratia	spp	(Dowd	et	al.	2008).	However	it	is	interesting	to	note	that	
the	 population	 profile	 of	 each	 type	 of	 chronic	wound	 varied,	with	 pressure	 ulcers	
housing	more	obligate	anaerobes	(62%)	than	both	diabetic	and	venous	ulcers	(Dowd	
et	 al.	 2008).	 Further	 research	 has	 shown	 Streptococcus,	 Corynebacterium,	
Staphylococcus,	 and	 Pseudomonas	 spp.	 to	 be	 among	 the	 most	 common	 primary	





under	 researched.	 In	order	 to	 investigate	 this	aspect	 further,	 James	and	colleagues	
examined	for	the	presence	of	biofilms	in	both	acute	and	chronic	wounds,	using	both	
scanning	 electron	microscopy	 (SEM)	 and	 polymerase	 chain	 reaction	 (PCR)	 coupled	
with	 DGGE.	 They	 discovered	 a	 significant	 difference	 in	 the	 presence	 of	 biofilms	
between	 chronic	 and	 acute	 wounds,	 with	 60%	 of	 chronic	 wounds	 containing	 a	
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biofilm	when	compared	to	just	6%	in	acute	wounds	(p<0.001).	Furthermore,	PCR	and	
DGGE	 revealed	 that	 these	 biofilms	 were	 polymicrobial	 (James	 et	 al.	 2008).	 The	
presence	of	biofilms	in	chronic	wounds	has	also	been	detected	using	peptide	nucleic	
acid-based	fluorescence	 in	situ	hybridisation	(PNA-FISH),	ultimately	determining	the	




techniques	 and	 PNA-FISH	 has	 been	 highlighted,	 with	 wound	 colonisation	 results	








control	 and	 tolerance	of	both	 commensal	 and	pathogenic	microorganisms.	Despite	
this,	a	large	portion	of	this	research	has	been	focussed	upon	invading	bacteria	within	
the	 single	 cell,	 planktonic	 state.	 It	 is	 now	 generally	 thought	 that	 the	 growth	 of	
microorganisms	in	both	environmental	and	clinical	settings	is	within	the	biofilm	form.	
Thus	 research	 into	 the	 host	 immune	 response	 toward	 microorganisms	 within	 a	
biofilm	has	gained	precedence.		
The	host’s	immune	responses	do	indeed	respond	to	the	presence	of	biofilms	and	has	
been	 associated	 with	 the	 infiltration	 of	 neutrophils	 to	 the	 wound	 site	 in	 human	
chronic	venous	leg	ulcers.	Furthermore,	the	number	of	neutrophils	in	chronic	venous	





vitro	 (Singh	 et	 al.	 2002).	 Cellular	 components	 of	 host	 immunity	 are	 not	 always	
effective	 in	 the	 prevention	 of	 biofilm	 formation.	 For	 example,	 the	 yeast	 Candida	
albicans	has	demonstrated	successful	biofilm	formation	in	the	presence	of	peripheral	
blood	mononuclear	 cells	 (PBMCs)	 in	 an	 cytokine-rich	 environment	 (Chandra	 et	 al.	
2007).	 Furthermore,	 the	 presence	 of	 polymorphonuclear	 leukocytes	 (PMNs)	 has	
been	 shown	 to	 enhance	P.	 aeruginosa	 biofilm	 formation	 and	development	 in	 vitro	
through	 the	deposition	of	 neutrophil-derived	polymers,	 actin	 and	DNA,	 acting	 as	 a	
scaffold	for	microbial	colonisation	and	biofilm	formation	(Walker	et	al.	2005).		
Biofilms	 have	 also	 demonstrated	 the	 ability	 to	 evade	 host	 immune	 responses.	 For	
instance,	the	EPS	matrix	of	P.	aeruginosa	biofilms	has	been	shown	to	protect	against	
interferon-γ-(IFN-γ)-mediated	macrophage	 killing	 (Leid	 et	 al.	 2005).	 Additionally,	P.	
aeruginosa	 biofilms	 have	 been	 shown	 to	 escape	 PMN-mediated	 phagocytosis	
through	 the	 secretion	 of	 a	 quorum	 sensing-regulated	 rhamnolipid,	 which	 effects	
PMN	cell	migration	and	causes	the	rapid,	necrotic	killing	of	PMNs	in	vitro	and	in	vivo	
(Jensen	 et	 al.	 2007).	 A	 study	 by	 Thurlow	 and	 colleagues	 (2011)	 investigated	 the	
innate	immune	responses	directed	towards	a	S.	aureus	biofilm	in	a	mouse	model	of	
catheter-associated	biofilm	infection.	The	latter	researchers	found	that	the	presence	
of	 the	biofilm	did	not	 elicit	 a	 response	 from	pattern	 recognition	 receptors	 such	 as	
Toll-like	 receptors	 (TLRs).	 Instead,	 significant	 reductions	 in	 the	 cytokines	 and	
chemokines	 IL-1β,	 tumour	 necrosis	 factor-alpha	 (TNF-α),	 CXCL2	 and	 CCL2,	 and	
reduced	macrophage	infiltration	into	the	biofilms	were	observed.	In	vitro	co-culture	
of	macrophages	and	S.	aureus	biofilms	showed	a	limited	phagocytosis	response	from	
macrophages,	 indicative	 of	 alternatively	 activated	 M2	 macrophages,	 a	 more	
reparative	 phenotype	 when	 compared	 to	 the	 pro-inflammatory	 phenotype	 of	 M1	








the	 planktonic	 form.	 In	 a	mouse	model	 of	P.	 aeruginosa-related	 corneal	 infection,	
there	 was	 a	 marked	 induction	 of	 MT-MMP-4,	 -5	 and	 -6	 (Dong	 et	 al.	 2001).	
Burkholderia	 cenocepacia	 infection	 of	 an	 in	 vitro	monolayer	 of	 lung	 epithelial	 cells	
resulted	in	the	up-regulation	of	MMP-2	and	MMP-9	genes	and	caused	an	increase	in	
the	 secretion	 of	 active	MMP-9	 protein.	 This	 increase	 in	 active	MMP-9	 resulted	 in	
delayed	 wound	 closure	 in	 lung	 epithelial	 cells	 in	 vitro,	 which	 was	 reversed	 in	 the	
presence	of	a	MMP-9-specific	inhibitor	(Wright	et	al.	2011).		
The	 importance	 of	 investigating	 bacteria	 in	 planktonic	 and	 biofilm	 form	 in	 chronic	
wound	pathogenesis	has	been	recognised.	Kirker	and	colleagues	(2012)	investigated	
the	 effect	 of	 methicillin-resistant	 S.	 aureus	 (MRSA)	 planktonic-	 and	 biofilm-




and	 a	 suppression	 of	MMP-3	when	 compared	 to	 controls	 (Kirker	 et	 al.	 2012).	 This	
study	 highlighted	 the	 differences	 in	 the	 soluble	 factors	 released	 by	 S.	 aureus	 in	
planktonic	 and	biofilm	 form	and	 that	 these	 two	different	 physiological	 states	 elicit	
differential	effects	on	the	production	of	growth	factors,	cytokines	and	MMPs	in	host	
cells.	Given	that	MMPs	have	been	shown	to	be	up-regulated	in	chronic	wounds,	the	




Bacterial	 proteases	 encompass	 a	 large	 and	 diverse	 group	 of	 proteases	 that	 are	
ubiquitously	produced	by	all	microorganisms	and	possess	varying	physiological	and	
biochemical	 functions	 (Schaechter	 2009).	 The	 intracellular	 expression	 and	
extracellular	 secretion	 of	 proteases	 in	 both	 Gram-positive	 and	 Gram-negative	
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bacteria	are	fundamental	contributors	to	infection	through	the	turnover	of	unfolded	
proteins	 in	 the	 host	 environment	 and	 the	 proteolysis	 of	 regulatory	 proteins	 upon	
environmental	stimuli.	The	main	 intracellular	conserved	proteases	 include	Lon,	Clp,	
High	 temperature	 requirement	 A	 (HtrA)	 and	 FtsH.	 The	 biological	 functions	 of	
intracellular	 bacterial	 proteases	 and	 their	 role	 in	 infection	 has	 been	 extensively	
studied	 and	 reviewed	 elsewhere;	 the	 reader	 is	 directed	 to	 an	 excellent	 review	 by	
Ingmer	 and	 Brøndsted	 for	 a	more	 in-depth	 account	 (Ingmer	 and	 Brøndsted	 2009).	
This	 section	of	 the	 introduction	shall	discuss	what	 is	known	about	 the	extracellular	
secreted	 proteases	 from	 the	 bacteria	 most	 commonly	 associated	 with	 infected	
chronic	 wounds,	 more	 specifically	 S.	 aureus	 and	 P.	 aeruginosa.	 Many	 species	 of	
bacteria	are	able	to	produce	and	secrete	proteases,	which	can	be	toxins	or	virulence	
factors,	whilst	others	may	have	a	more	central	 role	 in	 the	degradation	of	proteins.	







































strains,	 with	 fully	 sequenced	 genomes	 for	 14	 strains,	 one	 of	 those	 including	 the	
commonly	 used	 laboratory	 strain	 P.	 aeruginosa	 PA01	 (Rawlings	 et	 al.	 2012).	 P.	
aeruginosa	PA01	contains	5572	genes	 in	 its	genome,	of	which	166	are	 identified	as	
proteases.	 Of	 these	 proteases,	 the	 main	 proteases	 families	 include	 62	 serine-
proteases,	45	metallo-proteases,	8	cysteine-proteases	and	3	aspartic	proteases.	The	





Elastase	 B	 (LasB)	 is	 a	 metalloprotease	 that	 is	 produced	 within	 the	 cell	 in	 a	 pre-
proenzyme	 form,	 consisting	 of	 two	 pro-peptide	 domains	 and	 a	 third	 catalytic	
domain.	 The	 first	 23	 amino	 acids	 on	 the	 N-terminal	 codes	 for	 the	 signal	 peptide,	
which	directs	 the	 translocation	of	 the	pro-enzyme	across	 the	 inner	membrane	 into	
the	periplasm	via	 the	 secretory	 system.	 This	 process	 results	 in	 the	 cleavage	of	 the	
signal	 peptide.	 The	 unfolded,	 inactive	 pro-enzyme	 is	 then	 folded	 into	 its	 mature,	
active	form	by	the	pro-peptide	domains,	which	act	as	a	chaperone	to	assist	correct	




















in	 a	 range	 of	 pathologies.	 The	 pathophysiology	 of	 corneal	 ulcers	 for	 instance,	 has	
been	 characterised	 as	 the	 breakdown	 of	 extracellular	 matrix,	 and	 indeed,	 P.	
aeruginosa–derived	 extracellular	 proteases	 have	 been	 implicated	 in	 the	
development	of	corneal	ulcers.	Matsumoto	and	colleagues	showed	that	the	presence	
of	 P.	 aeruginosa	 599A	 strain,	 isolated	 from	 a	 vitamin	 A-deficient	 rat	 eye,	 and	 P.	
aeruginosa-RPS,	 isolated	 from	human	corneal	ulcer,	 resulted	 in	 the	cleavage	of	 the	
pro-MMP-2	 to	 release	 the	 active	 MMP-2	 from	 human	 corneal	 fibroblasts.	 The	
authors	stated	that	the	cleavage	of	pro-MMP-2	might	have	been	due	to	the	presence	
of	53kDa,	70kDa	and	110kDa	proteases,	and	53kDa	extracellular	proteases	from	the	
P.	 aeruginosa-RPS	 and	 P.	 aeruginosa	 599A	 strain	 respectively	 (Matsumoto	 et	 al.	
1993).	 P.	 aeruginosa	 is	 a	 common	 bacterial	 pathogen	 identified	 in	 cystic	 fibrosis	
sufferers.	There	is	evidence	to	suggest	that	bacterial	serine	proteases	secreted	by	P.	
aeruginosa	may	affect	the	concentration	of	mucins	within	the	mucus	in	the	airways	





significant	 degradation	 of	 mucins	 by	 the	 synthetic	 Pseudomonas	 LasB,	 which	 was	
comparable	 to	 degradation	 by	 HNE.	 Furthermore,	 the	 incubation	 of	 cystic	 fibrosis	
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sputum	 with	 the	 serine-protease	 inhibitors	 diisopropyl	 fluorophosphates	 (DFP),	
phenylmethylsulfonyl	 fluoride	 (PMSF)	 and	 1-chloro-3-tosylamido-7-amino-2-
heptanone	HCl	 (TLCK),	 significantly	 reduced	mucin	 degradation	when	 compared	 to	
inhibitors	of	cysteine	and	metallo-proteases	(Henke	et	al.	2011).	
In	 the	 context	 of	 chronic	 wounds,	 there	 is	 some	 evidence	 to	 suggest	 that	 P.	
aeruginosa-derived	metalloproteases	may	contribute	to	the	pathogenesis	of	chronic	
wounds.	 One	 of	 the	 first	 research	 papers	 to	 acknowledge	 protease-producing	
bacteria	 in	 chronic	wounds	was	published	 in	2001,	whereby	P.	aeruginosa	 isolated	
from	chronic	leg	ulcers	showed	varying	levels	of	P.	aeruginosa	elastase,	AprA	and	an	
unidentified	 100kDa	 protease	 (Schmidtchen	 et	 al.	 2001).	 Wysocki	 and	 colleagues	
identified	 18	 different	 bacterial	 species	 in	 chronic	 venous	 leg	 ulcers	 (10	 Gram-
positive	 and	 8	 Gram-negative)	 that	 displayed	 proteolytic	 activity.	 This	 proteolytic	
activity	 was	 not	 found	 to	 be	 consistent	 in	 any	 of	 these	 species	 after	 repeated	
isolation	(Wysocki	et	al.	2012).	However	it	is	important	to	note	that	in	this	study,	no	
quantitative	 data	 were	 presented	 to	 determine	 the	 varying	 levels	 of	 protease	
production	 between	 species,	 nor	was	 there	 an	 attempt	 to	 identify	 these	 bacterial	
proteases.	 Another	 study	 by	 Wildeboer	 and	 colleagues	 sought	 to	 determine	 a	
correlation	 between	 protease	 activity	 and	 bacterial	 load	 in	 chronic	 wounds	 using	
fluorescent-labelled	peptide	substrates.	Although	there	was	no	correlation	between	
most	 species	 identified	 in	 the	wound	and	protease	activity,	 the	 signal	detection	of	
two	 substrates	 strongly	 correlated	 with	 P.	 aeruginosa	 numbers	 (Wildeboer	 et	 al.	





subspecies	 and	 strains	 of	 S.	 aureus	 (Rawlings	 et	 al.	 2012).	 In	 general,	 S.	 aureus	
produce	 499	 proteases,	 of	 which	 the	 major	 protease	 groups	 consist	 of	 75	 serine	
proteases,	 169	metalloproteases,	 84	 cysteine	 proteases	 and	 13	 aspartic	 proteases	
respectively.	 The	 most	 commonly	 secreted	 proteases	 from	 S.	 aureus	 include	 the	
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In	 its	 inactive	 form,	 the	metalloprotease	 aureolysin	 consists	 of	 a	 27	 amino	 acid	N-
terminal	 signal	 peptide,	 a	 pro-peptide	 domain	 and	 a	 catalytic	 domain.	 Glutamyl	
peptidase	 I	 or	 SspA	 serine	 protease	 contains	 a	 29	 amino	 acid	 N-terminal	 signal	
peptide,	 pro-peptide	 doman	 and	 catalytic	 domain	 and	 is	 activated	 through	 its	
proteolytic	cleavage	by	aureolysin.	The	cysteine	protease	ScpA	contains	a	25	amino	
acid	N-terminal	 signal	 peptide,	 a	 pro-peptide	 domain	 and	 a	 catalytic	 domain	 in	 its	
inactive	 form.	 Post-translational	 modification	 of	 the	 ScpA	 protease	 into	 its	 active	
form	 is	most	 likely	 through	 auto-catalytic	 processing.	 Similarly	 in	 its	 inactive	 form,	
the	 SspB	 protease	 has	 an	 N-terminal	 signal	 peptide	 (36	 amino	 acids	 long),	 a	 pro-





infection.	 Links	 between	 specific	 S.	 aureus-derived	 extracellular	 proteases	 and	
various	 types	 of	 infection	 has	 not	 received	 much	 attention.	 However	 a	 study	 by	
Zdzalik	 and	 co-workers	 investigated	 the	 prevalent	 S.	 aureus	 extracellular	 protease	
genes	derived	from	cases	of	wound	infection,	pneumonia,	sepsis,	cystic	fibrosis,	skin	
infection	and	bone	infection	to	name	a	few	(Zdzalik	et	al.	2012).	In	this	study	they	did	
not	 determine	 any	 correlation	 in	 gene	 expression	 patterns	 with	 specific	 types	 of	
infection,	however	they	do	state	that	most	of	the	S.	aureus	proteases	 investigated,	
are	expressed	and	secreted	in	the	course	of	infection.		
In	 order	 for	 a	 pathogen	 to	 successfully	 invade	 the	 host	 and	 cause	 persistent	
infection,	 the	 pathogen	must	 be	 able	 to	 evade	 host	 immune	 responses.	 S.	 aureus	
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expresses	 and	 secretes	 proteases	 that	 have	 been	 shown	 to	 target	 components	 of	
host	 immunity	 such	 as	 the	 complement	 system.	 For	 example,	 the	 S.	 aureus	
metalloprotease	aureolysin	 targets	 components	of	 the	 immune	system	to	 facilitate	
immune	evasion.	Laarman	and	colleagues	showed	that	the	S.	aureus	aureolysin	could	
effectively	prevent	complement-mediated	phagocytosis	through	the	cleavage	of	the	
C3	 protein	 complex	 (Laarman	 et	 al.	 2011).	 S.	 aureus	 cysteine	 proteases	 have	 also	
been	 implicated	 in	 the	 cleavage	 of	 a	 major	 protein	 in	 pulmonary	 surfactant,	
pulmonary	 surfactant	 protein	 A,	 which	 has	 been	 linked	 to	 a	 reduction	 in	 innate	




The	 treatment	 of	 chronic	wounds	 depends	 on	 the	 type	 of	 chronic	wound	 and	 the	
severity	 of	 the	 wound.	 For	 example,	 pressure	 ulcers,	 in	 part,	 can	 arise	 from	
persistent	 mechanical	 pressure	 in	 those	 who	 have	 limited	 mobility	 and	 therefore	
using	the	technique	of	repositioning	can	help	prevent	the	progression	of	this	type	of	
wound.	 Other	 treatment	 strategies	 such	 as	 negative	 pressure	 therapy	 (NPT),	
nutritional	 therapy	 and	 debridement	 are	 also	 used	 in	 the	 treatment	 of	 chronic	
wounds	(see	Table	1.3).	However	for	all	chronic	wounds,	the	use	of	wound	dressings	
is	 an	 integral	 part	 of	 wound	 care	 and	 can	 help	manage	 excessive	 exudate	 and	 in	
some	 cases	 bacterial	 bioburden.	 A	 variety	 of	 wound	 dressings	 are	 used	 in	 the	
treatment	of	chronic	wounds	(see	Table	1.4).	Many	of	these	dressings	focus	on	the	
absorption	 of	 excessive	 wound	 exudate,	 whilst	 others	 combine	 absorptive	 and	
antimicrobial	 properties	 through	 the	 incorporation	 of	 ionic	 silver	 (Percival	 et	 al.	
2011b).	With	regards	 to	 the	regulation	of	excessive	MMPs	observed	within	chronic	











With	 hypotheses	 surrounding	 the	 pathogenesis	 of	 chronic	 wounds	 relating	 to	 the	
involvement	of	biofilms,	much	 research	 is	now	 taking	place	 to	 identify	 compounds	
with	 ‘anti-biofilm’	 or	 biofilm-disrupting	 properties.	 Although	 there	 is	 a	 plethora	 of	
claims	towards	the	anti-biofilm	properties	of	many	agents	such	as	xylitol,	lactoferrin	
and	ethylenediaminetetraacetic	 acid	 (EDTA)	 in	 vitro,	 the	evidence	 for	 their	efficacy	
within	 in	 vivo	models	 is	 currently	 lacking	 (Wolcott	 and	Rhoads	2008,	Ammons	and	
Copié	 2013).	Nevertheless,	 the	development	 and	potential	 use	of	 small	molecules,	
bioactive	 molecules	 and	 enzymes	 provide	 promising	 opportunities	 for	 biofilm	
management	in	chronic	wounds.	Gawande	and	colleagues	demonstrated	the	efficacy	
of	 a	 novel,	 naturally	 occurring	 enzyme-based	 gel	 on	 chronic	 wound–associated	
microorganisms	 (Gawande	 et	 al.	 2014).	 Dispersin-B®	 -KSL-W	 gel	 containing	 the	
Aggregatibacter	 actinomycetemcomitans-derived	 enzyme	 Dispersin-B®,	 inhibits	
biofilm	 formation	 and	 disperses	 pre-formed	 biofilms.	 This	 gel	 showed	 both	
antimicrobial	and	anti-biofilm	activity	by	significantly	reducing	log	counts	in	chronic-
wound	 associated	 MRSA,	 S.	 epidermidis,	 CoNS,	 Acinetobacter	 baumannii	 and	
Klebsiella	pneumoniae	 (Gawande	et	al.	2014).	Despite	this,	the	dispersal	of	biofilms	
will	 ultimately	 lead	 to	 parts	 of	 the	 biofilm	 colonising	 new	 sites,	 resulting	 in	 the	





enhanced	 virulence,	 making	 it	 an	 intriguing	 target	 for	 pharmacological	 action	
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(Hentzer	et	al.	2003).	The	proposed	targets	in	the	quorum	sensing	system	include	the	
signal	 generator,	 the	 quorum-sensing	 molecule	 and	 the	 signal	 receptor.	 In	 many	
cases,	 it	 is	 the	 signal	 receptor	 that	 is	 targeted	by	using	molecules	 that	block	 these	
receptors	 and	 disrupt	 signalling	 pathways	 (Rasmussen	 and	 Givskov	 2006).	
Christensen	and	colleagues	showed	that	P.	aeruginosa	biofilms	 in	an	 in	vivo	mouse	
model	 could	 be	 disrupted	 by	 the	 use	 of	 the	 antibiotic	 tobramycin	 and	 several	
quorum-sensing	molecules	including	furanone	and	horseradish	juice	extract.	Synergy	
was	 seen	 between	 both	 treatments	 and	 the	 presence	 of	 quorum	 sensing	 inhibitor	




of	 the	quorum	 sensing	 disruptor	 RNAIII	 inhibiting	 peptide	 significantly	 restored	 re-
epithelialisation	 when	 compared	 to	 the	 antibiotic	 oxacilin,	 due	 to	 reduced	
quantifiable	 bacterial	 burden.	 In	 addition,	 the	 staphylococcal	 biofilm	 signalling-
associated	gene,	TRAP,	appeared	to	play	an	important	role	in	the	reduction	of	wound	




Photodynamic	 therapy	 (PDT)	 is	 the	 application	 of	 a	 photoactive	 dye	 coupled	 with	











PDT,	 resulting	 in	complete	eradication	of	S.	aureus	 in	 three	of	 five	mice	 (Gad	et	al.	
2004).	 In	 humans,	 the	 treatment	 of	 two	 autoimmune	 ulcers	 in	 an	 Italian	 patient	
using	PDT	resulted	in	significant	wound	closure	from	4.0cm	to	1.8cm	diameter.	Given	
that	 these	 ulcers	 were	 previously	 shown	 to	 be	 highly	 recalcitrant	 to	 systemic	
antibiotics	and	the	application	of	wound	dressings;	 it	 is	 thought	that	the	successful	
use	of	PDT	could	be	through	such	mechanisms	as	enhanced	keratinocyte	migration,	
immunomodulatory	activity	and	antimicrobial	effectiveness	(Motta	and	Monti	2007).	
PDT	 has	 been	 shown	 to	 significantly	 reduce	 bacterial	 load	 and	 complete	 wound	
closure	in	50%	of	patients	with	chronic	leg	ulcers	in	a	phase	IIa,	randomized,	blinded	
and	single	treatment	study	(Morley	et	al.	2013).	The	use	of	PDT	to	reduce	bacterial	




The	 therapeutic	 targeting	 of	 proteases	 by	 pharmacologically	 attractive	 compounds	
has	 been	 successfully	 used	 in	 the	 treatment	 of	 many	 diseases,	 including	
hypertension,	human	 immunodeficiency	virus	 (HIV)	and	hepatitis	C	virus	 (HCV).	For	
instance,	pharmacologically	approved	serine	protease	inhibitor	boceprevir	(Victrelis;	
Merck)	 reversibly	 binds	 to	 and	 inhibits	 the	 HCV	 non-structural	 3	 (NS3)	 active	 site,	
preventing	 viral	 replication	 and	 thus	 sustaining	 the	 virologic	 response	 in	 patients	
with	previously	untreated,	chronic	HCV	infection	(Venkatraman	2012,	Poordad	et	al.	
2011).		
The	 pharmacological	 targeting	 of	 bacterial	 proteases	 in	 the	 context	 of	 bacterial	
infection	has	not	been	fully	exploited.	Yet	many	of	the	secreted	bacterial	proteases	
are	 involved	 in	 bacterial	 virulence	 or	 growth	 and	 therefore	 the	 inhibition	 of	 these	
proteases	may	disrupt	biofilm	 formation	or	 increase	susceptibility	 to	antimicrobials	
(Kaman	 et	 al.	 2014).	 In	 the	 context	 of	 chronic	 wound-associated	 bacteria,	 P.	
aeruginosa	LasB	protease	has	been	investigated	as	a	target	of	protease	inhibition.	A	
novel	 and	 potent	 inhibitor	 of	 LasB,	 N-mercaptoacetyl-Phe-Tyr-amide,	 has	 been	
	 56	
developed	and	shown	to	reduce	P.	aeruginosa	biofilm	growth,	and	when	combined	
with	 additional	 antimicrobials	 such	 as	 ciprofloxacin	 and	 gentamycin,	 can	 fully	
eradicate	the	biofilm	in	vitro	(Cathcart	et	al.	2011).	Similarly,	the	deletion	of	LasB	in	
P.	aeruginosa	PA01,	referred	to	as	a	Lasb	deletion	mutant	strain,	has	been	shown	to	
exhibit	 decreased	 bacterial	 attachment	 and	 microcolony	 formation.	 However	
microcolony	 formation	 in	 the	 LasB	 deletion	 mutants	 was	 restored	 following	




S.	 aureus	 aureolysin,	 and	 to	 a	 lesser	 extent,	 the	proteases	 ScpA	and	SspB,	 actually	


















































































NPT,	whereby	 a	 vacuum	 is	 applied	 to	 a	 sealed	wound	 dressing,	 is	 a	method	 that	 has	
been	 shown	 to	 increase	blood	 flow	and	 reduce	oedema,	promoting	 granulation	 tissue	
formation	 and	 wound	 closure.	 There	 is	 conflicting	 evidence	 for	 the	 management	 of	
microbial	bioburden.	
	
(Levine	 et	 al.	 2013,	
Argenta	 and	 Morykwas	
1997,	 Mouës	 et	 al.	
2011)	
Repositioning	 Particular	method	used	in	the	management	of	pressure	ulcers.	Patients	are	repositioned	
to	 reduce	mechanical	 stress	on	 the	chronic	wound.	For	 instance,	adjusting	 the	patient	




Debridement	 A	 method	 used	 to	 remove	 non-viable	 tissue	 or	 infected	 tissue	 to	 promote	 the	
development	of	healthy	tissue.	Methods	of	debridement:	
Biological	 -	 Larvae	 or	 maggots	 used	 to	 remove	 necrotic	 tissue;	 Autolytic	 -	 Naturally	
occurring	enzymes	breakdown	dead	tissue;	Chemical	-	Use	of	chemical	compounds	such	




(Dryburgh	 et	 al.	 2007,	
Wolcott	et	al.	2009)	
































The	 first	 research	 aim	 is	 to	 assess	 the	 proteolytic	 activity	 of	 P.	 aeruginosa	 and	 S.	
aureus	 isolated	 from	 equine	 and	 human	 chronic	 wounds	 and	 determine	 whether	
there	is	a	difference	in	proteolytic	activity	between	the	planktonic	and	biofilm	form	
of	these	isolates.	The	second	research	aim	will	then	focus	on	the	effect	of	planktonic-
conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	 medium	 (BCM)	 from	 equine	
clinical	 isolates	 on	 the	 in	 vitro	 wound	 closure	 of	 normal	 fibroblasts	 (NFs)	 isolated	
from	 uninjured	 equine	 lower	 limb	 skin	 and	 granulation	 tissue	 fibroblasts	 (GTFs)	
cultured	 from	 equine	 chronic	 wound	 granulation	 tissue.	 The	 technique	 of	
zymography	will	be	utilised	 to	determine	 the	 release	of	host-derived	MMPs	 in	 this	
wound	model.	In	order	to	gain	a	better	understanding	of	how	infection	affects	MMP	
expression	 in	 host	 tissues,	 both	 normal	 skin	 and	 chronic	wound	 granulation	 tissue	
from	 horse	 lower	 limbs	 will	 be	 assessed	 histologically	 for	 the	 presence	 of	
microorganisms	within	a	biofilm,	and	the	corresponding	expression	of	MMPs	in	the	
surrounding	tissue.		
The	 next	 aim	 will	 then	 address	 the	 effect	 of	 PCM	 and	 BCM	 from	 human	 chronic	
wound-derived	 isolates	on	 the	 in	 vitro	wound	 closure	of	human	dermal	 fibroblasts	
(HDFs)	and	human	epidermal	keratinocytes	(HEKs).	As	with	the	equine	model,	host-
MMP	 expression	 in	 response	 to	 PCM	 and	 BCM	 will	 be	 assessed.	 In	 addition,	 the	
generation	of	an	in	vitro	3-dimensional	keratinocyte-fibroblast	co-culture	model	will	
be	developed,	and	wound	repair	observed	in	response	to	microbial	bioburden.	
I	 hypothesise	 that	 clinically	 derived	 isolates	 from	 both	 equine	 and	 human	 chronic	
wounds	 will	 secrete	 high	 levels	 of	 proteases.	 Furthermore,	 I	 believe	 that	 the	
presence	 of	 S.	 aureus	 and	P.	 aeruginosa	 biofilms,	 but	 not	 planktonic	 bacteria,	will	
reduce	wound	closure	in	equine	and	human	models	in	vitro	and	will	elicit	the	release	
of	host-derived	proteases.	 In	addition	I	postulate	that	the	identification	of	bacterial	


































Approval	 for	 the	 isolation	of	 equine-derived	bacteria	was	 carried	out	 in	 a	previous	
study	 at	 the	 University	 of	 Liverpool	 and	 informed	 consent	was	 obtained	 from	 the	
owners	of	the	animals	that	participated	in	the	study	(Westgate	et	al.	2011).	Human	










Equine-derived	 microorganisms	 were	 obtained	 from	 the	 University	 of	 Liverpool	
relating	 to	 the	 research	 undertaken	 by	Westgate	 and	 colleagues	 (Westgate	 et	 al.	
2011).	Briefly,	bacterial	sampling	in	the	form	of	a	swabbing	technique	was	performed	
on	 both	 acute	 and	 chronic	 equine	 wounds.	 Wound	 type	 was	 determined	 by	 the	






microbiological	 techniques,	 including	 selective	 agars,	 Gram-staining	 and	 tests	 to	







by	 a	 local	 research	 ethics	 committee	 and	 after	 informed	 consent	 was	 taken	 from	
patients	 attending	 the	Wound	Healing	 Research	Unit,	 University	Hospital	 of	Wales	
(Cardiff,	 UK).	 Microbiological	 methods	 such	 as	 selective	 agars,	 Gram-staining	 and	




Prior	 to	 use,	microorganisms	were	 stored	 on	Microbank™	 green	 colour	 beads	 at	 -
80°C	 before	 inoculating	 onto	 Mueller	 Hinton	 Agar	 (MHA)	 (Lab	 M,	 Bury,	 UK)	 and	
incubating	 overnight	 at	 37°C.	 Following	 incubation,	 a	 loop	 of	 bacteria	 was	
transferred	 to	 Mueller	 Hinton	 Broth	 (MHB)	 (Lab	 M),	 Dulbecco’s	 Modified	 Eagle	
Medium	 (DMEM)	 or	 EpiLife	 (Life	 Technologies,	 Paisley,	 UK)	 to	 obtain	 planktonic-
conditioned	medium	 (PCM)	 and	biofilm-conditioned	medium	 (BCM)	 (see	2.3.4	 and	
2.3.5).	 In	 general	 and	 for	 this	 study,	 the	 term	 planktonic	was	 defined	 as	 bacterial	
cells	 that	 are	 grown	 in	 a	 free-floating,	 single-cell	 state.	 The	 term	 biofilm	 was	
described	as	bacterial	cells	that	are	attached	to	a	surface	and	each	other,	and	grow	
as	a	community	of	cells	within	a	self-synthesised	matrix.	Growth	curves	of	bacteria	
within	 a	 planktonic	 state	 was	 performed	 by	 inoculating	 MHB	 with	 the	 chosen	








bacteria	 on	MHA	 was	 used	 to	 inoculate	 either	 MHB,	 DMEM	without	 phenol	 (Life	
Technologies,	 Paisley,	 UK)	 containing	 10%	 Foetal	 Bovine	 Serum	 (FBS),	 2mM	 L-
glutamine	 (Life	 Technologies,	 Paisley,	 UK),	 10mM	 N-2-hydroxyethylpiperazine-N-2-
ethane	 sulfonic	 acid	 (HEPES)	 (Life	 Technologies,	 Paisley,	 UK)	 and	 0.5μg/ml	
Fungizone®Amphotericin	 B	 (Life	 Technologies,	 Paisley,	 UK)	 or	 Epilife	 medium	
containing	 human	 keratinocyte	 growth	 supplement	 (HKGS)	 (Life	 Technologies,	
Paisley,	UK)	before	incubating	overnight	at	37°C.	This	specific	preparation	of	DMEM	
is	referred	to	as	‘DMEM	(without	antibiotics)’	throughout	this	thesis.	Addtionally,	this	
preparation	of	Epilife	 is	referred	to	as	 ‘EpiLife	(without	antibiotics)’	 throughout	this	

















which	was	 determined	 by	 using	 the	 Cecil	 CE	 2040	 spectrophotometer.	Membrane	
filter	 discs	 of	 0.2µm	 pore	 size	 (Whatman	 Anodisc,	 Scientific	 Laboratory	 Supplies,	
Yorkshire,	UK)	were	sterilised	using	ultraviolet	 light	exposure	for	30	minutes	before	
transferring	 the	 discs	 to	MHA	 plates.	 Forty	microliters	 of	 the	 bacterial	 suspension	
was	 added	 to	 the	 filter	 disc.	 The	MHA	plates	 containing	 the	 inoculated	 filter	 discs	
were	 incubated	 for	 72	 hours	 at	 37°C	 in	 humidified	 conditions	 (see	 Figure	 2.1).	
Following	 incubation,	 the	 discs	 were	 transferred	 to	 a	 Deep-Well	 plate	 (BD	
Biosciences,	 Oxford,	 UK).	 The	 wells	 of	 the	 plate	 were	 filled	 with	 8ml	 of	 MHB	 or	
DMEM	(without	antibiotics),	allowing	the	medium	to	touch	the	base	of	the	filter	disc.	
The	 Deep-Well	 plate	 containing	 the	 72-hour	 biofilm	 was	 incubated	 at	 37°C	 in	
humidified	conditions	for	24	hours.	The	conditioned-medium	was	collected	after	24	
hours	and	centrifuged	at	11,000	x	g	at	4°C	for	10	minutes.	Supernatants	were	then	
sterile-filtered	 (0.2	 µm)	 before	 being	 stored	 at	 -20°C	 until	 needed	 for	 further	 use.	








Figure	 2.1	 Representative	 image	 of	 a	 72-hour	 human-derived	 clinical	 strain	 of	P.	
aeruginosa	grown	as	a	biofilm.	
The	characteristic	yellow/green	P.	aeruginosa	biofilm	(b)	can	be	seen	on	the	surface	





To	 assess	 the	 biofilm	 forming	 potential	 of	 bacterial	 isolates,	 bacteria	was	 cultured	
overnight	in	MHB	at	37°C	and	diluted	to	108	colony	forming	units/ml.	Two-hundred	
microliters	 of	 the	 bacterial	 suspension	 in	MHB	 was	 added	 to	 a	 96-well	 microtitre	
plate	before	covering	the	plate	with	a	96-peg	lid.	The	plate	was	incubated	for	either	
24,	 48	 or	 72	 hours	 at	 37°C	 with	 gentle	 shaking	 of	 125rpm,	 allowing	 the	 bacteria	
within	 the	 suspension	 to	attach	 to	 the	pegs	 (see	Figure	2.2).	 Following	 incubation,	
the	 pegs	 were	 removed	 from	 the	 bacterial	 suspension	 and	 were	 washed	 twice	 in	
phosphate	 buffered	 saline	 (PBS)	 and	 allowed	 to	 air-dry.	 The	 pegs	 were	 then	
incubated	in	a	0.5%	crystal	violet	solution	for	15	minutes	at	room	temperature.	The	
pegs	were	rinsed	with	distilled	water,	removing	any	excess	crystal	violet	that	had	not	







wavelength	of	 550nm.	High	 absorbance	 values	 (strong	 crystal	 violet	 staining)	were	
indicative	of	strong	biofilm	formation	due	to	a	greater	number	of	adhered	bacteria	to	




















(A)	 Microorganisms	 suspended	 in	 culture	 medium	 were	 added	 to	 the	 wells	 of	 a	
microtiter	 plate.	 (B)	 A	microtiter	 lid	 containing	 plastic	 pegs	was	 used	 to	 cover	 the	
plate,	 resulting	 in	 the	 submersion	 of	 the	 pegs	 into	 the	 microbial	 suspension.	 (C)	
Following	 incubation,	 the	 pegs	 were	 removed	 from	 the	 plate	 and	 washed.	






identified	 three	 potential	 biofilm-disrupting	 technologies,	 which	 were	 tested	 on	
three	skin-	and	wound-related	microorganisms,	P.	aeruginosa	ATCC	9027,	S.	aureus	
ATCC	6538	and	Candida	albicans	ATCC	10321	(CultiLoops®,	Remel,	Thermo	Scientific,	
US).	 The	 three	 potential	 biofilm-disrupting	 technologies	 included	 a	 chelating	 agent	
and	 two	 surfactants,	 surfactant	 A	 and	 surfactant	 B.	 The	 aim	 of	 this	 study	 was	 to	
identify	 whether	 these	 technologies	 could	 disrupt	 biofilms	when	 combined	with	 a	
commercially	 available	 polymer	 antimicrobial.	 More	 specifically,	 the	 minimum	
biocidal	 concentration	 (MBC)	 and	 minimum	 biofilm	 eradication	 concentration	
(MBEC)	 was	 determined.	 MBC	 was	 defined	 as	 the	 minimum	 concentration	 of	
antimicrobial	that	eradicates	the	growth	of	the	dispersed,	planktonic	cells	 from	the	































Prior	 to	 use,	microorganisms	were	 stored	 on	Microbank™	 green	 colour	 beads	 at	 -
80°C	 before	 inoculating	 onto	 MHA	 and	 incubating	 overnight	 at	 37°C.	 Following	
incubation,	 a	 loop	 of	 bacteria	was	 transferred	 to	MHB	 and	 incubated	 overnight	 at	
37°C.	The	microbial	suspension	was	then	diluted	to	108	colony	forming	units/ml	and	

















covered	with	a	96-peg	 lid	and	 incubated	 in	a	shaking	 incubator	(125rpm)	for	either	
24,	48	or	72	hours	at	37°C.	Biofilms	grown	on	pegs	for	24,	48	or	72	hours	were	then	
gently	 washed	 once	 in	 PBS	 before	 being	 transferred	 to	 the	 respective	 treatment	
plate	and	placed	in	a	shaking	incubator	(125rpm)	for	24	hours	at	37°C.	The	96-peg	lid	
was	 subsequently	 removed	 from	 the	 treatment	 plate	 and	 transferred	 to	 a	 plate	
containing	PBS	(wash	step).	Each	well	of	the	treatment	plate	was	then	transferred	to	






well	 was	 transferred	 to	 individual	 MHA	 plates	 and	 incubated	 at	 37°C	 in	 order	 to	




Bacterial	 biofilms	 grown	 on	 membrane	 filter	 discs	 were	 visualised	 using	 scanning	
electron	microscopy	 (SEM).	 Stock	 solutions	 of	 25%	 gluteraldehyde	were	 diluted	 in	
PBS	 to	a	2.5%	working	concentration.	Bacteria	grown	for	72	hours	were	washed	 in	
PBS	to	remove	non-adherent	cells	and	fixed	in	2.5%	gluteraldehyde	for	90	minutes	at	
room	 temperature.	 Gluteraldehyde	 fixative	 was	 removed	 and	 the	 biofilms	 were	
washed	twice	in	PBS.	Biofilms	were	dehydrated	in	a	series	of	ethanol	concentrations	
ranging	from	50%	to	100%.	Following	dehydration	the	samples	were	sputter-coated	
using	 a	 Polaron	 E5100	 sputter-coater	 with	 a	 gold/palladium	 target.	 Once	 coated,	
membrane	 filters	 containing	 the	bacterial	 biofilms	were	attached	 to	25mm	x	6mm	
aluminium	 stubs	 (Agar	 Scientific,	 Essex,	 UK)	 using	 two-sided	 sticky	 tape.	 Biofilms	






Milk-casein	 agar	 was	 used	 to	 assess	 the	 proteolytic	 activity	 of	 equine	 PCM	 at	 a	
preliminary	 level	 (see	 Appendix	 I).	 Milk-casein	 agar	 was	 prepared	 by	 adding	 25g	
skimmed	milk	 powder	 (BD,	Oxford,	UK),	 2.5g	 casein	 (BDH,	 VWR,	 Lutterworth,	UK),	
used	for	casein	nutritional	experiments,	1.25g	yeast	extract	(Oxoid,	Basingstoke,	UK),	
0.5g	D-glucose	(BDH,	Oxford,	UK)	and	6.25g	Number	1	agar	(LabM	Bury,	UK)	to	500ml	
distilled	 water.	 The	 agar	 was	 autoclaved,	 poured	 into	 petri	 dishes	 (approximately	
30ml	per	plate)	and	allowed	to	cool	until	set.	Milk-casein	agar	plates	were	dried	in	an	
oven	to	remove	excess	moisture	before	creating	two	8mm	wells	in	the	agar,	of	equal	
distance	 apart,	 using	 a	 sterile	 punch	 biopsy.	 One	 hundred	 microlitres	 of	 bacterial	
supernatant	was	added	to	the	first	well	followed	by	100µl	of	MHB	in	the	second	to	
act	 as	a	negative	growth	and	protease	activity	 control.	 This	was	 repeated	 for	each	












Images	of	P.	aeruginosa	 planktonic-conditioned	medium	 (PCM)	protease	activity	 in	
milk-casein	 agar	 at	 24-	 (A)	 and	 48-hours	 (B)	 Black	 arrows	 indicate	 the	 zones	 of	
clearance	whereby	the	casein	has	been	degraded	by	proteases	in	the	P.	aeruginosa	





To	measure	 the	 general	 protease	 activity	 of	 PCM	 and	 BCM,	 an	 assay	 utilising	 the	
chromogenic	 substrate	Azo-casein,	 a	non-specific	protease	 substrate	 conjugated	 to	
an	azo-dye,	was	performed.	Briefly,	Azo-casein	solution	was	made	by	dissolving	Azo-
casein	 in	 distilled	 water	 to	 a	 concentration	 of	 5mg/ml.	 Fresh	 Azo-casein	 was	
prepared	 for	every	new	assay.	Blank	 samples	were	made	using	50µl	medium,	50µl	
Azo-casein	 solution	 and	 500µl	 PBS.	 Test	 samples	 were	made	 using	 50µl	 bacterial-
conditioned	 medium,	 50µl	 Azo-casein	 solution	 and	 500µl	 PBS.	 All	 samples	 were	
tested	 in	duplicate	and	 incubated	overnight	at	37°C.	Following	 incubation,	600µl	of	
ice	cold	5%	trichloroacetic	acid	(TCA)	was	added	to	each	sample	and	incubated	on	ice	




96-well	 plate	 before	 reading	 the	 absorbance	 on	 a	 Thermo	 Scientific	 Multiscan	 FC	
plate	 reader	 at	 a	 wavelength	 of	 405nm.	 Absorbance	 values	 for	 duplicate	 blank	










Test	 samples	 were	 made	 using	 50µl	 bacterial-conditioned	medium	 (PCM	 or	 BCM)	
and	90µl	Azocoll	solution.	All	samples	were	run	in	duplicate	per	assay	and	all	assays	
repeated	 three	 times	 using	 triplicate	 bacterial-conditioned	medium.	 Samples	were	
incubated	in	a	shaker	(200rpm)	overnight	at	37°C.	Following	incubation,	all	samples	
were	 centrifuged	 at	 10,000	 x	 g	 for	 8	 minutes	 at	 4°C.	 Sample	 supernatants	 were	










and	the	Azocoll	 solution	after	 incubation	at	37°C.	The	presence	of	proteases	 in	 the	
bacterial-conditioned	medium	causes	the	hydrolysis	of	the	collagen	substrate,	which	
releases	the	azo-dye.	Black	arrows	indicate	strong	proteolytic	activity,	which	appears	





A	 Miniprotean	 II	 gel	 system	 (Bio-Rad,	 Hemel	 Hempstead,	 UK)	 was	 employed	 for	
zymography	gels.	Samples	were	prepared	1:1:3	bacterial-conditioned	medium	(PCM	




















of	 the	 SDS.	 Following	 incubation	 the	 gel	was	washed	 thoroughly	 in	 distilled	water	
before	 being	 placed	 in	 1x	 refolding	 buffer	 (concentrated	 10x	 –	 6.05g	 Tris-base,	
11.68g	 sodium	 chloride,	 5.50g	 calcium	 chloride,	 670µl	 Brij,	 pH	 7.6)	 and	 incubated	
overnight	 at	 37°C.	 Following	 incubation,	 the	 gel	 was	 removed	 from	 the	 refolding	
buffer	and	stained	in	0.5%	Coomassie	Brilliant	Blue	G250	for	40	minutes.	Stained	gels	
were	de-stained	 in	a	de-staining	solution	 (150ml	methanol,	35ml	glacial	acetic	acid	
and	 315ml	 distilled	 water),	 changing	 the	 de-stain	 solution	 every	 15	 minutes	 until	
clear	 bands	 were	 visible	 on	 a	 blue	 background.	 Following	 de-staining,	 bands	
representing	 enzymatic	 activity	 were	 present	 as	 clear	 bands	 on	 a	 dark	 blue	
background.	To	determine	an	approximate	molecular	weight	for	the	protease	bands,	
7μl	 of	Novex®	 Sharp	 Pre-stained	Protein	 Standards	 (Life	 Technologies,	 Paisley,	UK)	














A	 15%	 Acrylamide	 gel	 (resolving	 gel)	 was	 made	 and	 cast	 using	 7.5ml	 30%	
acrylamide/bis-acrylamide,	3.5ml	distilled	water,	3.75ml	resolving	buffer	(1.5M	Tris-
HCL,	pH8.8),	150µl	10%	SDS,	75µl	10%	APS	and	10µl	TEMED.	Once	the	gel	was	added	
to	 the	 1mm	 glass	 plates,	 a	 small	 amount	 of	 isobutanol	 was	 added	 to	 the	 gel	 to	
provide	an	even	surface.	Once	the	gel	had	set,	the	isobutanol	was	removed	and	the	
gel	was	washed	with	distilled	water.	A	stacking	gel	was	made	and	cast	using	0.67ml	
acrylamide/bis-acrylamide,	 3ml	 distilled	 water,	 1.25ml	 stacking	 buffer	 (0.5M	 Tris-
HCL,	pH	6.8),	50µl	10%	SDS,	50µl	10%	APS	and	20µl	TEMED	before	inserting	a	10-well	
comb.	Test	samples	were	prepared	by	diluting	bacterial-conditioned	medium	in	1:1	
in	 2x	 Laemmli	 sample	 buffer	 (Bio-Rad,	 Hemel	 Hempstead,	 UK)	 containing	
dithiothreitol	(DTT)	and	heated	for	10	minutes	at	100°C.	When	the	gels	were	set,	the	
comb	was	 removed	 and	 the	wells	washed	 thoroughly	 in	 distilled	water.	Gels	were	
transferred	 to	 the	 gel	 tank	 and	 filled	 with	 NuPAGE	 MES	 SDS	 running	 buffer	 (Life	
Technologies,	Paisley,	UK)		(1x)	before	loading	the	samples	into	the	wells	of	the	gel	at	
20µl	per	well.		A	Novex	Sharp	Unstained	Protein	Standard	(Life	Technologies,	Paisley,	
UK)	 (7µl)	 was	 added	 to	 one	 of	 the	 wells	 to	 determine	 the	 molecular	 weight	 of	
proteins	 within	 the	 samples.	 Electrophoresis	 occurred	 at	 150V	 until	 the	 dye	 front	
reached	the	bottom	of	the	gel.	The	gels	were	removed	and	placed	in	0.5%	Coomassie	









found	 that	 55%	 AS	was	 sufficient	 to	 precipitate	 the	 target	 protease(s).	 Depending	
upon	the	working	temperature	and	volume	of	the	protein	solution,	the	amount	of	AS	
solid	to	be	added	to	the	protein	solution	can	be	calculated	from	an	AS	precipitation	




tube	 centrifuged	at	10,000	 x	 g	 for	15	minutes	at	4°C.	After	 centrifugation,	 a	pellet	
was	 observed,	 which	 contained	 the	 AS	 and	 the	 precipitated	 protein	 fraction.	 The	
supernatant	was	removed	and	the	pellet	was	re-suspended	 in	PBS	 (10%	of	starting	
volume).	The	re-suspended	pellet	was	then	transferred	to	dialysis	tubing	and	placed	
in	PBS	overnight	 at	 4°C	 to	 remove	 the	AS.	 The	protein	 concentration,	 content	 and	
proteolytic	activity	of	the	solution	was	then	assessed	using	the	BCA	assay,	SDS-PAGE,	
non-specific	 proteases	 assay	 and	 zymography.	 This	 solution	 was	 referred	 to	 as	 a	
partially	 purified	 protease.	 Partially	 purified	 protease	 was	 obtained	 from	 three	 P.	
aeruginosa	 biological	 replicates	 (P1097,	 P1140	 and	 P1145).	 These	 proteases	 were	




The	 detection	 and	 quantification	 of	 total	 protein	 in	 the	 partially	 purified	 protease	
solution	was	performed	using	the	Pierce®	BCA	Protein	Assay	Kit	(Fisher	Scientific	UK	
Ltd,	 Loughborough,	 UK)	 to	 the	manufacturer’s	 instructions.	 Bovine	 serum	 albumin	
(BSA)	was	diluted	in	PBS	to	create	BSA	standard	concentrations	between	0mg/ml	to	
2mg/ml.	The	partially	purified	protease	sample	was	diluted	in	BCA	working	reagent.	
BSA	 standards	 and	 test	 samples	 were	 performed	 in	 duplicate.	 The	 assay	 was	
incubated	 for	 30	minutes	 at	 37°C	 before	 the	 absorbance	was	 read	on	 the	 Thermo	
Scientific	Multiscan	FC	plate	reader	at	a	wavelength	of	570nm.	Average	absorbance	
values	 of	 the	 BSA	 standards	 were	 plotted	 against	 the	 known	 concentration	 to	









Equine	normal	 fibroblasts	 (NFs)	were	obtained	from	cadavers	 (see	Figure	2.6).	Hair	
was	 removed	 using	 hair	 clippers	 and	 the	 surface	 of	 the	 skin	 was	 washed	 with	
Hibiscrub	 (containing	 4%	 Chlorhexidine	 Gluconate)	 (MediSupplies,	 Poole,	 UK)	 to	
remove	 any	microorganisms	 that	may	 have	 caused	 infections	 in	 subsequent	 tissue	
culture.	 A	 small	 section	 of	 the	 skin	 was	 removed	 and	 dissected	 into	 small	 pieces	
(approximately	 2mm	 x	 2mm)	 using	 a	 scalpel	 and	washed	 in	 HBSS.	 The	 tissue	was	
then	added	to	a	25cm2	tissue	culture	flask	containing	DMEM	(with	phenol	red)	(Life	
Technologies,	 Paisley,	 UK)	 supplemented	with	 100	 units/ml	 penicillin-streptomycin	
(Life	 Technologies,	 Paisley,	 UK),	 0.5μg/ml	 Fungizone®Amphotericin	 B	 (Life	
Technologies,	 Paisley,	 UK),	 10mM	 HEPES	 (Life	 Technologies,	 Paisley,	 UK)	 and	 10%	
FBS.	This	formulation	of	DMEM	culture	medium	used	to	culture	mammalian	cells	 is	
referred	 to	 as	 DMEM	 (complete)	 throughout	 this	 thesis.	 For	 the	 initial	 culture	 of	
equine	 tissue,	DMEM	 (complete)	 contained	 an	 additional	 10ng/ml	 gentamicin	 (Life	
Technologies,	Paisley,	UK).	The	tissue	was	 incubated	 in	humidified	conditions	 in	5%	
CO2	at	37°C	for	5	days	before	changing	the	medium.	Following	this	 incubation	step,	
the	tissue	culture	flask	was	microscopically	checked	on	a	daily	basis	for	the	presence	
of	 adherent	 fibroblasts.	 When	 adherent	 fibroblasts	 were	 observed,	 the	 tissue	
explants	 were	 removed	 and	 fibroblasts	 were	 cultured	 to	 90%	 confluence	 before	
passage.	 Adherent	 cells	 were	 removed	 from	 the	 tissue	 culture	 flask	 using	 0.05%	
Trypsin/EDTA	 (Life	 Technologies,	 Paisley,	UK).	 The	monolayer	was	washed	 twice	 in	
Hanks	 balanced	 salt	 solution	 (HBSS)	 without	 calcium	 and	 magnesium	 (Life	
Technologies,	Paisley,	UK)	before	adding	Trypsin/EDTA	to	the	tissue	culture	flask	(just	
enough	to	coat	the	cells)	and	incubating	at	37°C	for	5	minutes.	Once	lifted	from	the	
flask,	 the	 cells	 were	 centrifuged	 at	 1000	 x	 g	 for	 4	 minutes	 and	 re-suspended	 in	
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DMEM	 (complete).	 Fibroblasts	 from	 three	 donors	 were	 used	 for	 scratch	 assays.	
Equine	 normal	 fibroblasts	 were	 used	 in	 experiments	 between	 passages	 three	 and	
five.		
Equine	granulation	tissue	fibroblasts	(GTFs)	were	obtained	from	chronic	wounds	that	
were	 being	 debrided	 as	 part	 of	 routine	 clinical	 treatment	 to	 remove	 excessive	
granulation	tissue.	This	 involved	sharp	dissection	and	removal	of	granulation	tissue	
raised	 above	 the	 level	 of	 the	 epithelial	 margin.	 The	 debrided	 tissue	 was	 treated	
similarly	to	normal	skin,	as	described	above,	for	fibroblast	isolation.	After	five	days	in	
culture,	 the	 medium	 was	 changed,	 explants	 removed	 and	 GTFs	 were	 cultured	 to	





Figure	 2.6	 Schematic	 representation	 of	 the	 collection	 of	 equine	 tissue	 for	 tissue	
culture.	
Normal	 skin	 from	 the	 lower	 leg	 of	 cadavers	 or	 granulation	 tissue	 from	 chronic	
wounds	 located	on	 the	 lower	 leg	was	obtained	using	a	 scalpel.	Tissue	was	cut	 into	
2mm	 x	 2mm	 pieces	 and	 transferred	 to	 a	 tissue	 culture	 flask	 containing	 DMEM	









FBS,	 100	 units/ml	 penicillin-streptomycin	 (Life	 Technologies,	 Paisley,	 UK),	 0.5μg/ml	
Fungizone®Amphotericin	B	(Life	Technologies,	Paisley,	UK)	and	10mM	HEPES	buffer	
(Life	 Technologies,	 Paisley,	 UK),	 also	 referred	 to	 as	 DMEM	 (complete).	 Cells	 were	





Adult	 human	 epidermal	 keratinocytes	 (HEKs)	 (Life	 Technologies,	 Paisley,	 UK)	 were	
cultured	 in	 EpiLife	 medium	 (Life	 Technologies,	 Paisley,	 UK)	 supplemented	 with	
human	keratinocyte	growth	supplement	(HKGS),	100	units/ml	penicillin-streptomycin	
(Life	 Technologies,	 Paisley,	 UK),	 0.5μg/ml	 Fungizone®Amphotericin	 B	 (Life	
Technologies,	Paisley,	UK).	HEKs	were	cultured	until	80%	confluence	before	passage.	
HEKs	were	used	 to	 create	 the	 epithelial	 layer	 of	 the	 skin	 construct	 and	were	used	





of	 MMP	 sequestration	 by	 a	 variety	 of	 wound	 dressings	 (see	 method	 2.11	 and	
Appendix	II),	the	isolation	and	purification	of	MMP-2	from	equine	normal	fibroblasts	
(NFs)	was	carried	out.	The	isolation	of	NFs	was	carried	out	as	described	earlier	in	this	
chapter	 (see	2.9.1).	NFs	were	cultured	 in	T175	 tissue	culture	 flasks	 for	 the	optimal	
volume	 of	 crude	 MMP-2.	 When	 the	 NFs	 were	 approximately	 90-95%	 confluent,	





0.5μg/ml	 Fungizone®Amphotericin	 B	 and	 10mM	 HEPES	 buffer	 (approximately	 30-
35ml	 in	 a	 T175	 tissue	 culture	 flask)	 and	 incubated	 in	 5%	 CO2	 at	 37°C	 for	 5	 days.	
Following	 incubation,	 the	NF-conditioned	medium	was	collected	and	centrifuged	at	
1000	x	g	for	4	minutes	to	remove	cells.	The	NFs	that	remained	in	the	tissue	culture	




The	 gelatin	 sepharose	 chromatography	 column	 was	 prepared	 by	 placing	 a	 small	
amount	of	glass	wool	in	the	bottom	of	a	20ml	syringe	(without	needle)	before	adding	
5ml	 of	 gelatin	 sepharose	 (GE	Healthcare,	 Little	 Chalfont,	UK)	 to	 the	 surface	 of	 the	
wool.	The	column	was	washed	twice	 in	equilibration	buffer	 (0.05M	Tris	Base,	0.5M	
NaCl2,	0.005M	CaCl2,	0.05%	Brij,	0.02%	sodium	azide,	pH	7.6)	before	adding	the	cell	






collected	 in	 15ml	 centrifuge	 tubes.	 The	 eluted	 MMP-2	 was	 then	 transferred	 to	
dialysis	tubing,	which	was	incubated	in	MMP	dialysis	buffer	(0.05M	Tris	HCl,	0.005M	
CaCl2,	 0.05%	 Brij	 35,	 0.02%	 sodium	 azide,	 pH	 7.6)	 at	 4°C	 overnight.	 Post-dialysis,	
MMP-2	was	stored	 in	aliquots	at	 -20°C	until	needed.	The	gelatin	sepharose	column	
was	washed	 four	 times	 in	 equilibration	 buffer	 (5ml	 each	wash)	 before	 adding	 5ml	










sample	was	 individually	 incubated	with	250µl	of	purified	MMP-2,	 in	a	12-well	plate	














were	 determined	 using	 trypan	 blue	 exclusion	 dye.	 Cells	 were	 cultured	 until	 95%	
confluence	 before	 creating	 a	 scratch	 using	 a	 sterile	 100µl	 pipette	 tip.	 Cells	 were	
washed	 using	 PBS	 to	 remove	 cell	 debris	 caused	 from	 the	 scratch.	 Bacterial-
conditioned	medium,	 both	 PCM	 and	 BCM,	 were	 diluted	 1:1	 with	 DMEM	 (without	
antibiotics).	 Two	millilitres	of	 the	diluted	bacterial-conditioned	medium	was	 added	
per	 well.	 Both	 untreated	 unscratched	 and	 scratched	monolayers	 were	 included	 in	









zymography.	 At	 48	 hours,	 the	 cells	 were	 lysed	 in	 1	 ml	 of	 TriZol	 reagent	 (Life	





















‘scratch	 area’.	 (B)	 The	 scratch	 cell	 monolayer	 was	 imaged	 at	 24-hour	 intervals	 to	
assess	 the	 scratch	area	and	 the	potential	movement	of	 cells	 into	 the	 scratch	area.	








and	 48-hour	 intervals	 were	 opened,	 in	 a	 consecutive	 manner,	 in	 ImageJ.	 These	
images	were	then	stacked	into	one	file	(Image-->Stacks-->Images	to	Stack)	and	then	
converted	 to	 an	 “8-bit”	 image	 before	 saving	 the	 file.	 The	 saved	 file	with	 all	 three	
images	 of	 the	 scratch	 wound	 at	 0,	 24	 and	 48	 hours	 was	 then	 defined	 (Process--
>Sharpen	and	Process-->	Find	Edges)	and	the	threshold	was	adjusted	to	produce	a	
black	 and	white	 image	 (Image-->Adjust-->Threshold),	 which	 allowed	 for	 a	 suitable	
contrast	 between	 cells	 and	 the	 blank	 scratch	 area.	 The	 image	 was	 defined	 again	
(Process-->	Find	Edges)	before	using	the	Wand	(tracing)	tool	to	outline	the	scratch	
area	 (shown	 by	 a	 yellow	 line).	 The	 area	was	 then	measured	 (Analyse-->Measure),	
which	 appeared	 in	 a	 summary	 window.	 Measurements	 of	 the	 scratch	 area	 were	
taken	 of	 0-,	 24-,	 and	 48-hour	 images,	 for	 all	 treatment	 conditions.	Wound	 closure	







The	 cell	 viability	 of	 HEKs	 and	HDFs	was	 quantified	 using	 PrestoBlue™	 Cell	 Viability	
Reagent	Protocol	(Life	Technologies,	Paisley,	UK).	Cells	were	seeded	into	the	wells	of	







medium	was	 then	 removed	and	 a	 scratch	was	 created,	 as	with	 the	 scratch	wound	





PrestoBlue™	 reagent	 was	 then	 added	 to	 each	 well	 (10μl)	 and	 incubated	 for	 30	
minutes	 at	 37°C.	 The	 fluorescence	 of	 each	well	 was	 then	 read	 (excitation	 525nm)	
using	 the	 GloMax®-Multi+	Microplate	Multimode	 Reader	 with	 Instinct®	 (Promega,	
Southhampton,	 UK).	 The	 PrestoBlue™	 reagent	 was	 discarded	 and	 the	 cells	 were	










(Enzyme	Research	 Laboratories,	 Swansea,	UK)	was	diluted	 in	PBS	with	 calcium	and	
magnesium	 to	 a	 concentration	 of	 4	 mg/ml.	 The	 fibrin	 gel	 was	 created	 by	 mixing	
2.1ml	 of	 the	 fibrinogen	 solution	 with	 157μl	 PBS	 and	 265μl	 of	 a	 3	 x	 105	 cells/ml	
suspension	 of	 HDFs.	 Bovine	 thrombin	 was	 diluted	 in	 a	 0.1%	 BSA	 solution	 to	 a	




was	 submersed	 in	 3ml	 of	 DMEM	 containing	 10%	 FBS,	 100	 units/ml	 penicillin-










times	 to	 remove	 traces	 of	 the	 DMEM	 culture	medium	 before	 adding	 the	 HEKs.	 A	
keratinocyte	cell	density	of	1	x	106	cells	was	added	to	the	top	of	the	fibroblast	dermal	
layer	 and	 then	 submerged	 in	 EpiLife	 medium	 (Life	 Technologies,	 Paisley,	 UK)	
containing	HKGS	(Life	Technologies,	Paisley,	UK),	100units/ml	penicillin-streptomycin	
(Life	 Technologies,	 Paisley,	 UK),	 0.5μg/ml	 Fungizone®Amphotericin	 B	 (Life	






(with	 phenol	 red)	 (Life	 Technologies,	 Paisley,	 UK)	 and	 Ham’s	 F12	 medium	 (Life	
Technologies,	 Paisley,	 UK)	 and	 was	 supplemented	 with	 100	 units/ml	 penicillin-
streptomycin	 (Life	 Technologies,	 Paisley,	 UK),	 5μg/ml	 human	 transferrin,	 10ng/ml	
epidermal	growth	factor	(EGF),	200	units/ml	aprotinin,	400ng/ml	hydrocortisone,	1.8	
x	 10-4M	 adenine,	 5μg/ml	 insulin,	 50μg/ml	 L-ascorbic	 acid	 and	 2	 x	 10-7M	 triiodo-L-
thyronine	 sodium	 salt.	 The	 culture	 medium	 was	 changed	 twice	 daily	 for	 10	 days	
before	 transferring	 the	 cell	 culture	 insert	 to	 a	 Deep-Well	 plate	 (BD	 Biosciences,	
Oxford,	UK)	and	adding	3:1	DMEM	and	Ham’s	F12	medium	without	the	addition	of	
antibiotics	and	aprotinin.	The	constructs	were	cultured	for	a	further	4	days	with	daily	










before	 adding	 the	 fibroblast-containing	 solution	 to	 the	 cell	 culture	 insert	 and	
allowing	 for	 the	 solution	 to	 set.	The	cell	 culture	 insert	 containing	 the	 fibroblasts	 in	
the	fibrin	gel	matrix	was	suspended	in	supplemented	DMEM	culture	medium	for	6-7	
days.	The	 fibroblast-fibrin	gel	was	 termed	the	 ‘dermal	 layer’.	The	dermal	 layer	was	
washed	 before	 adding	 human	 epidermal	 keratinocytes	 (HEKs)	 to	 the	 top	 of	 the	









Cells	 in	monolayer	 culture	were	washed	 in	 PBS	 before	 1ml	 of	 TRIzol	 reagent	 (Life	
Technologies,	 Paisley,	 UK)	 was	 added	 to	 each	 6-well	 plate.	 The	 suspension	 was	





dissociation	 of	 the	 nucleoprotein	 complex,	 before	 adding	 200μl	 of	 chloroform	 to	
each	 sample.	 Samples	 were	 vortexed	 and	 incubated	 at	 room	 temperature	 for	 10	
minutes	before	centrifugation	at	12,000	x	g	for	15	minutes	at	4°C.	The	upper,	clear,	
aqueous	 phase	 of	 the	 sample	 was	 transferred	 to	 a	 clean	 centrifuge	 tube,	 being	
careful	not	to	take	up	any	of	the	interphase	layer.	Isopropanol	(500μl)	was	added	to	
each	 sample	 and	 incubated	 at	 room	 temperature	 for	 10	 minutes	 before	
centrifugation	at	12,000	x	g	 for	10	minutes	at	4°C.	One	ml	of	75%	molecular	grade	
ethanol	made	up	with	0.1%	Diethyl	Pyrocarbonate	 (DEPC)	water	was	added	 to	 the	
samples	and	gently	mixed.	The	samples	were	then	transferred	to	a	RNeasy	Mini	spin	
column	and	 collection	 tube,	 part	 of	 the	RNeasy	Mini	 Kit	 (Qiagen,	Manchester,	UK)	
before	 centrifugation	 at	 8000	 x	 g	 for	 15	 seconds.	 The	 flow-through	was	 discarded	
and	350μl	of	Buffer	RW1	was	added	to	the	RNeasy	column	before	centrifugation	for	
15	seconds	at	8000	x	g.	Flow-through	was	discarded	before	adding	10μl	of	DNase	I	
stock	 solution	 (Qiagen,	 Manchester,	 UK)	 and	 70μl	 Buffer	 RDD	 to	 the	 column	
membrane	 and	 incubating	 at	 room	 temperature	 for	 15	 mins.	 Incubation	 was	
followed	 by	 another	 Buffer	 RW1	wash	 step.	 Buffer	 RPE	 (500μl)	 was	 added	 to	 the	









cDNA	 was	 prepared	 by	 adding	 1μg	 of	 RNA	 to	 1μl	 of	 Random	 Primers	 (Promega,	
Southampton,	UK)	which	was	made	up	to	a	volume	of	13.4μl	with	0.1%	DEPC	water.	




Murine	 Leukemia	 Virus	 Reverse	 Transcriptase	 (M-MLV	 RT)	 Buffer	 (Promega,	
Southampton,	UK),	1.25μl	dATP	(10mM)	(Promega,	Southampton,	UK),	1.25μl	dCTP	
(10mM)	(Promega,	Southampton,	UK),	1.25μl	dTTP	(10mM)	(Promega,	Southampton,	
UK),	 1.25μl	 dGTP	 (10mM)	 (Promega,	 Southampton,	 UK),	 0.6μl	 RNasin®	 Plus	 RNase	
Inhibitor	 (Promega,	Southampton,	UK)	and	1μl	M-MLV	RT	(Promega,	Southampton,	
UK)	 to	 each	 sample.	 Samples	 were	 heated	 for	 60	minutes	 at	 37°C,	 followed	 by	 5	





were	 used	 to	 assess	 regulation	 at	 a	 transcriptional	 level.	 The	 housekeeping	 gene	


































was	 performed	 as	 part	 of	 a	 service	 provided	 by	 the	 on-site	 Veterinary	 Pathology	
Department.	 All	 tissue	 samples	 were	 fixed	 in	 10%	 neutral-buffered	 formalin	 for	 a	
minimum	 of	 24	 hours.	 Fixed	 samples	 were	 processed	 in	 a	 series	 of	 ethanol	
dehydration	 steps,	 a	 clearing	 xylene	 step	 to	 displace	 residual	 ethanol	 and	 remove	
fats,	 and	 then	 finally	 infiltrated	 with	 paraffin	 wax.	 Following	 processing,	 samples	
were	 embedded	 in	 paraffin	 wax	 blocks	 and	 sectioned	 (4-6	 micron	 sections)	 onto	
slides.	 Routine	 haematoxylin	 and	 eosin	 stains	were	 performed	on	 all	 specimens.	 A	
Gram	stain	for	normal	and	chronic	equine	tissue	samples	was	performed	to	identify	
any	presence	of	bacteria	within	the	tissue.	
For	 immunohistochemistry	 staining,	 unstained	 sections	 were	 mounted	 onto	 slides	
coated	with	poly-L-lysine.	Sections	were	deparaffinised	in	xylene	for	5	minutes,	three	








200,	 Goat	 anti-rabbit	 MMP-13:	 1	 in	 100)	 was	 added	 to	 the	 slide	 and	 incubated	
overnight	at	4°C	in	a	humidified	chamber.	Excess	primary	antibody	was	removed	and	
the	 slides	 were	 washed	 three	 times	 in	 PBS	 for	 5	 minutes	 each	 wash.	 Diluted	




were	dehydrated	 in	80%	ethanol	 for	one	minute,	95%	ethanol	 for	one	minute	and	






Statistical	 analysis	 of	 data	 from	 the	 non-specific	 protease	 assays,	 scratch	 wound	
assays,	 cell	 viability	 assays,	 quantitative	 RT-PCR	 data	 and	 crystal	 violet	 assays	was	
performed	 using	 Graphpad	 Prism®	 Version	 6.0.	 Specifically,	 data	 from	 the	 non-
specific	protease	assays	and	quantitative	RT-PCR	was	statistically	analysed	using	the	
Kruskal-Wallis	 non-parametric	 analysis	 of	 variants	 (ANOVA)	with	 a	 Dunn’s	multiple	
comparison	 test.	Data	 from	 the	 scratch	wound	assay	 and	 cell	 viability	 assays	were	
assessed	 using	 a	 two-way	 ANOVA	 with	 a	 Tukey’s	 multiple	 comparisons	 test.	 The	































The	 detrimental	 aspects	 of	 bacterial	 infection	 in	 human	 wounds	 have	 long	 been	
recognised	 and	 their	 control	 is	 crucial	 for	wound	management.	 However	 it	 is	 now	
thought	that	the	presence	of	biofilms,	complex	communities	of	microorganisms	that	
reside	 in	 a	 self-synthesised	matrix,	 are	 responsible	 for	 the	development	of	 chronic	
outcomes	 in	 many	 wounds	 in	 humans	 (James	 et	 al.	 2008).	 In	 human	 medicine,	
biofilms	 are	 a	 great	 burden	 on	 healthcare	 establishments	 due	 to	 their	 association	




In	 terms	 of	 veterinary	 medicine,	 biofilms,	 particularly	 in	 the	 context	 of	 chronic	
wounds,	are	greatly	under-researched.	Indeed,	the	development	of	chronic	wounds	
is	 prevalent	 in	 horses.	 Horse	 wounds	 can	 be	 categorised	 as	 either	 surgical	 or	




suggests,	occur	as	a	 result	of	 invasive	surgery.	Both	 traumatic	and	surgical	wounds	
can	 show	 signs	 of	 delayed	 healing	 due	 to	 factors	 such	 as	 ischemia,	 the	 horse’s	
nutritional	state,	wound	pH	and	wound	location	(Westgate	et	al.	2010).	Equine	distal	
limb	 wounds,	 are	 notoriously	 difficult	 to	 heal	 when	 compared	 to	 wounds	 on	 the	
proximal	 limb,	 or	 main	 body,	 which	 has	 been	 described	 in	 ponies.	 This	 is	
predominantly	due	to	a	greater	deal	of	wound	retraction	in	the	limbs	than	the	main	
trunk	of	the	body	(Jacobs	et	al.	1984).	
Due	 to	 the	 nature	 of	 the	 environment	 where	 horses	 reside,	 they	 are	 exposed	 to	
many	 environmental	 pathogens	 and	 therefore	 there	 is	 an	 obvious	 risk	 of	 infection	
Page	97	of	253	
	
and	 biofilm	 formation	 in	 lower	 limb	 wounds,	 potentially	 delaying	 wound	 closure	
further.	However	this	is	yet	to	be	fully	investigated	in	equine	wounds.	Cochrane	and	




2009).	 Westgate	 and	 co-workers	 identified	 Gram-positive	 and	 Gram-negative	
bacterial	aggregates	in	61.5%	(8	of	13)	equine	wounds,	with	the	predominant	species	
in	these	wounds	being	P.	aeruginosa	and	Enterococcus	faecium,	and	Staphylococcus	
being	 the	most	 commonly	 isolated	 genus	 (Westgate	 et	 al.	 2011).	 A	 study	 into	 the	
presence	 of	 biofilms	 on	 the	 surgical	 sutures	 of	 wounds	 in	 cats,	 dogs	 and	 horses,	
identified	 Gram-positive	 biofilms	 using	 staining	 techniques	 and	 microscopy.	
However,	of	the	91	tissue	samples	examined,	only	two	contained	bacterial	colonies	
resembling	 a	 biofilm	 from	 canine	 tissue	 (König	 et	 al.	 2014).	 These	 results	 do	 not	
support	the	findings	of	Westgate	and	colleagues	and	also	in	human	studies,	whereby	
it	was	shown	that	approximately	60%	of	chronic	wounds	contained	a	biofilm	(James	
et	 al.	 2008).	Although	König	and	 colleagues	assessed	 samples	 from	 tissue	 that	had	
been	 categorised	 as	 having	 inflammation,	 it	 is	 still	 unclear	 as	 to	 whether	 this	
presence	of	inflammation	was	in	an	acute	or	chronic	setting.	Whilst	the	identification	
of	 equine	 wound-derived	 biofilms	 has	 been	 achieved	 microscopically	 in	 these	
studies,	the	clinical	assessment	and	diagnosis	of	biofilms	in	equine	wounds	relies	on	




It	 has	 been	 demonstrated	 that	 there	 is	 an	 imbalance	 of	 matrix	 metalloproteases	
(MMPs)	and	their	 inhibitors,	tissue	inhibitors	of	metalloproteases	(TIMPs)	in	human	
chronic	wounds,	 and	wound	 fluid	 has	 shown	 to	 have	 a	 significant	 up-regulation	 in	
MMPs	 (Yager	 et	 al.	 1996).	 A	 similar	 theory	 has	 been	 proposed	 in	 the	 context	 of	
equine	chronic	wounds	(Clutterbuck	et	al.	2010),	although	there	is	a	lack	of	relevant	
research	 studies.	 Nevertheless,	 if	 equine	 chronic	 wounds	 also	 share	 a	 similar	
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dysregulation	 in	 the	 proteolytic	 environment	 of	 the	 wound,	 it	 is	 important	 to	
consider	 the	 contribution	 of	 bacterial	 proteases.	 Indeed,	 bacterial	 proteases	 have	
been	implicated	in	human	pathologies,	including	chronic	lung	infections,	whereby	P.	
aeruginosa	 elastase	 B	 (LasB)	 has	 been	 shown	 to	 degrade	 airway	 mucins,	 an	
important	component	of	the	mucus	barrier	defence	against	microorganisms	(Henke	
et	al.	2011).	In	equine	pathology,	the	Bacillus-derived	metalloprotease,	thermolysin,	








The	 bacterial	 isolates	 used	 in	 this	 chapter	 were	 derived	 from	 equine	 acute	 and	
chronic	 wounds,	 including	 limb	 wounds	 and	 surgical	 wounds	 (see	 Table	 3.1),	 and	
were	isolated	and	identified	as	part	of	a	previous	study	at	the	University	of	Liverpool	
(Westgate	 et	 al.	 2011).	 For	 a	 detailed	 description	 of	 the	 methods	 used	 in	 this	
chapter,	 the	 reader	 is	 directed	 to	 Chapter	 2	 of	 this	 thesis	 (2.3	Microbiology,	 2.3.6	











plate	 format,	whereby	 the	 absorbance	 of	 each	well	was	measured	 at	 several	 time	
points	 over	 a	 72-hour	 period.	 S.	 aureus	 isolates	 followed	 similar	 growth	 curve	
profiles	to	each	other,	with	most	isolates	entering	the	exponential	phase	between	0	




profiles	 to	 each	other,	with	 ‘Ha14’	 and	 ‘Ba19’	 showing	 a	 slightly	 higher	 amount	of	
proliferation	 than	 other	 isolates	 (see	 Figure	 3.1,	 B).	 Most	 of	 the	 P.	 aeruginosa	
isolates	entered	the	exponential	phase	of	growth	between	0	and	12	hours,	however	
both	 ‘Ha14’	 and	 ‘Ba19’	 reached	 20	 hours	 before	 exponential	 growth	 reached	 a	
plateau.	 P.	 aeruginosa	 isolates	 entered	 the	 stationary	 phase	 between	 12	 and	 32	
hours	 respectively,	 before	 a	 decline	 in	 the	 growth	 curves	was	 seen,	 indicating	 cell	
death.	No	growth	was	detected	in	the	DMEM	control	throughout	the	duration	of	the	
experiment	(see	Figure	3.1,	A	and	B).	
The	next	experiment	 tested	 the	ability	of	 each	S.	 aureus	 and	P.	aeruginosa	 clinical	
isolate	 to	 form	 a	 biofilm	 on	 plastic	 pegs	 within	 a	 96-well	 plate,	 as	 described	 in	
Chapter	2	of	this	thesis.	Within	this	experiment,	the	equine	wound-derived	isolates	
were	 cultured	 in	 the	 assay	 for	 72	 hours	 before	 assessing	 biofilm-formation	 on	 the	
pegs.	Crystal	violet	was	used	to	stain	the	biofilms	before	solubilisation,	whereby	the	
denser	 the	 biofilm,	 the	 stronger	 the	 intensity	 of	 the	 dye.	 The	 majority	 of	 P.	
aeruginosa	 isolates	 displayed	 strong	 biofilm	 forming	 potential,	 shown	 by	 the	 high	
absorbance	values	from	the	crystal	violet	staining	(see	Figure	3.2,	A).	Variability	was	
seen	between	P.	aeruginosa	 isolates,	with	 isolates	 such	as	 ‘Ma3’	and	 ‘Mt’	 showing	
relatively	weak	biofilm	formation.	S.	aureus	isolates	showed	particularly	weak	biofilm	
formation	with	 negative	 absorbance	 values	 for	 the	majority	 of	 isolates	 (see	Figure	
3.2,	B).		







however,	 formed	dense	 layers,	with	the	rod-like	morphology	of	 the	bacteria	barely	
visible	on	the	surface	of	the	biofilm.	P.	aeruginosa	appeared	to	be	surrounded	by	a	

















These	 isolates	 were	 obtained	 from	 a	 previous	 study	 held	 at	 the	 University	 of	
Liverpool	by	Westgate	and	colleagues	(Westgate	et	al.	2011).	
	























Figure	 3.1	Growth	 curves	 of	 equine-derived	S.	 aureus	 and	P.	 aeruginosa	over	 72	
hours.	
S.	 aureus	 (n=7)	 (A)	 and	 P.	 aeruginosa	 (n=7)	 (B)	 clinical	 isolates	 were	 individually	
seeded	into	a	96-well	plate	and	incubated	for	72	hours,	whereby	the	absorbance	of	




































































hours	before	being	 stained	with	 crystal	 violet,	 solubilised	and	absorbance	 readings	
recorded	 at	 a	 wavelength	 of	 550nm.	 Mueller	 Hinton	 broth	 (MHB)	 was	 used	 as	 a	
negative	control.	The	experiment	was	repeated	three	times	before	taking	an	average	
of	the	absorbance	values.	Error	bars	represent	standard	deviation.	






































Figure	 3.3	 Scanning	 electron	 microscopy	 (SEM)	 of	 72-hour	 biofilms	 grown	 on	
membrane	filter	discs.	
Images	 represent	S.	 aureus	 ‘Tg’	 at	 x5000	 (A)	 and	 x20,000	 (B)	magnification	 and	P.	
aeruginosa	 ‘Ba19’	 at	 x5000	 (C)	 and	 x12,000	 (D)	 magnification.	 Both	 isolates	 were	
grown	 on	membrane	 filters	 for	 72	 hours	 before	 being	washed	 in	 PBS	 and	 fixed	 in	
2.5%	gluteraldehyde	and	dehydrated	in	ethanol.	Images	were	taken	using	the	Hitachi	








To	 assess	 the	 general	 proteolytic	 activity	 of	 the	 equine-derived	 S.	 aureus	 and	 P.	
aeruginosa	 planktonic-	 and	 biofilm-conditioned	 medium	 (PCM	 and	 BCM),	 the	
substrates	 Azo-casein	 and	 Azocoll	 were	 used.	 The	 Azo-casein	 assay	 revealed	 low	
levels	 of	 proteolytic	 activity	 in	 S.	 aureus	 PCM	 and	 BCM	 (see	 Figure	 3.4).	 No	
differences	 in	proteolytic	activity	were	 recorded	between	S.	aureus	PCM	and	BCM.	
On	 the	 other	 hand,	 both	 P.	 aeruginosa	 PCM	 and	 BCM	 showed	 high	 levels	 of	
proteolytic	 activity,	 with	 P.	 aeruginosa	 PCM	 and	 BCM	 showing	 significantly	 higher	
activity	 than	 S.	 aureus	 PCM	 and	 BCM,	 respectively	 (P	 <0.01	 and	 P	 <0.05).	 No	
differences	 in	 proteolytic	 activity	 were	 recorded	 between	 P.	 aeruginosa	 PCM	 and	
BCM.	Similarly	the	Azocoll	assay	revealed	low	levels	of	activity	in	S.	aureus	PCM	and	
BCM,	 with	 no	 significant	 difference	 between	 PCM	 and	 BCM	 (see	 Figure	 3.5).	 P.	
aeruginosa	PCM	and	BCM	showed	high	levels	of	protease	activity,	with	P.	aeruginosa	
PCM	 showing	 higher	 activity	 than	 S.	 aureus	 PCM	 (P	 <0.01).	 Although	 proteolytic	
activity	 appeared	higher	 in	P.	 aeruginosa	 BCM	 than	S.	 aureus	 BCM,	no	 statistically	
significant	differences	were	determined.	
In	 order	 to	 determine	 whether	 the	 high	 proteolytic	 activity	 seen	 in	 P.	 aeruginosa	
PCM	and	BCM,	was	 in	part,	due	 to	 the	presence	of	metalloproteases,	all	bacterial-







of	 the	major	 groups	 of	 proteases	 this	 52kDa	 protease	 belonged	 to,	 P.	 aeruginosa	
PCM	 was	 run	 on	 several	 gelatin	 zymograms	 and	 either	 incubated	 with	 a	 serine	
protease	inhibitor	(Benzamidine	hydrochloride	hydrate),	a	metalloprotease	inhibitor	
(EDTA)	 or	 a	 cysteine	 protease	 inhibitor	 (N-ethylmaleimide	 or	 NEM).	 The	 use	 of	
100mM	 EDTA	 inhibited	 the	 equine	 fibroblast-derived	 MMP-2	 positive	 control	 but	
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failed	 to	 inhibit	 the	 P.	 aeruginosa-derived	 protease	 bands.	 Furthermore,	 50mM	
Benzamidine	hydrochloride	hydrate	and	10mM	NEM	did	not	have	an	inhibitory	effect	






Data	 from	the	biological	 replicates	were	combined	 in	order	 to	assess	 the	statistical	
difference	 between	 clinical	 S.	 aureus	 (n=7)	 and	 P.	 aeruginosa	 (n=7).	 All	 biological	
replicates	in	the	assay	were	run	in	duplicate.	Error	bars	represent	standard	deviation.	























































Data	 from	the	biological	 replicates	were	combined	 in	order	 to	assess	 the	statistical	
difference	 between	 clinical	 S.	 aureus	 (n=7)	 and	 P.	 aeruginosa	 (n=7).	 All	 biological	
replicates	in	the	assay	were	run	in	duplicate.	Error	bars	represent	standard	deviation.	
Statistical	 analysis	was	performed	using	 the	Kruskal-Wallis	 non-parametric	ANOVA,	
























































aeruginosa	 PCM	 and	 BCM	were	 run	 on	 a	 gelatin	 zymogram	 for	 comparison	 in	 the	
abundance	 of	 the	 protease	 (B).	Molecular	weight	 is	 displayed	 in	 kilodaltons	 (kDa).	
Protease	 activity	 is	 shown	 as	 a	 white	 band	 against	 a	 Coomassie	 blue-stained	
background.	 Experiments	 were	 performed	 using	 all	 biological	 replicates	 of	 P.	
aeruginosa	 (n=	 7)	 and	 were	 repeated	 three	 times.	 Abbreviations	 include	




3.3.3 Identification	 of	 equine-derived	 P.	 aeruginosa	 protease	 using	 mass	
spectrometry	






and	 used	 for	 mass	 spectrometric	 analysis	 (carried	 out	 by	 the	 University	 of	
Manchester).	Data	in	the	form	of	amino	acid	sequences	in	the	protease	sample	were	
entered	 into	 the	Mascot	 search	 engine	 against	 the	 SwissProt	 database	 under	 the	
‘Eubacteria’	 taxonomy	 in	 order	 to	 identify	 potential	 bacterial-derived	proteases.	 In	
this	experiment,	 I	 focused	on	proteins	 identified	by	 the	Mascot	 search	engine	 that	
shared	significant	identity	or	shared	homology	(P	<0.05)	to	the	peptide	sequence	in	
the	protease	 sample.	Therefore,	 although	each	 sample	 received	protein	 ‘hits’,	only	
the	results	that	were	deemed	significant	by	Mascot	were	assessed.	Results	from	the	
Mascot	search	showed	that	all	biological	replicates	of	the	protease	received	at	least	
one	protein	hit,	 however	 the	 results	 for	 each	protease	 sample,	 differed	 from	each	
other	(see	Table	3.2).	The	sample	‘Ca1’	had	four	protein	hits,	however	these	proteins	
were	also	detected	 in	 the	control	 sample.	Protease	samples	 ‘Ba19’	and	 ‘Ma1’	each	
had	one	protein	hit	that	were	not	detected	in	the	control	sample.	The	85kDa	protein	
DNA	translocase	ftsK	was	detected	in	‘Ma1’	and	was	shown	to	be	associated	with	the	
bacterium	 Xanthomonas	 axonopodis	 pv.	 For	 ‘Ba19’,	 a	 35kDa	 protein	 named	 S-
adenosyl-L-methionine-dependent	 methyltransferase	 mraW,	 associated	 with	 the	














biological	 replicates	 (n=3)	 of	 the	 previously	 identified	P.	 aeruginosa	 protease	 sample	 (P	 <0.05).	 For	 the	 control,	MHB	was	 run	on	 a	 gelatin	
zymogram	and	a	sample	of	the	same	molecular	weight	as	the	P.	aeruginosa-derived	protease	was	cut	out	of	the	gel	for	mass	spectrometric	
analysis.		Peptide	sequence	data	was	entered	into	the	Mascot	search	engine	to	identify	proteins	from	the	SwissProt	database	under	Eubacteria	
taxonomy.	 Bacteria	 associated	 with	 the	 identified	 protein,	 according	 to	 the	 Mascot	 search	 is	 listed	 in	 the	 table.	 Peptide	 sequences	 are	
represented	as	one-letter	symbol	amino	acids,	whereby	K=	Lysine,	T=	Threonine,	A=	Alanine,	D=	Aspartic	acid,	N=	Asparagine,	P=	Proline,	R=	











84,992	 KTAAADNPRR	 Ma1	 No	
Protein	nrdI		 Klebsiella	pneumonia	
	
15,387	 LGLPAVR	 Ca1	 	 yes	
Exodeoxyribonuclease	 V	 beta	
chain		
Mycobacterium	tuberculosis	 119,106	 LGLPGLR	 Ca1	 yes	
Lipid-A-disaccharide	synthase		 Ralstonia	solanacearum	
	

















The	 involvement	 of	 bacterial	 proteases	 in	 equine	wounds	 has	 not	 previously	 been	
investigated.	 For	 the	 first	 time,	 this	 study	 identifies	 the	 presence	 of	 proteolytic	
activity	 from	bacteria	 isolated	 from	both	acute	and	chronic	equine	wounds	using	a	
combination	of	basic	enzymatic	assays	and	substrate	zymography.	More	specifically,	
P.	aeruginosa	isolates	were	shown	to	secrete	a	52kDa	protease.	Unfortunately	at	this	
stage	of	 the	 investigations,	 there	 is	no	definitive	answer	as	 to	 the	 identification	of	






weight	of	56kDa	 in	gelatin	and	casein	 zymography	 (Caballero	et	al.	 2001).	Another	
study	 compared	 the	 protease	 profiles	 of	 the	 P.	 aeruginosa	 reference	 strain	 ATCC	
27853	and	 two	clinical	 strains	of	P.	aeruginosa,	which	displayed	different	protease	
profiles	 in	 zymography	 depending	 on	 the	 strain	 and	 growth	 medium	 used.	 More	
specifically,	AprA	was	only	detected	using	gelatin	zymography	in	the	strains	grown	in	
minimal	 M9	 culture	 medium	 but	 not	 Luria-Bertani	 (LB)	 broth,	 with	 a	 molecular	
weight	 of	 52kDa	 (Andrejko	 et	 al.	 2013).	Nevertheless,	many	 studies	 have	 reported	
the	inhibition	of	metalloproteases	and	indeed,	AprA,	with	the	chelator	EDTA,	which	
deactivates	 metalloproteases	 by	 sequestering	 zinc	 ions	 (Caballero	 et	 al.	 2001,	
Twining	et	al.	1993).	However	within	this	chapter,	100mM	EDTA,	failed	to	inhibit	the	
52kDa	 P.	 aeruginosa-derived	 protease,	 despite	 successfully	 inhibiting	 the	 MMP-2	
positive	control.	The	reason	for	this	remains	unknown;	however	there	is	a	possibility	
that	 the	 52kDa	 protease	 secreted	 from	 equine-derived	 P.	 aeruginosa	may	 display	
EDTA	 resistance.	 An	 example	 of	 EDTA	 resistance	 in	 bacterial	metalloproteases	 has	
been	recorded	in	Xenorhabdus,	whereby	it	was	hypothesised	that	the	zinc	ion	within	
the	 metalloproteases	 may	 be	 tightly	 bound,	 making	 the	 protease	 inaccessible	 to	
EDTA	 inhibition	 (Massaoud	 et	 al.	 2011).	 Mass	 spectrometric	 analysis	 of	 the	 P.	
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aeruginosa-derived	 protease	 was	 based	 on	 a	 sample	 that	 was	 extracted	 from	 a	
gelatin	 zymogram.	While	 zymography	works	 in	 the	 same	manner	 as	 an	 SDS-PAGE,	
whereby	the	proteins	of	a	particular	sample	are	separated	through	the	gel	according	
to	 size	 under	 the	 influence	 of	 a	 current,	 a	 zymogram	 contains	 a	 substrate,	 and	
therefore	any	proteases	that	have	been	separated,	effectively	digest	the	substrate	in	






and	 the	 cysteine	 protease	 SspB,	 as	 mentioned	 in	 Chapter	 1	 of	 this	 thesis.	 Other	
studies	 have	 identified	 these	 particular	 S.	 aureus-derived	 extracellular	 proteases	
using	 gelatin	 zymography	 (Shaw	 et	 al.	 2004),	 however	 the	 detection	 of	 these	
proteases	may	be	strain-dependant.	


















one	would	 be	 able	 to	 determine	 how	host	 proteases	 are	 regulated	 in	 response	 to	
these	 external	 stimuli,	 in	 order	 to	 create	 a	more	 complete	 picture	 of	 how	 equine	
tissue	responds	to	bacterial	infection	within	a	wound.	To	then	assess	whether	the	P.	
aeruginosa-derived	 exogenous	 protease	 highlighted	 in	 this	 chapter	 contributes	 to	







high	 levels	 of	 proteolytic	 activity,	 which	 was	 identified	 through	 the	 use	 of	 non-
specific	 protease	 activity	 assays.	P.	 aeruginosa	 in	 planktonic	 and	 biofilm	 form	was	
shown	to	release	a	52kDa	protease,	detected	in	gelatin	zymography,	which	was	not	
inhibited	by	broad	spectrum	protease	inhibitors.	The	subsequent	attempt	to	identify	












Results	 II:	 The	 effect	 of	 equine	 wound-derived	
bacteria	 on	 the	 wound	 closure	 and	 protease	






















In	 the	 aim	 of	 understanding	 how	 biofilms	 prevent	 wound	 closure,	 many	 in	 vivo	
models	 of	 biofilm-infected	 chronic	 wounds	 have	 been	 developed.	 For	 example,	 a	
model	 using	 wounded	 New	 Zealand	 rabbit	 ears	 has	 shown	 sustained	 low	 grade	
inflammation,	 decreased	 granulation	 tissue	 formation	 and	 reduced	 re-
epithelialisation	 in	 the	presence	of	S.	 aureus	 biofilms	 (Gurjala	 et	 al.	 2011).	 Though	
not	 all	 biofilm-infected	 wound	 models	 have	 resulted	 in	 impaired	 wound	 healing.	
Kanno	and	colleagues	infected	full	thickness	wounds	with	P.	aeruginosa	biofilm	in	a	
murine	model.	The	authors	visualised	biofilm	presence	on	the	wounds	at	as	early	as	




of	 the	environment	 that	 the	horse	 resides,	but	also,	wounds	 to	 the	 limb	are	often	
deemed	difficult	to	heal	due	to	the	high	tension	(tightness	of	the	skin)	and	increased	
risk	 of	 infection	 (Jacobs	 et	 al.	 1984).	 Furthermore,	 unlike	 wound	 healing	 in	 the	
mouse,	 which	 predominantly	 relies	 on	 wound	 contraction	 rather	 than	
epithelialisation,	 wound	 healing	 in	 the	 horse	 is	 driven	 more	 by	 epithelialisation,	
drawing	 parallels	 to	 human	 wound	 repair.	 The	 clinical	 characteristics	 of	 equine	
chronic	 wounds	 shares	 similarities	 to	 those	 in	 human,	 with	 frequent	 signs	 of	
persistent	 inflammation	 and	 exudate.	 However	 a	 distinct	 characteristic	 of	 chronic	
wounds	 on	 horse	 limbs	 is	 the	 exuberant	 production	 of	 granulation	 tissue	 that	
requires	 regular	 debridement.	 In	 human	 hard-to-heal	 chronic	 wounds,	 there	 is	 a	
suboptimal	 production	 of	 granulation	 tissue	 in	many	 cases,	 potentially	 due	 to	 the	
high	proteolytic	environment	(Nunan	et	al.	2014).	However	similarities	can	be	drawn	
to	 human	 fibroproliferative	 disorders	 such	 as	 keloids,	 where	 excessive	 scar	 tissue	
formation	 is	 present.	 For	 example,	 Theoret	 and	 colleagues	 using	 histological	




however	 there	were	also	differences	 identified	 in	 inflammatory	cell	 types	between	
these	tissues	(Theoret	et	al.	2013).	Furthermore,	significant	differences	in	fibroblasts	
isolated	 from	normal	healthy	equine	 tissue	and	equine	 chronic	wounds	have	been	
noted.	 Cochrane	 and	 colleagues	 identified	 morphological	 differences	 between	
normal	 fibroblasts	 (NFs)	 and	 chronic	 granulation	 tissue	 fibroblasts	 (GTFs),	whereby	
NFs	 appear	 spindle-like	 and	 GTFs	 were	 spread-out	 and	 cuboidal	 in	 appearance	
(Cochrane	et	al.	1996).	Furthermore,	the	proliferation	rates	of	GTFs	were	determined	
significantly	lower	than	NFs	after	20	day	in	culture	(P	<0.01).		
Host	 proteases	 have	 been	 extensively	 studied	 in	 terms	 of	 their	 role	 in	 the	
mammalian	 wound	 healing	 process.	 Although	 it	 is	 known	 that	 in	 human	 chronic	
wounds,	 there	 is	 an	 imbalance	 in	 matrix	 metalloproteases	 (MMPs)	 and	 their	









biofilm	 within	 an	 open	 wound	 is	 understandable,	 particularly	 considering	 the	
surrounding	 environment	 of	 a	 horse,	 it	 remains	 to	 be	 answered	 whether	 these	
biofilms	 directly	 affect	 wound	 closure.	 Furthermore,	 it	 remains	 unknown	whether	
the	presence	of	 bacterial	 biofilms	within	 the	wound,	 affects	 the	 secretion	of	 host-
derived	 proteases.	 Indeed,	 it	 has	 been	 documented	 that	 bacteria	 and	 the	 purified	
bacterial	 protease	 thermolysin,	 caused	 the	 activation	 of	 host	MMP-2	 and	MMP-9,	






aureus	 and	 P.	 aeruginosa	 planktonic-conditioned	 medium	 (PCM)	 and	 biofilm-
conditioned	medium	(BCM),	and	assess	the	secretion	of	host	proteases	under	these	
experimental	 conditions.	 Furthermore,	 the	 overall	 expression	 of	 MMPs	 in	 equine	
skin	 and	 chronic	 wound-derived	 granulation	 tissue	 was	 investigated	 using	











GTFs)	 in	 response	 to	 P.	 aeruginosa	 and	 S.	 aureus	 planktonic-	 and	 biofilm-
conditioned	medium		
Upon	 culturing	 fibroblasts	 from	 normal	 equine	 skin	 and	 chronic	 wound-derived	
granulation	tissue,	differences	in	cell	morphology	were	identified.	Normal	fibroblasts	
(NFs)	 appeared	 elongated	 and	 spindle-like	 in	 shape,	 whereas	 granulation	 tissue	
fibroblasts	 (GTFs)	 appeared	 cuboidal	 in	 shape	and	 in	 some	cases,	 particularly	 after	
treatment	with	bacterial-conditioned	medium,	appeared	 stellate	 (see	Figure	4.1,	A	
and	B).	
NF’s	 were	 cultured	 and	 seeded	 into	 a	 6-well	 plate	 format	 to	 perform	 an	 in	 vitro	







hours	when	compared	 to	 the	untreated	scratch	control	 (97.4%	±	3.6%)	 (see	Figure	
4.3).	 After	 48	 hours,	 NFs	 treated	 with	 P.	 aeruginosa	 PCM	 and	 BCM	 showed	 a	
significant	 reduction	 in	 percentage	 closure	 (-48.3%	 ±	 40.4%	 and	 -17.8%	 ±	 63.0%)	
when	compared	to	the	control	(78.5%	±	11.4%)	(P	<0.05	and	P	<0.0001	respectively)	
with	 BCM	 causing	 a	 significant	 reduction	 in	 closure	 when	 compared	 with	 PCM	 (P	
<0.0001).	 Furthermore	 a	 significant	 reduction	 in	 closure	 was	 detected	 in	 P.	
aeruginosa	PCM	treated	cultures	in	comparison	with	S.	aureus	PCM	(36.5%	±	14.4%)	
treated	 cultures	 at	 48	 hours	 (P	 <0.0001).	 After	 72	 hours,	 significant	 differences	 in	
percentage	closure	were	still	seen	in	NFs	treated	with	P.	aeruginosa	PCM	and	BCM	(-
64.7%	 ±	 29.2%	 and	 -17.7%	 ±	 63.0%)	 when	 compared	 with	 the	 untreated	 scratch	
control	 (P	 <0.0001).	 Furthermore	 differences	 in	 closure	 were	 noted	 between	 S.	
aureus	 and	 P.	 aeruginosa	 PCM	 (P	 <0.0001),	 S.	 aureus	 and	 P.	 aeruginosa	 BCM	 (P	
<0.0001)	and	P.	aeruginosa	PCM	and	BCM	(P	<0.01).		





hours	 and	 99.5%	±	 0.9%	 closure	 after	 48	 hours	 (see	Figure	 4.4).	 After	 24	 hours	 in	
culture,	 cells	 treated	with	 S.	 aureus	 PCM	 showed	 55.6%	 ±	 11.1%	 closure	 that	was	
significantly	 reduced	when	 compared	 to	 the	untreated	 control	 (P	 <0.05).	S.	 aureus	
BCM-treated	 cells	 showed	 a	 89.0%	 ±	 7.8%	 closure	 after	 24	 hours,	 which	 was	
significantly	higher	than	percentage	wound	closure	in	S.	aureus	PCM-	treated	cells	(P	
<0.0001).	 Furthermore,	 GTFs	 treated	 with	 P.	 aeruginosa	 PCM	 and	 BCM	 showed	
significant	 reduction	 in	 scratch	 closure	 (12.8%	 ±	 8.1%	 and	 37.6%	 ±	 10.3%	
respectively)	when	 compared	with	 the	 control	 (P	 <0.0001)	 and	when	 compared	 to	













the	granulation	tissue	of	equine	chronic	 lower	 limb	wounds	 following	debridement	
for	clinical	purposes.	Skin	and	tissue	samples	were	gently	cleaned	and	cut	into	2mm	x	
2mm	 pieces	 before	 culturing	 the	 tissue	 in	 supplemented	 cell	 culture	 medium.	
Fibroblasts	could	be	visualised	after	5	days	in	culture.	Images	were	taken	at	passage	
























with	 Tukey’s	 multiple	 comparisons	 test.	 Statistical	 significance	 is	 indicated	 as	 *P	
<0.05	and	**P	<0.0001	when	compared	with	the	control	group.	
	
































Figure	 4.4	 Percentage	 scratch	 wound	 closure	 of	 granulation	 tissue	 fibroblasts	
(GTFs)	in	vitro.	
Results	are	shown	for	GTFs	treated	with	either	S.	aureus	or	P.	aeruginosa	planktonic-









S.	 aureus	 and	 P.	 aeruginosa	 planktonic-conditioned	 medium	 (PCM)	 and	
biofilm-conditioned	medium	(BCM)	
In	 order	 to	 determine	 whether	 the	 treatment	 of	 equine	 fibroblasts	 taken	 from	

































BCM,	 conditioned	 medium	 samples	 from	 the	 in	 vitro	 scratch	 assay	 were	 run	 on	
gelatin	 zymograms.	 Controls	 included	 DMEM	 culture	 medium	 alone	 and	 the	
conditioned	medium	from	untreated	scratches.	S.	aureus	and	P.	aeruginosa	PCM	and	
BCM	alone	were	also	 run	on	 the	 zymogram	 to	determine	 the	proteases	 that	were	
bacterial-derived.	 Proteolytic	 bands	 of	 approximately	 80kDa	 and	 60kDa	 were	
detected	in	the	DMEM	and	untreated	NF	and	GTF	scratch	controls	(see	Figure	4.5,	A	
and	Figure	4.6,	A).	 Interestingly,	 the	80kDa	band	was	not	present	 in	P.	aeruginosa	
PCM	and	BCM	alone	and	P.	aeruginosa	PCM-	and	BCM-treated	NFs	and	GTFs.		
The	bacterial-conditioned	medium	used	in	the	NF	scratch	assay	showed	only	a	60kDa	
protease	 band	 (see	 Figure	 4.5,	 A).	 Interestingly,	 the	 conditioned	 medium	 of	 NFs	
treated	with	P.	 aeruginosa	PCM	 showed	 the	 presence	 of	 an	 approximately	 57kDa	
protease	band	at	48	and	72	hours.	The	57kDa	protease	band	was	also	detected	in	the	
conditioned	medium	 of	 NFs	 treated	 with	 P.	 aeruginosa	 BCM	 at	 48	 and	 72	 hours,	
however	an	additional	protease	band	of	approximately	38kDa	was	also	detected	at	
48	 and	 72	 hours	 (see	 Figure	 4.5,	 A).	 To	 see	 whether	 the	 proteolytic	 bands	 were	
metalloproteases,	the	zymograms	were	inhibited	with	EDTA	(see	Figure	4.5,	B).	The	
80kDa,	 60kDa	 and	38kDa	protease	bands	were	 successfully	 inhibited,	 however	 the	
62kDa	protease	present	in	P.	aeruginosa	BCM	alone	and	P.	aeruginosa	BCM-treated	
NF	conditioned	medium	remained	uninhibited	(see	Figure	4.5,	B).	
Zymography	of	P.	 aeruginosa	 PCM	and	BCM	alone,	 used	 in	 the	GTF	 scratch	 assay,	
showed	the	presence	of	a	62kDa	band	but	also	the	presence	of	the	52kDa	bacterial-
derived	 band,	 previously	 identified	 in	 Chapter	 3	 of	 this	 thesis.	 However	 another	
bacterial-derived	band	of	approximately	42kDa	was	present,	as	shown	by	the	red	box	
in	 Figure	 4.6,	A.	 Furthermore,	 upon	 treating	 the	 zymograms	with	 EDTA,	 all	 bands	











were	 run	 on	 gelatin	 zymograms,	 which	 were	 either	 untreated	 (A)	 or	 inhibited	 for	
metalloproteases	 using	 100mM	EDTA	 (B).	 Controls	 include	DMEM	 culture	medium	
alone	 and	 an	 untreated	 scratch	 control.	 The	 red	 arrows	 indicate	 the	 presence	 of	
proteases	that	are	of	interest	and	the	black	arrows	indicate	the	loss	of	protease	band	






Figure	 4.6	 Representative	 zymography	 of	 supernatants	 from	 granulation	 tissue	
fibroblast	 (GTF)	 scratch	 wound	 assay	 following	 P.	 aeruginosa	 PCM	 and	 BCM	
treatment.	
Supernatants	from	P.	aeruginosa	PCM-	and	BCM-treated	cells	after	24	and	48	hours	
were	 run	 on	 gelatin	 zymograms,	 which	 were	 either	 untreated	 (A)	 or	 inhibited	 for	
metalloproteases	 using	 100mM	EDTA	 (B).	 Controls	 include	DMEM	 culture	medium	
alone	and	an	untreated	scratch	control.	The	red	box	indicates	point	of	interest.	The	









and	 eosin	 (H&E)	 to	 reveal	 a	 distinct	 epidermal	 layer	 whereby	 the	 basal	 cell	 layer	
(stratum	basale),	stratum	spinosum	and	the	stratum	coreum	were	easily	identifiable.	
The	dermis	of	the	normal	skin	was	composed	of	a	network	of	collagen	fibres,	which	
could	 be	 seen	 as	 pale	 pink	 using	 H&E	 staining	 or	 blue	 using	 Masson’s	 trichrome	
staining.	Furthermore,	the	dermis	contained	hair	follicles,	shown	by	the	right-facing	
arrows	(see	Figure	4.7),	which	were	seen	as	hollow	circular	structures	surrounded	by	
an	 epithelial	 layer.	 Sebaceous	 glands	 were	 identified	 near	 to	 the	 base	 of	 the	 hair	
follicles	 (see	 Figure	 4.7,	 A	 and	 C).	 Histological	 assessment	 of	 equine	 granulation	
tissue	taken	from	chronic	wounds	showed	a	complete	absence	of	an	epidermal	layer	
at	the	wound	edge	and	a	 large	 inflammatory	cell	 infiltrate,	which	was	 identified	by	
the	 presence	 of	 blue/purple	 nuclei.	 In	 addition,	 there	 appeared	 to	 be	 numerous	
‘pockets’	of	 red	staining	present	 in	 the	granulation	tissue,	which	are	 thought	 to	be	
the	presence	of	red	blood	cells.	Masson’s	trichrome	staining	showed	the	presence	of	
collagen	(pale	blue),	however	the	staining	was	not	as	strong	as	the	collagen	staining	
in	 normal	 skin	 and	 there	 was	 a	 distinct	 lack	 of	 collagen	 fibre	 organisation.	 The	
presence	 of	 hair	 follicles	 and	 sebaceous	 glands	 were	 not	 detected	 in	 granulation	
tissue	(see	Figure	4.7,	B	and	D).		
Normal	 skin	 and	 granulation	 tissue	were	 treated	with	 a	Gram	 stain	 to	 identify	 the	
presence	of	microorganisms	within	the	tissue	(see	Figure	4.8,	B	and	C).	Infected	lung	
tissue	 was	 used	 as	 a	 positive	 control	 (provided	 by	 Veterinary	 histopathology	
laboratory,	 University	 of	 Liverpool),	 clearly	 showing	 clusters	 of	 Gram-positive	
bacteria	 (black)	 (see	Figure	4.8,	A).	 As	 expected,	 the	presence	of	Gram-positive	or	
Gram-negative	 bacteria	was	 not	 detected	 in	 normal	 skin.	 However	 after	 thorough	
microscopic	examination,	the	presence	of	bacteria	in	any	chronic	wound	granulation	








basal	 layer	 and	 epithelium	 surrounding	 the	 hair	 follicles.	 The	 dermal	 layer	 of	 the	
normal	skin	showed	faint	MMP-2	positive	staining	that	was	comparable	in	intensity	
to	 the	 positive-control	 stained	 tissue	 (see	 Figure	 4.9,	A,	C	 and	E).	MMP-2	 staining	




Similarly,	 normal	 skin	 sections	 stained	 with	 an	 MMP-9	 antibody	 showed	 strong	
staining	in	the	basal	cell	layer	and	stratum	spinosum	of	the	epidermal	layer	and	the	
epithelium	 surrounding	 the	 hair	 follicles	 and	 sebaceous	 glands,	 which	 was	
comparable	 to	 the	MMP-9-positive	control.	The	collagen	 fibres	of	 the	dermal	 layer	
were	not	positive	for	MMP-9	and	were	comparable	to	the	MMP-9	negative	control	
(see	 Figure	 4.10,	 A,	 C	 and	 E).	 Chronic	 wound	 granulation	 tissue	 samples	 showed	
MMP-9	 positivity	 ubiquitously	 throughout	 the	 tissue	 when	 compared	 with	 the	




whilst	 MMP-13	 staining	 was	 detected	 throughout	 the	 dermal	 layer,	 particularly	
strong	 staining	 was	 seen	 in	 the	 epithelium	 surrounding	 the	 hair	 follicles	 and	 the	
sebaceous	glands	 (see	Figure	4.11,	A,	C	 and	E).	 In	 chronic	wound	 tissue,	MMP-13-
positive	 staining	was	 ubiquitous	when	 compared	 to	 the	 negatively	 stained	 control	
section,	however	the	intensity	of	staining	was	not	as	strong	as	the	MMP-13-positive	
















For	 a	 positive	 control,	 chronic	 infected	 lung	 tissue	 (A)	was	 used.	 Black	 left-pointing	 arrows	 indicate	Gram-positive	 bacterial	 colonies;	 black	
right-pointing	 arrow	 indicates	 hair	 follicle;	 vertical	 line	 highlights	 the	 epidermal	 layer	 and	 the	 asterisk	 (*)	 indicates	 the	 outer	wound	 edge.	












Figure	4.10	 The	presence	of	matrix	metalloprotease-9	 (MMP-9)	 in	 equine	normal	 skin	 (A	 and	C)	 and	 chronic	wound-derived	 granulation	
tissue	(B	and	D).	
Tissue	from	the	mammary	mass	of	a	cat	was	used	for	MMP-9	positive	control	(E).	Images	(A)	and	(B)	represent	negative	staining	controls.	Black	














One	 of	 the	 aims	 of	 this	 chapter	 was	 to	 assess	 the	 effect	 of	 bacterial-conditioned	
medium,	 in	planktonic	and	biofilm	form,	on	the	wound	healing	of	NFs	and	GTFs,	to	
understand	 the	 potential	 role	 bacteria	 plays	 in	 equine	 wound	 repair.	 A	 study	 by	
Kirker	 and	 colleagues	 showed	 a	 significant	 decrease	 in	 human	 dermal	 fibroblast	
scratch	 closure	when	 treated	with	methicillin-resistant	 S.	 aureus	 (MRSA)	 PCM	 and	
BCM	 (Kirker	 et	 al.	 2012),	 therefore	 it	 was	 expected	 that	 the	 bacterial-conditioned	
medium	 used	 in	 this	 chapter	 would	 also	 reduce	 scratch	 closure	 in	 equine-derived	




In	 this	 chapter,	 it	 appeared	 that	NFs	were	much	more	 sensitive	 to	 treatment	with	
bacterial-conditioned	 medium	 than	 the	 GTFs.	 Furthermore,	 NFs	 took	 72	 hours	 to	
reach	over	95%	scratch	closure,	compared	to	GTFs,	which	were	able	to	achieve	this	
closure	 in	 48	 hours.	 The	 differences	 noted	 between	 the	 effects	 of	 bacterial-
conditioned	 medium,	 particularly	 P.	 aeruginosa	 PCM	 and	 BCM,	 on	 NFs	 and	 GTFs	
could	 indicate	 potential	 differential	 effects	 of	 bacterial	 biofilms	 in	 acute	 wounds,	
where	one	may	expect	the	presence	of	normal	fibroblasts,	and	in	granulating	chronic	
wounds,	 where	 the	 presence	 of	 granulation	 tissue	 fibroblasts	 reside.	 Therefore,	
although	it	 is	thought	that	biofilms	may	lead	to	the	development	of	human	chronic	
wounds	(Bjarnsholt	et	al.	2008),	the	presence	of	biofilms	 in	equine	chronic	wounds	
with	 exuberant	 granulation	 tissue,	 may	 not	 have	 a	 significant	 effect	 on	 fibroblast	
migration	and	viability	in	vivo.		
There	are	a	number	of	studies	that	have	investigated	equine	wound	healing,	utilising	
equine	 limb	 fibroblasts	 (normal	 fibroblasts).	 For	 example	 Rose	 investigated	 the	 in	
vitro	 wound	 closure	 rates	 of	 fibroblasts	 isolated	 from	 equine	 oral	 muscosa	 and	
equine	limb	skin	in	response	to	various	growth	factors	(Rose	2012).	The	author	found	
that	 transforming	 growth	 factor	 beta-1	 (TGF-β1),	 platelet-derived	 growth	 factor	
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(PDGF)	 and	 fibroblast	 growth	 factor-2	 (FGF-2)	 had	 differential	 effects	 on	 limb	
fibroblasts	 and	 oral	 mucosa	 fibroblasts,	 potentially	 providing	 an	 insight	 into	 the	
varying	 clinical	 outcomes	 of	 wounding	 in	 these	 different	 regions.	 In	 the	 study	 by	
Rose,	limb	fibroblasts	showed	complete	wound	closure	in	36	hours,	in	contrast	to	the	
72	 hours	 for	NFs	 in	 this	 chapter,	 however	 this	may	 be	 due	 to	 the	 collagen-coated	
surface	 in	 which	 the	 fibroblasts	 were	 able	 to	 migrate	 across.	 Furthermore,	 the	
method	in	which	the	scratch	was	created	in	this	study	differs	to	the	scratch	made	by	
Rose,	where	a	vacuum	suction	and	a	200μl	pipette	tip	were	used	to	make	a	circular	
wound.	 Another	 study,	 reported	 increased	 equine	 dermal	 fibroblast	 migration	 in	
response	 to	mesenchymal	 stromal	 cell	 conditioned	medium,	 in	 an	 in	 vitro	 scratch	
closure	 model	 (Bussche	 et	 al.	 2015),	 however	 these	 cells	 were	 from	 an	 already	
established	 cell	 line.	 The	 isolation	 and	 characterisation	 of	 fibroblasts	 from	 normal	
skin	 and	 the	 granulation	 tissue	 of	 chronic	 wounds	 have	 been	 performed	 before.	
Cochrane	 and	 colleagues	 assessed	 the	morphology	 and	 proliferation	 rates	 of	 both	
NFs	 and	 GTFs	 and	 subsequently	 found	 that	 GTFs	 appeared	 more	 cuboidal	 in	





of	 the	medium	 taken	at	 varying	 time	points	of	 the	 in	 vitro	 scratch	assays.	 The	aim	
was	 to	 determine	 whether	 equine-derived	 fibroblasts	 from	 normal	 skin	 and	
granulation	tissue	secrete	proteases	in	response	to	the	soluble	products	of	bacteria	
(isolated	from	wounds)	 in	planktonic	and	biofilm	form.	 In	addition	to	the	bacterial-
derived	 proteases	 and	 proteases	 secreted	 by	 the	 fibroblasts	 cultured	 in	 DMEM	
(complete),	 a	 57kDa	 metalloprotease	 was	 secreted	 by	 NFs	 in	 response	 to	 P.	
aeruginosa	PCM	and	BCM,	but	also	a	38kDa	metalloprotease	was	secreted	from	NFs	






have	 the	 same	 molecular	 weight	 when	 run	 on	 a	 gelatin	 zymogram.	 Therefore	
additional	 studies	 whereby	 known	 MMP-3	 and	 MMP-10	 controls	 are	 run	 on	 the	
same	zymograms	would	help	to	confirm	this.		
Interestingly,	no	additional	and	potentially	host-derived	proteases	were	detected	in	
the	 medium	 of	 GTFs	 treated	 with	 bacterial-conditioned	 medium.	 Given	 the	
characteristic	over-production	of	granulation	tissue	in	chronic	wounds,	these	results	
could	 suggest	 a	 potential	 dampening	 in	 the	 secretion	 of	 MMPs	 from	 granulation	
tissue	 fibroblasts	 in	 the	 context	 of	 the	 complex	 environment	 of	 equine	 chronic	
wounds,	 leading	 to	 an	 overproduction	 of	 extracellular	 matrix	 components	 and	 a	
fibroproliferative	 state.	 However	 research	 into	 keloid-derived	 fibroblasts	 in	 human	
has	shown	an	increase	in	the	secretion	of	active	MMP-2	when	compared	to	a	normal	
skin	 dermal-derived	 fibroblasts	 (Imaizumi	 et	 al.	 2009).	 Though	 the	 use	 of	 gelatin	
zymography	alone	does	not	 allow	 the	 identification	of	 all	MMPs,	 therefore	 further	
investigation	 of	 other	 MMPs	 in	 this	 experimental	 setting	 using	 such	 methods	 as	











Therefore	 the	 change	 in	 growth	 medium	 could	 have	 affected	 the	 release	 of	
proteases	 from	 P.	 aeruginosa.	 There	 is	 however,	 the	 matter	 of	 differing	 protease	
profiles	 between	 the	 P.	 aeruginosa-conditioned	 medium	 used	 in	 the	 NF	 and	 GTF	
scratch	assay,	whereby	an	additional	band	of	42kDa	was	detected	in	the	GTF	scratch	
assay.	 Indeed,	fresh	batches	of	bacterial-conditioned	medium	were	used	for	the	NF	







assess	 potential	 differences	 in	 the	 expression	 of	 MMPs	 between	 these	 tissues.	
Furthermore,	 following	 the	 identification	 of	 bacterial	 biofilms	 in	 equine	 chronic	
wounds	(Westgate	et	al.	2011),	I	aimed	to	discover	whether	the	presence	of	bacterial	






means	 of	 cleansing	 or	 scrubbing	 the	 wound	 with	 antimicrobials.	 However	 it	 is	
possible	 that	 treatment	with	antibiotics	could	have	occurred,	which	may	affect	 the	
bioburden	of	the	wound.		
Immunohistochemistry	 showed	 MMP-2	 positive	 staining	 was	 near	 to	 the	 wound	
edge	 of	 the	 granulation	 tissue,	 with	 faint	 staining	 in	 the	 surrounding	 tissue.	 A	
significant	up-regulation	in	the	expression	of	MMP-2,	TIMP-1	and	TIMP-2	mRNA	and	
secreted	 TIMP-1	 in	 keloid	 tissue	 and	 hypertrophic	 scars	 has	 been	 recorded	 in	
humans,	 whereby	 the	 ratio	 of	 MMPs:TIMPs	 is	 reduced	 (Ulrich	 et	 al.	 2010).	
Furthermore,	the	expression	of	MMP-2	has	been	shown	to	be	located	in	the	collagen	
bundles	of	human	keloid	tissue	(Imaizumi	et	al.	2009),	which	may	provide	a	possible	
explanation	 for	 this	 localisation.	 Strong	 MMP-9	 staining	 was	 detected	 evenly	
throughout	equine	granulation	tissue,	which	has	also	been	demonstrated	in	human	
tissue.	MMP-9	plays	a	 role	 in	 keratinocyte	migration	 in	 the	wound	healing	process	
and	has	been	shown	to	be	localised	to	the	epithelium	in	the	oral	mucosa,	but	is	also	




MMP-13	 was	 detected	 ubiquitously	 in	 equine	 chronic	 wound-derived	 granulation	
tissue.	MMP-13	has	been	documented	to	regulate	the	growth	of	granulation	tissue,	
which	 has	 been	 demonstrated	 by	 delayed	 myofibroblast	 organisation	 and	
granulation	 tissue	 growth	 in	 MMP-13-/-	 mice	 (Toriseva	 et	 al.	 2012).	 Furthermore,	
MMP-13	has	also	been	associated	with	pathologies	such	as	equine	laminitis	whereby	





There	are	of	course	 limitations	 to	 this	 study	 for	example;	 the	mechanism	by	which	
wound	closure	 is	achieved	 in	 this	 study	 is	neither	due	 to	migration	or	proliferation	
alone,	 but	more	 likely	 a	 combination	 of	 both.	 Therefore	 the	 term	 ‘migration’	with	
relation	 to	 fibroblast	wound	 closure	 is	 avoided.	 Studies	 such	 as	 those	of	 Rose	 and	
Bussche	 and	 colleagues,	 as	mentioned	 earlier,	 assess	 fibroblast	migration	 in	 the	 in	
vitro	 scratch	 assay	 only	 after	 the	 incorporation	 of	 mitomycin	 C,	 which	 effectively	
inhibits	mitosis,	 eliminating	 proliferation	 as	 a	 source	 for	wound	 closure.	Albeit	 the	
contribution	of	proliferation	towards	wound	closure	 in	these	studies	were	minimal.	
Furthermore,	the	fibroblasts	isolated	from	normal	equine	skin	and	granulation	tissue	




medium	 to	 treat	 fibroblasts	 may	 not	 reflect	 the	 outcomes	 of	 using	 planktonic	 of	
biofilm	 bacteria	 directly	 within	 the	 assay.	 Whilst	 the	 soluble	 products	 of	 bacteria	
within	planktonic	and	biofilm	form	clearly	affect	fibroblast	scratch	closure,	this	assay	
does	not	account	for	direct	interactions	between	host	cells	and	bacteria,	nor	does	it	
account	 for	 the	 effects	 of	 host-derived	 soluble	 products	 on	 bacterial	 secretions,	
particular	 extracellular	 proteases.	 Indeed,	 it	 was	 the	 intention	 to	 incorporate	







The	 use	 of	 zymography	 in	 this	 chapter	 was	 a	 good	 way	 to	 identify	 host-derived	
secreted	proteases,	however	future	work	would	aim	to	use	more	sensitive	methods	
such	 as	 enzyme-linked	 immunosorbent	 assay	 (ELISA)	 to	 quantitatively	 assess	
secreted	 MMPs.	 Furthermore	 the	 use	 of	 reverse	 transcriptase-polymerase	 chain	
reaction	(RT-PCR)	will	aid	the	understanding	of	protease	gene	expression	within	cells	
treated	with	 bacterial-conditioned	medium.	 Unfortunately	 due	 to	 technical	 issues,	
the	 detection	 of	 TIMPs	 from	equine	 fibroblasts	 using	 reverse	 zymography	was	 not	
possible.	 Given	 the	 characteristic	 excessive	 granulation	 tissue	 formation	 seen	 in	




viability	 and	 proliferation	 assays	 such	 as	 PrestoBlue™.	 In	 addition,	 repeating	 these	
studies	on	equine	keratinocytes	may	also	provide	more	information	on	the	effects	of	
bacteria	on	the	re-epithelialisation	of	an	equine	wound.	Advancing	upon	this,	normal	
equine	 skin	 fibroblasts	 and	 equine	 keratinocytes	 could	 be	 used	 to	 create	 a	 3-






caused	 a	 significant	 reduction	 in	 the	 wound	 closure	 of	 NFs	 and	 GTFs	 in	 vitro.	





assessed	 for	 proteases	 using	 gelatin	 zymography.	 The	 conditioned	medium	 of	 NFs	
treated	with	P.	aeruginosa	BCM	contained	57kDa	and	38kDa	metalloproteases	that	
were	 not	 present	 in	 P.	 aeruginosa	 BCM	 alone	 and	 the	 NF	 control	medium.	 There	
appeared	to	be	no	host-derived	proteases	secreted	into	the	conditioned	medium	of	
GTFs	treated	with	bacterial-conditioned	medium.		
Histological	 analysis	of	 chronic	wound-derived	granulation	 tissue	 showed	a	distinct	
lack	of	an	epidermal	layer,	hair	follicles	and	sebaceous	glands	when	compared	with	
normal	equine	skin.	Furthermore,	 there	was	a	 lack	of	collagen	fibre	organisation	 in	
granulation	 tissue.	 Surprisingly,	 the	 presence	 of	 bacterial	 colonies	 in	 granulation	
tissue	samples	was	not	detected.	MMP-9	and	MMP-13	positive	antibody	staining	was	
found	 to	 be	 localised	 in	 the	 epidermis	 and	 the	 epithelial	 cells	 surrounding	 hair	
follicles	 and	 sebaceous	 glands	 in	 normal	 skin,	 whereas	 positive	 staining	 was	
ubiquitous	throughout	the	granulation	tissue.	MMP-2	positive	antibody	staining	was	
localised	to	the	epidermis	 in	normal	skin,	however	whilst	 faint	staining	was	seen	 in	




















































As	 mentioned	 in	 chapter	 1,	 biofilms	 have	 been	 identified	 in	 chronic	 wounds	 of	
humans	 and	 other	 species	 such	 as	 horse	 and	 dog,	 and	 both	 in	 vitro	 and	 in	 vivo	
research	 has	 shown	 that	 the	 presence	 of	 a	 biofilm	 can	 significantly	 delay	 wound	
closure	(Kirker	et	al.	2012,	Gurjala	et	al.	2011)	and	ultimately	retard	wound	healing.	
However,	one	might	question	whether	all	biofilms	are	detrimental	to	wound	healing,	








2013).	However	 the	microorganisms	 that	dominated	sutures	 from	 infected	wounds	
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included	 S.	 epidermidis,	 P.	 aeruginosa,	 methicillin-sensitive	 S.	 aureus	 and	 MRSA.	
Although	 there	was	 a	 significant	 difference	 in	 the	 presence	 of	 biofilms	 in	 infected	
wounds	when	compared	to	uninfected	wounds,	66.6%	of	uninfected	wound-derived	
sutures	were	still	positive	for	biofilms.	Research	by	Thomas	Bjarnsholt	and	colleagues	
in	Denmark	have	 advanced	 the	hypothesis	 that	 it	 is	 the	presence	of	P.	 aeruginosa	
biofilms	 that	 prevents	 a	 chronic	 wound	 from	 healing,	 following	 research	 into	 the	
pathogenic	role	of	P.	aerguinosa	in	cystic	fibrosis	(Bjarnsholt	et	al.	2008).	S.	aureus	is	
another	 microorganism	 that	 poses	 a	 potential	 threat	 to	 wound	 healing,	 as	 it	 is	 a	
microorganism	 that	 can	 reside	 asymptomatically	 on	 the	 skin	 of	 approximately	 one	
third	of	human	beings	(Kluytmans	et	al.	1997).	Staphylococcal	infection	on	indwelling	
medical	 devices	 such	 as	 catheters	 is	 a	 common	problem	 in	 the	 healthcare	 setting.	
The	potential	theory	behind	this	complication	identifies	the	lack	of	vascularisation	at	
implantation	 sites,	 which	 impedes	 host	 defences	 against	 colonisation	 (Kiedrowski	
and	Horswill	2011).		
The	 characteristic	 tissue	 degradation	 often	 seen	 in	 chronic,	 non-healing	 wounds	




the	 gelatinases	 MMP-2	 and	 MMP-9	 in	 chronic	 wound	 fluid,	 has	 been	 a	 common	
finding	in	a	variety	of	non-healing	chronic	wounds	(Nwomeh	et	al.	1999,	Yager	et	al.	
1996,	Wysocki	et	al.	1993).	In	these	studies,	and	indeed	in	many	studies	investigating	
host	 proteases,	 the	 method	 of	 zymography	 is	 used,	 whereby	 a	 substrate	 is	
incorporated	into	a	polyacrylamide	gel	in	order	to	determine	the	molecular	weight	of	
the	protease	that	degrades	that	particular	substrate	within	the	gel.	This	method	of	
protease	 detection	 is	 not	 specific	 to	 mammalian-derived	 proteases	 and	 is	 also	 a	
method	 used	 to	 identify	 many	 bacterial-derived	 proteases	 (Lantz	 and	 Ciborowski	
1994).	Therefore	with	reference	to	these	earlier	studies,	it	is	interesting	to	consider	





Despite	 the	 already	well-documented	 altered	proteolytic	 environment	of	 a	 chronic	
wound	 and	 the	more	 recent	 implications	 of	 bacterial	 biofilms,	 the	 contribution	 of	
bacterial-derived	 extracellular	 proteases	 in	 chronic	 wounds	 has	 been	 poorly	
researched.	One	only	has	to	enter	‘bacterial	proteases	AND	chronic	wounds’	into	the	
PubMed	search	engine	to	reveal	a	mere	43	results,	of	these,	only	2	primary	research	
papers	 specifically	 address	 bacterial	 proteases	 in	 the	 context	 of	 chronic	 wounds	
(Schmidtchen	 et	 al.	 2001,	Wysocki	 et	 al.	 2012).	 These	 studies	 typically	 assess	 the	
proteolytic	 activity	 of	 bacteria	 grown	 in	 a	 planktonic	 or	 ‘free-floating’	 state.	 For	
example,	Wysocki	and	colleagues	assessed	bacterial	gelatinase	activity	using	gelatin-
agarose	 gel	 in	 which	 they	 diluted	 a	 single	 bacterial	 colony	 in	 HEPES	 buffer	 and	
directly	 incubated	with	 the	 gel	 (Wysocki	 et	 al.	 2012).	 There	 is	 currently	 very	 little	
evidence	of	the	proteolytic	activity	of	human	chronic-wound-derived	bacteria	when	
grown	in	a	biofilm	state.	However,	one	study	touched	upon	this	area	with	respect	to	
antimicrobial	 resistance	 and	 bacterial	 virulence,	 when	 questioning	 whether	 P.	
aeruginosa	protease	production	was	affected	after	antibiotic	treatment.	Here	it	was	
found	that	extracellular	proteases	secreted	from	two	burn	wound-derived	strains	of	
P.	 aeruginosa,	 in	 biofilm	 form,	 secreted	 elastase	 B	 (LasB)	 post-ciprofloxacin	
treatment,	although	total	proteolytic	activity	was	reduced	(Ołdak	and	Trafny	2005).	
Given	 the	 increased	 antimicrobial	 resistance	 of	 bacterial	 biofilms,	 this	 research	
highlighted	the	persistence	and	virulence	of	 those	biofilm-derived	cells	 that	remain	
unaffected	by	antimicrobials.	
Given	 that	 some	 of	 the	 most	 commonly	 isolated	 bacteria	 from	 human	 chronic	
wounds	include	S.	aureus	(93.5%)	and	P.	aeruginosa	(52.2%)	(Gjødsbøl	et	al.	2006),	it	
was	the	objective	of	this	chapter	to	assess	the	proteolytic	activity	of	human	chronic	
wound-derived	 P.	 aeruginosa	 and	 S.	 aureus	 in	 both	 planktonic	 and	 biofilm	 states,	
followed	by	 the	 identification	of	 these	proteases.	More	specifically,	 clinical	 isolates	
were	 used	 to	 produce	 planktonic-conditioned	 medium	 (PCM)	 and	 biofilm-
conditioned	medium	(BCM),	which	were	subjected	to	non-specific	proteases	assays	














the	 reader	 is	 directed	 to	 Chapter	 2	 of	 this	 thesis	 (2.3	 Microbiology,	 2.3.6	 Crystal	
Violet	 Biofilm	 Forming	 Assay,	 2.5	 Scanning	 Electron	 microscopy,	 2.6	 Non-specific	








the	 absorbance	 of	 each	well	was	measured	 at	 several	 time	 points	 (every	 4	 hours)	
over	 a	 72-hour	 period.	 Within	 each	 bacterial	 species,	 both	 P.	 aeruginosa	 and	 S.	
aureus	 isolates	 followed	 similar	 growth	 curve	 profiles.	 However	 two	P.	 aeruginosa	
isolates,	 P1139	 and	 P1145,	 showed	 a	 greater	 amount	 of	 proliferation	 when	
compared	to	the	other	P.	aeruginosa	isolates	(see	Figure	5.1,	A).	All	isolates	entered	
the	 exponential	 phase	 between	 0-hours	 and	 4-hours,	 which	 reached	 its	 peak	
between	 8	 and	 12	 hours.	 After	 this,	 growth	 curves	 for	 all	 isolates	 then	 reached	 a	
plateau	(stationary	phase)	that	was	either	maintained	throughout	the	course	of	the	








for	 the	 identification	 of	 biofilm-specific	 morphology	 and	 the	 spatial	 location	 of	
individual	 cells	at	a	high	 resolution	 (Oates	et	al.	2014).	 In	 this	experiment,	biofilms	
were	grown	on	sterile	0.2μm	membrane	filter	discs	for	72	hours.	Upon	washing	the	
biofilms	prior	to	fixation,	it	was	noted	that	a	large	proportion	of	S.	aureus	was	easily	
washed	 away	 from	 the	 membrane	 filter	 and,	 although	 some	 P.	 aeruginosa	 was	
removed	 from	 the	 membrane	 filter	 upon	 washing,	 the	 P.	 aeruginosa	 biofilm	
remained	relatively	intact.	This	observation	was	substantiated	upon	SEM	imaging	of	
the	 biofilms.	 It	 was	 evident	 that	 clinically	 derived	 P.	 aeruginosa	 formed	 a	 dense	
biofilm,	with	P.	aeruginosa	rods	barely	visible	under	what	was	believed	to	be	an	EPS	









absorbance	 values	 (low	 intensity	 of	 stain	 in	 the	 well)	 indicate	 low	 numbers	 of	
adherent	bacterial	cells,	and	thus	poor	biofilm	formation	(see	Figure	5.2,	C).	 In	this	
study,	the	majority	of	clinical	S.	aureus	isolates	showed	low	biofilm	forming	potential	
which	 did	 not	 significantly	 alter	 between	 24,	 48	 and	 72	 hours.	 However	 some	
anomalies	 with	much	 higher	 biofilm	 forming	 potential	 were	 recorded	 such	 as	 the	
clinical	isolates	S1007,	S1010	and	S1070	(see	Figure	5.2,	A).		
Although	 it	 was	 the	 primary	 aim	 of	 this	 chapter	 to	 assess	 differences	 between	
bacterial	 isolates,	 bacterial	 isolates	were	 taken	 from	a	 variety	 of	wounds	 including	
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chronic	and	surgical	wounds	 (see	Table	5.1).	Therefore	 it	 is	 important	 to	note	 that	
there	 appeared	 to	 be	 no	 correlation	 between	 the	 higher	 biofilm	 forming	 potential	
phenotype	and	 the	wound	type.	There	were	no	significant	differences	 in	 the	mean	
absorbance	 values	 between	 S.	 aureus	 biofilms	 at	 24,	 48	 and	 72	 hours.	 Clinical	 P.	
aeruginosa	 isolates	 showed	 varied	 biofilm	 forming	 potential	 and,	 although	 the	
strongest	 biofilm	 forming	 potential	 appeared	 to	 be	 at	 72	 hours,	 variability	 in	

























P.	aeruginosa	 P1006a	 Leg	ulcer	 56	 F	
P.	aeruginosa	 P1007a	 Leg	ulcer	 85	 F	
P.	aeruginosa	 P1097a	 Surgical	wound	 85	 F	
P.	aeruginosa	 P1102a	 Venous	leg	ulcer	 59	 M	
P.	aeruginosa	 P1120a	 Venous	leg	ulcer	 50	 M	
P.	aeruginosa	 P1126a	 Leg	ulcer	 90	 F	
P.	aeruginosa	 P1131a	 Leg	ulcer	 61	 F	
P.	aeruginosa	 P1134a	 Surgical	wound	 76	 F	
P.	aeruginosa	 P1139a	 Leg	ulcer	 78	 F	
P.	aeruginosa	 P1140a	 Leg	ulcer	 65	 M	
P.	aeruginosa	 P1145a	 Foot	ulcer	 69	 F	
P.	aeruginosa	 P1146a	 Venous	leg	ulcer	 66	 F	
P.	aeruginosa	 P1147a	 Leg	ulcer	 79	 F	
P.	aeruginosa	 P1151a	 Leg	ulcer	 93	 F	
P.	aeruginosa	 P1152a	 Foot	ulcer	 66	 M	
	 	 	 	 	
S.	aureus	 S1002a	 Leg	ulcer	 63	 F	
S.	aureus	 S1003a	 Venous	leg	ulcer	 47	 M	
S.	aureus	 S1006a	 Leg	ulcer	 56	 F	
S.	aureus	 S1007c	 Leg	ulcer	 85	 F	
S.	aureus	 S1010a	 Venous	leg	ulcer	 67	 M	
S.	aureus	 S1012a	 Venous	leg	ulcer	 57	 M	
S.	aureus	 S1014a	 Surgical	wound	 54	 M	
S.	aureus	 S1016	 Venous	leg	ulcer	 60	 F	
S.	aureus	 S1019a	 Venous	leg	ulcer	 76	 F	
S.	aureus	 S1030a	 Surgical	wound	 52	 M	
S.	aureus	 S1059a	 Leg	ulcer	 50	 F	
S.	aureus	 S1060a	 Surgical	wound	 75	 M	
S.	aureus	 S1068a	 Venous	leg	ulcer	 49	 M	
S.	aureus	 S1069a	 Foot	ulcer	 38	 M	
S.	aureus	 S1070a	 Leg	ulcer	 39	 F	
S.	aureus	 S1071b	 Leg	ulcer	 65	 M	
S.	aureus	 S1078a	 Surgical	wound	 52	 F	
S.	aureus	 S1087a	 Leg	ulcer	 81	 M	












well	 plate	 and	 incubated	 for	 72	 hours,	 whereby	 the	 absorbance	 of	 each	 well	
containing	the	isolate	was	measured	every	4	hours.	Mueller	Hinton	broth	(MHB)	was	
used	 as	 a	 negative	 (no	 growth)	 control.	 The	 assay	 was	 repeated	 three	 times	
(technical	repeats)	and	the	average	absorbance	values	obtained	and	used	to	plot	the	
growth	curves.	






















































































































































































































hour	 biofilms.	 The	 red	 and	 black	 arrow	 indicates	 strong	 and	weak	 biofilm	 forming	
potential	 respectively.	 Controls	 include	 Mueller	 Hinton	 broth	 (MHB)	 without	








before	 being	 washed	 in	 PBS	 and	 fixed	 in	 2.5%	 gluteraldehyde	 and	 dehydrated	 in	
ethanol.	 Images	 were	 taken	 using	 the	 Hitachi	 TM300	 tabletop	 scanning	 electron	




5.3.2 Proteolytic	 activity	 of	 human	 chronic	 wound-derived	 P.	 aeruginosa	 and	 S.	
aureus	in	planktonic	and	biofilm	form		
The	 assessment	 of	 proteolytic	 activity	 using	 the	 Azo-casein	 assay	 revealed	 a	
significant	difference	in	the	proteolytic	activity	of	P.	aeruginosa	BCM	when	compared	








(see	 Figure	 5.5).	 Although	 the	majority	 of	 P.	 aeruginosa	 BCM	 biological	 replicates	
showed	high	proteolytic	activity,	there	was	still	variability	in	activity	across	biological	
replicates	with	some	isolates	showing	lower	activity	than	expected.		
Traditionally,	 collagen	zymography	 is	used	 to	 identify	collagenases	 such	as	MMP-1,	
MMP-9	 and	MMP-13	 (Snoek	 and	Von	den	Hoff	 2005).	However,	 as	 summarised	 in	






culture	medium	control	 sample	was	 loaded	to	represent	 the	medium	by	which	 the	
biofilm	was	suspended.	The	DMEM	control	sample	showed	faint	proteolytic	bands	of	
approximately	 80kDa	 and	 68kDa.	 Interestingly	 the	 clinical	 P.	 aeruginosa	 BCM	
samples	 showed	 strong	 proteolytic	 bands	 at	 approximately	 62kDa	 and	 52kDa.	 The	
presence	of	the	62kDa	band	was	seen	in	the	majority	of	the	BCM	samples,	however	a	
smaller	 number	 of	 isolates	 expressed	 both	 the	 62kDa	 and	 52kDa	 band	
simultaneously	 (see	 Figure	 5.6),	 highlighting	 the	 variability	 of	 proteolytic	 activity	
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separately	 on	 a	 collagen	 zymogram	 and	 subsequently	 incubated	 with	 broad	
spectrum	 inhibitors	 of	 either	 metallo-,	 serine	 or	 cysteine	 proteases	 (EDTA,	
benzaminide	hydrochloride	hydrate	and	N-ethylmaleimide	(NEM)).	The	treatment	of	
the	 proteolytic	 bands	 with	 EDTA,	 benzamidine	 and	 NEM	 revealed	 that	 the	










Data	 from	the	biological	 replicates	were	combined	 in	order	 to	assess	 the	statistical	
difference	 of	 average	 absorbance	 values	 between	 clinical	 S.	 aureus	 and	 P.	
aeruginosa.	 All	 biological	 replicates	 in	 the	 assay	 were	 run	 in	 duplicate.	 Error	 bars	

























































Data	 from	the	biological	 replicates	were	combined	 in	order	 to	assess	 the	statistical	
difference	 of	 average	 absorbance	 values	 between	 clinical	 S.	 aureus	 and	 P.	
aeruginosa.	 All	 biological	 replicates	 in	 the	 assay	 were	 run	 in	 duplicate.	 Error	 bars	



















































Figure	 5.6	 Collagen	 zymography	 of	 human-derived	 P.	 aeruginosa	 biofilm-
conditioned	medium	(BCM).	
Lanes	3-9	 (A)	 represent	clinical	 isolates	P1006-P1131	and	 lanes	13-20	(B)	 represent	
clinical	isolates	P1134-P1152	(see	Table	5.1	for	reference).	Lanes	1	and	11	represent	
the	 molecular	 weight	 ladder	 (labelled	 in	 kDa).	 Controls	 include	 equine	 fibroblast-









Clinical	 isolate	 P1097	 BCM	 was	 run	 on	 a	 collagen	 zymogram	 before	 cutting	 the	
zymogram	into	sections	containing	the	sample	and	 incubating	 in	either	(A)	Normal,	
untreated	buffer,	(B)	100mM	ethylenediaminetetraacetic	acid	(EDTA)-treated	buffer.	





Precipitation	 is	 a	 commonly	 used	method	 in	 the	 recovery	 of	 biomolecules	 such	 as	
proteins	 from	 complex	 protein	 samples.	 In	 this	 chapter,	 ammonium	 sulfate	 (AS)	
((NH4)2SO4)	precipitation	was	used	 in	 the	attempt	 to	purify	 the	bacterial	 proteases	
detected	 in	 zymography.	AS	precipitation	works	by	 interfering	with	 the	hydrophilic	
amino	acid	region	on	the	protein	and	water,	effectively	reducing	the	solubility	of	the	
protein	and	encouraging	hydrophobic	interactions,	leading	to	the	aggregation	of	the	




For	example,	a	protein	with	relatively	 few	hydrophilic	 regions	will	aggregate	at	 low	
concentrations	of	AS	and	a	protein	with	many	hydrophilic	regions	will	need	a	much	
higher	concentration	of	AS	to	precipitate	from	the	solution	(Scopes	1994).		
In	 order	 to	 investigate	 the	 role	 of	 human	 chronic	 wound-derived	 P.	 aeruginosa	
62kDa	 and	 52kDa	 proteases	 in	 wound	 healing,	 partial	 purification	 of	 BCM	 was	
performed	 using	 AS	 precipitation	 followed	 by	 dialysis	 in	 PBS.	 The	 dialysed	 AS	
fractions	were	 then	 subject	 to	 SDS-PAGE	 and	 zymography	 to	 evaluate	 the	 protein	
and	 enzyme	 profile	 of	 each	 fraction.	 The	 MMP-2	 positive	 control	 showed	 clear	
proteolytic	 bands	 at	 approximately	 68kDa	 and	 58kDa.	 	 However	 no	 bands	 were	
detected	in	SDS-PAGE	(see	Figure	5.8;	A	and	C,	 lane	2).	The	DMEM	culture	medium	
control	showed	a	dense	protein	profile	that	was	particularly	saturated	between	the	





showed	 the	 highest	 protein	 concentrations	 of	 835.1μg/ml	 and	 490.7	 μg/ml	
respectively	(see	Table	5.2).	Furthermore,	in	11	of	12	precipitate	fractions	there	was	
the	 presence	 of	 a	 52kDa	 proteolytic	 band,	 of	 varying	 intensities,	 seen	 in	 collagen	
zymography;	however	it	was	difficult	to	detect	the	presence	of	this	band	using	SDS-
PAGE	 (see	 Figure	 5.8;	 A,	 B,	 C	 and	 D,	 lanes	 4-8	 and	 11-16).	 The	 50%	 and	 55%	
precipitate	 fractions	were	 the	only	 fractions	 containing	both	 the	52kDa	and	62kDa	
proteolytic	 bands	 (see	 Figure	 5.8;	D,	 lanes	 12	 and	 13).	 There	 were	 no	 proteolytic	
bands	evident	in	the	40%	fraction	(see	Figure	5.8;	D,	lane	10).	Following	the	70%	AS	
precipitation	of	 the	BCM,	 the	 remaining	 supernatant	was	 collected	and	 run	on	 the	
SDS-PAGE	gel	and	collagen	zymogram.	It	was	clear	from	zymography	that	the	desired	
proteolytic	bands	were	not	present	in	the	remaining	supernatant	(see	Figure	5.8;	D,	





The	 Azocoll	 assay	 showed	 high	 levels	 of	 protease	 activity	 in	 all	 fractions,	 however	








Table	 5.2	 Multiple	 protein	 fractions	 of	 P1097	 BCM	 using	 ammonium	 sulfate	
precipitation	 and	 the	 subsequent	 protein	 concentration	 of	 the	 dialysed	 protein	
fractions.	
The	 concentration	 of	 protein	 at	 the	 various	 ammonium	 sulfate	 saturation	











11.8	 15	 0.96	 266.8	
11.8	 20	 0.32	 231.2	
11.2	 25	 0.31	 202.1	
10.7	 30	 0.30	 158.4	
10.4	 35	 0.30	 197.3	
9.9	 40	 0.29	 172.8	
9.4	 45	 0.28	 206.8	
9.1	 50	 0.27	 835.1	
8.6	 55	 0.26	 490.7	
8.2	 60	 0.26	 286.0	
8.0	 65	 0.25	 248.7	































































remaining	 supernatant	 following	 AS	 precipitation	 is	 shown	 in	 lane	 17.	 Subsequent	
protease	 assays	of	 the	AS	precipitation	 fractions	 including	 the	Azo-casein	 assay	 (E)	
and	Azocoll	 assay	 (F)	were	performed.	All	 experiments	were	 repeated	 three	 times.	
Error	 bars	 represent	 standard	 error.	 Statistical	 analysis	 was	 performed	 using	 a	























































Bacterial	biofilms	are	a	key	area	of	clinical	 interest	 in	 the	developed	world	and	are	
being	 recognised	 as	 an	 important	 area	 of	 wound	 healing	 research	 by	 large	




aimed	 to	 utilise	 both	 P.	 aeruginosa	 and	 S.	 aureus	 obtained	 from	 human	 chronic	





existing	 evidence	 to	 suggest	 the	 involvement	 of	 bacterial	 intracellular	 proteases	 in	
biofilm	formation.	Marr	and	colleagues	identified	the	gene	encoding	Lon	protease	to	
be	induced	in	P.	aeruginosa	PA01	after	exposure	to	sub-inhibitory	concentrations	of	
the	 antibiotic	 gentamicin.	 Furthermore,	 Lon	 protease	 mutants	 showed	 reduced	
bacterial	 swimming	 and	 twitching,	 two	 factors	 that	 are	 important	 in	 biofilm	
formation	(Marr	et	al.	2007).	Another	more	recent	study	tested	the	biofilm	forming	
potential	 of	P.	 aeruginosa	 that	 housed	mutations	 in	 the	 protease-related	 proteins	
PfpI,	 ClpS,	 and	 ClpP	 and	 subsequently	 found	 up	 to	 a	 70%	 reduction	 in	 biofilm	
formation	when	 compared	 to	 the	wild-type	 (Fernández	 et	 al.	 2012).	 Research	 into	
the	 involvement	 of	 P.	 aeruginosa	 extracellular	 proteases	 in	 biofilm	 formation	 and	
EPS	 production	 has	 been	 documented.	 The	 over-expression	 of	 the	 P.	 aeruginosa	
extracellular	protease	elastase	B	(LasB)	has	been	shown	to	significantly	affect	biofilm	
architecture,	reduce	alginate	concentration,	increase	hydrophobicity	and	viscosity	of	
EPS,	 and	 increase	 swimming,	 swarming	 and	 twitching	 motility	 of	 P.	 aeruginosa	
mucoid	 strains	 (Tielen	 et	 al.	 2010).	 This	 evidence	 supports	 a	 role	 of	 bacterial	
extracellular	proteases	in	biofilm	formation.	Indeed,	the	crystal	violet	assay	showed	
varying	 levels	 of	 biofilm	 forming	 potential	 in	P.	 aeruginosa.	However	 comparisons	
between	 biofilm	 forming	 potential	 and	 proteolytic	 activity	 were	 not	 made	 in	 this	
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study.	 The	 reason	 for	 this	 is	 due	 to	 the	 difference	 in	 biofilm	models	 used	 for	 the	
crystal	 violet	 assay	 (peg-lid	method)	 and	 to	 obtain	 the	BCM	 (grown	on	membrane	





(50kDa)	 respectively	 (Schmidtchen	 et	 al.	 2001).	 In	 addition,	 the	 zymography	
performed	 in	 the	 latter	 paper	 showed	 the	 presence	 of	 a	 faint	 proteolytic	 band	
around	 64kDa;	 however	 the	 authors	 did	 not	 discuss	 this	 result.	 In	 my	 study,	 P.	










an	 artificial	 environment	 and	 the	 thickness	 of	 the	 biofilm	 in	 vitro	 is	 probably	 not	
reflective	 of	 a	 biofilm	 that	 resides	 in	 the	 human	 tissue	 of	 a	 chronic	 wound.	 In	
addition	to	this,	the	proteolytic	activity	that	has	been	documented	in	this	study	may	
differ	 in	 an	 in	 vivo	 setting,	 where	 factors	 such	 as	 nutrient	 availability	 and	 host-
derived	growth	 factors	and	cytokines	may	have	an	effect.	Furthermore,	 in	order	 to	
normalise	the	protease	results	between	PCM	and	BCM,	the	bacterial	cell	numbers	for	
the	preparation	of	PCM	were	diluted	to	similar	bacterial	cell	numbers	of	the	72-hour	
biofilms.	 However	 this	 method	 of	 normalisation	 has	 limitations	 in	 that	 it	 is	 an	





differ.	 The	 bacteria	 for	 PCM	 is	 grown	 for	 24	 hours	 in	 nutrient-rich	 conditions,	
however	the	biofilms	are	grown	for	72	hours	on	the	surface	of	membrane	filter	discs	
with	 potentially	 limited	 nutrients	 from	 the	 agar	 beneath	 due	 to	 the	 0.2μm	 pore	
surface	 of	 the	 filter.	 However,	 it	 has	 been	 documented	 that	 nutrient	 depletion	
encourages	biofilm	 formation	as	a	mechanism	 to	 survive	hostile	environments	and	




In	 this	 study,	 I	have	demonstrated	 that	P.	aeruginosa	 in	biofilm	 form	produce	high	
levels	of	proteases.	This	led	to	the	discovery	of	two	proteolytic	bands	at	52kDa	and	
62kDa	 produced	 by	 some	 of	 the	 isolates.	 Although	 uncertainty	 still	 surrounds	 the	
identification	of	these	bands,	it	would	be	interesting	to	determine	the	effect	of	these	
partially	 purified	 bacterial	 proteases	 on	 wound	 closure,	 in	 order	 to	 determine	
whether	they	may	play	a	role	in	reduced	wound	closure	in	infected	chronic	wounds.	
To	 do	 so,	 initial	 studies	 could	 investigate	 the	 effect	 PCM,	 BCM	 and	 the	 partially	
purified	 bacterial	 proteases	 on	 fibroblast	 and	 keratinocyte	wound	 closure	 in	 an	 in	
vitro	scratch	wound	model.	The	presence	of	MRSA	PCM	and	BCM	on	human	dermal	
fibroblasts	 has	 been	 shown	 to	 reduce	 cellular	 migration	 and	 viability	 in	 vitro.	
Furthermore,	differential	effects	in	MMP	expression	in	human	dermal	fibroblasts	was	
recorded,	 with	MRSA	 PCM	 causing	 an	 increase	 in	MMP-1	 and	MMP-3	 production	
compared	to	MRSA	BCM	(Kirker	et	al.	2012).	Thus,	as	 the	bacterial	 isolates	used	 in	
the	present	study	are	of	chronic	wound	origin	and	not	a	typical	 laboratory	strain,	 it	
would	 be	 interesting	 to	 investigate	 the	 effect	 of	 both	 S.	 aureus	 and	P.	 aeruginosa	
clinical	 isolates,	 in	planktonic	and	biofilm	form	on	the	expression	and	production	of	
host	proteases	in	a	similar	model.	Furthermore,	it	would	be	intriguing	to	determine	
whether	 protease	 expression	 and	 production	 is	 altered	 in	 the	 presence	 of	 the	
partially	 purified	 P.	 aeruginosa-derived	 proteases.	 This	 type	 of	 study	 could	
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In	 summary,	 P.	 aeruginosa	 isolated	 from	 human	 chronic	 wounds	 displayed	 high	
levels	of	proteolytic	activity	when	grown	in	biofilm	form.	However	planktonic	growth	
of	 these	 P.	 aeruginosa	 isolates	 revealed	 little	 or	 no	 proteolytic	 activity.	 Using	
zymographic	analysis,	 two	proteolytic	bands	were	evident	 in	P.	aeruginosa	BCM	at	



















Results	 IV:	 The	 Effect	 of	 S.	 aureus	 and	 P.	
aeruginosa	Planktonic-	and	Biofilm-Conditioned	
Medium	 on	 Human	 Dermal	 Fibroblast	 and	






















the	 inflammatory	phase	of	 the	wound	healing	process	 (Velnar	et	al.	2009).	Chronic	
wounds	such	as	pressure	ulcers,	venous	 leg	ulcers	and	diabetic	 foot	ulcers,	present	
with	 an	 increased	 infiltration	 of	 neutrophils,	 increased	 levels	 of	 pro-inflammatory	
cytokines	and	an	exaggerated	proteolytic	environment.	There	are	known	host	factors	
that	contribute	to	the	development	of	a	chronic	wound,	such	as	 ischemia,	diabetes	
and	 abnormal	 white	 blood	 cell	 function	 (Guo	 and	 DiPietro	 2010).	 However	 it	 has	
been	proposed	that	it	is	not	these	factors	that	prevent	a	wound	from	healing,	rather	
the	 compromised	 immune	 response	 to	 invading	 bacteria,	 which	 are	 then	 able	 to	
form	 a	 biofilm,	 resulting	 in	 persistent	 inflammation	 (Wolcott	 et	 al.	 2008).	 Clinical	
studies	 and	 in	 vivo	 laboratory	 research	have	 shown	 that	 the	presence	of	 a	 biofilm	
may	be	detrimental	 to	 the	wound	healing	process.	 For	example,	 clinical	 studies	by	
Hurlow	 and	 Bowler	 described	 the	 presence	 of	 a	 slimy	 film,	 distinct	 from	 that	 of	
slough,	 in	wounds	showing	delayed	wound	healing	 (Hurlow	and	Bowler	2009).	This	
theory	is	strengthened	by	work	investigating	the	use	of	photodynamic	therapy	(PDT),	
which	 uses	 irradiation	 coupled	 with	 a	 photoactive	 dye	 resulting	 in	 microbial	 cell	
death,	which	resulted	in	improved	wound	healing.	Morley	and	colleagues	showed	a	
significant	reduction	in	bacterial	load	after	PDT	treatment	in	patients	with	chronic	leg	
ulcers	when	 compared	 to	 the	placebo	 controls	 in	 a	phase	 IIa,	 randomised,	blinded	
and	 single	 treatment	 study	 (Morley	 et	 al.	 2013).	 Results	 showed	 complete	wound	
closure	in	50%	of	patients	that	underwent	PDT	when	compared	to	12%	of	patients	on	
placebo.	Animal	studies	such	as	that	of	Gurjala	and	co-workers,	have	shown	that	the	
presence	 of	 S.	 aureus	 biofilms	 in	 wounded	 New	 Zealand	 rabbit	 ears,	 results	 in	





wounds	 could	 potentially	 contribute	 to	 the	 exaggerated	 proteolytic	 environment	
that	has	been	documented	in	chronic	wounds,	given	the	high	extracellular	protease	
production	 from	 chronic	 wound	 isolates	 such	 as	 P.	 aeruginosa	 (see	 Chapter	 5).	
Whether	 the	 presence	 of	 bacterial	 biofilms	 in	 a	 wound	 promotes	 the	 excessive	
release	of	proteases	 from	host	cells,	has	yet	 to	be	determined.	A	study	by	Twining	
and	colleagues	assessed	the	effect	of	P.	aeruginosa	extracellular	proteases,	elastase	
and	 alkaline	 protease	 (AprA)	 on	 the	 secretion	 of	 proteases	 from	 rabbit	 corneas	




of	 the	 P.	 aeruginosa	 virulence	 factor	 exotoxin	 A.	 This	 research	 highlighted	 the	
potential	 interaction	between	host	tissue	and	bacteria	 in	the	release	and	activation	
of	active	proteases	that	can	lead	to	tissue	destruction.	The	effect	of	bacterial	biofilms	
on	 host-protease	 expression	 in	 the	 context	 of	 chronic	 wounds	 has	 not	 been	 fully	
addressed.	 Cell	 types	 such	 as	 dermal	 fibroblasts	 play	 critical	 roles	 in	 all	 aspects	 of	
wound	 repair	 such	 as	wound	 contraction	 and	 extracellular	matrix	 (ECM)	 turnover,	
through	the	production	of	ECM	components	 including	collagen-I	and	the	release	of	
matrix	 metalloproteases	 (MMPs)	 (Bainbridge	 2013).	 Furthermore,	 increases	 in	 the	
expression	of	MMP-2	and	MMP-3	in	fibroblasts	from	human	diabetic	foot	ulcers	has	
been	 documented	 (Wall	 et	 al.	 2003).	 Keratinocytes,	 the	 major	 cell	 type	 in	 the	




derived	 S.	 aureus	 and	 P.	 aeruginosa	 planktonic-conditioned	 medium	 (PCM)	 and	
biofilm-conditioned	medium	 (BCM)	 on	 the	 wound	 closure	 of	 adult	 human	 dermal	
fibroblasts	(HDFs)	and	adult	human	epidermal	keratinocytes	(HEKs).	The	intracellular	
expression	and	extracellular	secretion	of	host-derived	proteases	was	investigated	to	
determine	 whether	 these	 cells	 altered	 the	 secretion	 of	 proteases	 in	 response	 to	
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bacterial-conditioned	 medium.	 This	 chapter	 also	 investigated	 the	 effect	 of	 the	 P.	
aeruginosa-derived	partially	purified	protease,	outlined	in	chapter	5	of	this	thesis,	on	
HDFs	 and	 HEKs	 wound	 closure.	 Finally	 this	 study	 aimed	 to	 assess	 the	 effect	 of	
bacterial-conditioned	medium	on	host	protease	expression	in	a	more	physiologically	
relevant	model,	which	 required	 the	 development	 of	 a	 3-dimensional	 keratinocyte-
fibroblast	 co-culture	 in	 vitro.	 Based	 on	 the	 findings	 in	 previous	 chapters,	 I	














6.3.1 Human	 dermal	 fibroblast	 (HDF)	 scratch	 closure	 and	 cellular	 viability	 in	













ImageJ	 analysis	 of	 the	 scratch	wounds,	 it	 was	 found	 that	within	 24	 hours,	 control	
scratches	 (treated	 with	 DMEM	 complete)	 were	 59.8%	 ±	 13.8%	 closed,	 while	 P.	
aeruginosa	 PCM	 and	 BCM	 were	 49.1%	 ±	 16.8%	 and	 26.6%	 ±	 17.2%	 closed	
respectively,	 with	 P.	 aeruginosa	 BCM-treated	 scratches	 showing	 a	 significant	
reduction	 in	 closure	when	 compared	 to	 control	 and	P.	 aeruginosa	 PCM	 (P	 <0.001)	
(see	Figure	6.2).	After	48	hours,	control	scratches	were	93.7%	±	5.5%	closed,	which	
was	comparable	to	scratches	treated	with	S.	aureus	PCM	that	showed	95.0%	±	6.9%	
closure.	 In	contrast,	 scratches	 treated	with	P.	aeruginosa	BCM	showed	significantly	








treatment	 with	 bacterial-conditioned	 medium,	 no	 significant	 changes	 in	 viability	
between	control	scratches	and	the	treatment	groups	were	recorded.	Similarly,	after	
24	 hours,	 HDFs	 treated	 with	 bacterial-conditioned	 medium	 did	 not	 show	 any	
significant	 reduction	 in	 viability	 when	 compared	 with	 the	 control,	 although	
differences	 between	 treatment	 groups	 were	 recorded.	 There	 was	 a	 significant	
reduction	in	the	viability	of	cells	treated	with	S.	aureus	BCM	when	compared	with	S.	
aureus	 PCM	and	P.	aeruginosa	BCM-treated	cells	 showed	a	 significant	 reduction	 in	
viability	when	compared	to	S.	aureus	BCM	(P	<0.0001).	After	48	hours	of	treatment	
the	viability	of	HDFs	treated	with	S.	aureus	and	P.	aeruginosa	BCM	was	significantly	
lower	 than	 that	 of	 the	 control	 (P	 <0.01	 and	 P	 <0.0001	 respectively),	 with	 P.	


























Figure	 6.2	 Percentage	 scratch	 wound	 closure	 of	 adult	 human	 dermal	 fibroblasts	
(HDFs)	in	vitro.	
Results	are	shown	for	HDFs	treated	with	either	S.	aureus	or	P.	aeruginosa	planktonic-






































aureus	 and	 P.	 aeruginosa	 planktonic-conditoned	 medium	 (PCM)	 and	 biofilm-
conditioned	 medium	 (BCM)	 over	 48	 hours.	 Results	 represent	 the	 mean	 values	 ±	






6.3.2 Secretion	 and	 expression	 of	 adult	 human	 dermal	 fibroblast	 (HDFs)	 matrix	
metalloproteases	 (MMPs)	 in	 response	 to	 P.	 aeruginosa	 and	 S.	 aureus	
planktonic-conditioned	 medium	 (PCM)	 and	 biofilm-conditioned	 medium	
(BCM)	
To	 establish	 whether	 the	 presence	 of	 S.	 aureus	 and	 P.	 aeruginosa	 bacterial-

































scratch	 assay	 at	 24	 and	 48	 hours	 (see	 Figure	 6.4).	 Control	 supernatants,	 including	
DMEM	 culture	 medium	 alone,	 untreated	 no-scratch	 control	 (NSC)	 and	 untreated	
scratch	control,	all	contained	two	proteases	of	approximately	60kDa	and	80kDa	(see	
Figure	 6.4,	 A).	 When	 evaluating	 the	 supernatants	 from	 scratches	 treated	 with	 P.	
aeruginosa	PCM,	zymography	showed	an	increase	in	the	intensity	of	the	60kDa	band	
at	24	hours	and	again	at	48	hours	when	compared	to	the	P.	aeruginosa	PCM	alone.	
Furthermore,	 the	 presence	 of	 the	 80kDa	 protease	 remained	 unchanged	 in	 the	 P.	
aeruginosa	PCM-treated	cell	supernatants.	Supernatants	treated	with	P.	aeruginosa	
BCM	 showed	 the	 presence	 of	 the	 bacterial-derived	 62kDa	 protease,	 which	 was	
identified	 in	 the	 previous	 chapter.	 Interestingly,	 at	 both	 24	 and	 48	 hours	 of	
treatment	 with	 the	 P.	 aeruginosa	 BCM,	 the	 appearance	 of	 an	 additional	 protease	
band	of	approximately	56kDa	was	noted	(see	red	arrow,	Figure	6.4,	A).	Additionally	
the	80kDa	protease	was	not	observed	 in	either	P.	aeruginosa	BCM	alone,	or	 in	 the	
24-	and	48-hour	scratch	supernatants	(see	black	arrow,	Figure	6.4,	A).	To	determine	
whether	 the	 additional	 protease,	 seen	 in	 the	 BCM-treated	 cell	 supernatants,	
belonged	to	the	metalloprotease	group,	the	zymograms	were	inhibited	with	100mM	




uninhibited	 by	 the	 EDTA	 treatment	 and	 was	 therefore	 still	 observed	 on	 the	
zymograms.	The	treatment	of	HDFs	with	S.	aureus	PCM	and	BCM	caused	a	change	in	
the	intensity	of	the	60kDa	band	after	48	hours	in	the	scratch	assay	(see	Figure	6.5).	
Furthermore,	 the	 80kDa	 was	 faint	 but	 present	 in	 all	 samples.	 All	 protease	 bands	
detected	 by	 gelatin	 zymography	were	 completely	 inhibited	 by	 100mM	 EDTA	 (data	
not	 shown).	 The	 presence	 of	 any	 further	 proteases	 within	 the	 supernatant	 of	 S.	
aureus	PCM-	and	BCM-treated	HDFs	were	not	detected.	





treatment	with	bacterial-conditioned	medium	 in	 the	scratch	assay	 (see	Figure	6.6).	
More	specifically,	the	collagenases	MMP-1	and	MMP-13	and	gelatinases	MMP-2	and	
MMP-9	were	 investigated.	 Furthermore,	 expression	 of	 the	major	 substrate	 for	 the	
collagenases	 (and	 also	 the	 gelatinases),	 collagen-I,	 was	 tested.	 The	 validity	 of	 the	
expression	data	for	MMP-9	and	MMP-13	were	considered	unreliable	given	high	delta	
Ct	values	of	approximately	30	(data	not	shown)	and	therefore	were	not	presented	in	




significantly	 higher	 expression	 of	 MMP-1	 in	 cells	 treated	 with	 P.	 aeruginosa	 PCM	
when	 compared	 to	 S.	 aureus	 PCM	 (P	 <0.01)	 was	 found.	 MMP-2	 expression	 in	 all	
treatment	groups	remained	relatively	constant	with	the	untreated	scratch	control.	In	











Figure	 6.4	 Representative	 zymography	 of	 supernatants	 from	 the	 HDFs	 scratch	
wound	assay	following	P.	aeruginosa	PCM	and	BCM	treatment.	
Supernatants	from	P.	aeruginosa	PCM-	and	BCM-treated	cells	after	24	and	48	hours	
were	 run	 on	 gelatin	 zymograms,	 which	 were	 either	 untreated	 (A)	 or	 inhibited	 for	
metalloproteases	 using	 100mM	EDTA	 (B).	 Controls	 include	DMEM	 culture	medium	
alone,	 untreated	 no-scratch	 control	 and	 untreated	 scratch	 control.	 Red	 and	 black	
arrows	represent	points	of	interest,	discussed	in	the	text.	Gelatin	zymography	of	all	
supernatants	from	P.	aeruginosa	PCM-	and	BCM-treated	cells	were	run	and	repeated	




Abbreviations	 include	 Dulbecco’s	 modified	 Eagles	 medium	 (DMEM),	 no-scratch	





Figure	 6.5	 Representative	 zymography	 of	 supernatants	 from	 HDF	 scratch	 wound	
assay	following	S.	aureus	PCM	and	BCM	treatment.	
Supernatants	from	S.	aureus	PCM-	and	BCM-treated	cells	after	48	hours	were	run	on	
gelatin	 zymograms.	 Controls	 include	 DMEM	 culture	 medium	 alone,	 untreated	 no-
scratch	 control	 and	 untreated	 scratch	 control.	 Gelatin	 zymography	 of	 all	
supernatants	 from	 S.	 aureus	 PCM-	 and	 BCM-treated	 cells	 were	 run	 and	 repeated	
twice	 (technical	 replicates,	 n=2).	 The	 molecular	 weight	 is	 in	 kilodaltons	 (kDa).	
Abbreviations	 include	 Dulbecco’s	 modified	 Eagles	 medium	 (DMEM),	 no-scratch	










































































































6.3.3 The	 effect	 of	 P.	 aeruginosa	 and	 S.	 aureus	 planktonic-conditioned	 medium	


















































taken	 at	 0,	 24	 and	 48	 hours	 and	 were	 analysed	 using	 ImageJ	 software.	 After	 24	
hours,	the	untreated	scratch	control	cells	showed	25.4%	±	12.1%	closure,	with	cells	
treated	with	S.	aureus	 PCM	and	BCM	showing	mixed	outcomes	between	biological	




continued	 to	 have	 profound	 effects	 on	 closure	with	 percentage	 values	 of	 29.3%	 ±	
107.7%	 and	 -17.4%	 ±	 85.3%.	 Similarly,	 most	 scratches	 treated	 with	 P.	 aeruginosa	
PCM	and	BCM	resulted	in	cell	detachment,	giving	percentage	closure	values	of	1.9%	
±	99.0%	and	-95.8%	±	53.6%.	There	were	huge	variability	in	these	results;	however,	





the	majority	 of	 cells	 treated	 with	 P.	 aeruginosa-conditioned	medium	 showing	 cell	
death.	 Therefore	 the	 cell	 viability	 of	 untreated	 HEKs	 and	 HEKs	 treated	 with	 the	
bacterial-conditioned	 medium	 were	 assessed.	 Results	 showed	 a	 large	 amount	 of	




the	 untreated	 control.	 After	 24	 hours,	 there	 were	 significant	 reductions	 in	
keratinocyte	viability	upon	treatment	with	S.	aureus	BCM	(P	<0.05)	and	P.	aeruginosa	
BCM	(P	<0.01)	when	compared	to	the	untreated	control.	After	48	hours,	only	HEKs	
treated	 with	 P.	 aeruginosa	 BCM	 showed	 a	 significantly	 lower	 viability	 when	
compared	to	the	untreated	control	(P	<0.05).		
Due	to	the	obvious	cell	death	observed	in	many	of	the	treatment	groups	in	the	HEKs	





Figure	 6.7	 Percentage	 scratch	 wound	 closure	 of	 adult	 human	 epidermal	
keratinocytes	(HEKs)	in	vitro.		
Results	are	shown	for	HEKs	treated	with	either	S.	aureus	or	P.	aeruginosa	planktonic-








































aureus	 and	 P.	 aeruginosa	 planktonic-conditoned	 medium	 (PCM)	 and	 biofilm-
conditioned	 medium	 (BCM)	 over	 48	 hours.	 Results	 represent	 the	 mean	 values	 ±	
standard	 deviation	 (biological	 replicates:	 S.	 aureus	 n=19	 and	 P.	 aeruginosa	 n=15,	
technical	replicates	n=2).	Statistical	analysis	was	performed	using	two-way	analysis	of	
variants	 (ANOVA)	with	 Tukey’s	multiple	 comparisons	 test.	 Statistical	 significance	 is	




6.3.4 The	 scratch	 closure	 and	 cellular	 viability	 of	 adult	 human	 dermal	 fibroblasts	
(HDFs)	 and	 adult	 human	 epidermal	 keratinocytes	 (HEKs)	 in	 response	 to	 P.	
aeruginosa-derived,	partially	purified	proteases	
P.	 aeruginosa	 isolated	 from	 human	 chronic	 wounds	 has	 shown	 high	 levels	 of	
extracellular	 protease	 activity	 and	 secretes	 proteases	 of	 approximately	 52kDa	 and	
62kDa	 (presented	 in	 the	previous	 chapter).	 These	proteases	were	partially	purified	




































and	 there	 was	 a	 significant	 reduction	 in	 viability	 after	 48	 hours	 exposure	 to	 100	
μg/ml	of	the	partially	purified	proteases	(P	<0.01)	(see	Figure	6.10).	Given	that	both	
PCM	 and	 BCM	 of	 both	 S.	 aureus	 and	 P.	 aeruginosa	 had	 a	 greater	 effect	 on	
keratinocyte	 scratch	 wound	 closure	 than	 HDFs	 wound	 closure,	 the	 effect	 of	 the	
partially	 purified	 proteases	 on	 keratinocyte	 scratch	 closure	 was	 tested.	 After	 24	
hours,	a	significant	reduction	in	closure	of	-120.2%	±	103.4	was	seen	after	treatment	
with	100	μg/ml	of	the	partially	purified	proteases	(P	<0.05)	(see	Figure	6.11).	After	48	
hours	 both	 50	 μg/ml	 and	 100	 μg/ml	 of	 the	 partially	 purified	 proteases	 caused	 a	
statistically	significant	reduction	in	closure	of	-112.9%	±	119.7%	and	-151%	±	57.3%	
respectively	 (P	 <0.01).	 Treatment	 with	 the	 partially	 purified	 proteases	 also	 had	 a	
greater	effect	on	 cell	 viability	 in	 the	keratinocytes	 than	 fibroblasts.	After	24	hours,	









Figure	 6.9	 Percentage	 scratch	 wound	 closure	 of	 adult	 human	 dermal	 fibroblasts	
(HDFs)	after	treatment	with	P.	aeruginosa-derived	partially	purified	proteases.	
Results	 represent	 mean	 values	 ±	 standard	 deviation	 (biological	 replicates:	 n=3,	




































treated	 with	 DMEM	 complete.	 Results	 represent	 the	 mean	 values	 ±	 standard	
deviation	(biological	replicates	n=3,	technical	replicates	n=2).Statistical	analysis	was	
performed	 using	 two-way	 analysis	 of	 variants	 (ANOVA)	 with	 Tukey’s	 multiple	






































Figure	 6.11	 Percentage	 scratch	 wound	 closure	 of	 adult	 human	 epidermal	
keratinocytes	 (HEKs)	after	 treatment	with	P.	aeruginosa-derived	partially	purified	
proteases.	




































Figure	 6.12	 Cell	 viability	 of	 adult	 human	 epidermal	 keratinocytes	 (HEKs)	 after	
treatment	 with	 P.	 aeruginosa-derived	 partially	 purified	 proteases,	 using	
PrestoBlue™.	
Results	 show	 two	 treatment	 groups,	where	HEKs	were	 treated	with	 50	 μg/ml	 and	
100	 μg/ml	 P.	 aeruginosa-derived	 protease.	 Results	 represent	 the	 mean	 values	 ±	
standard	 deviation	 (biological	 replicates	 n=3,	 technical	 replicates	 n=2). Statistical	










a	patchy	manner	with	the	majority	of	cells	aggregating	 in	 the	centre	of	 the	dermal	
fibroblast	layer	surface.	In	addition,	it	was	observed	that	a	large	number	of	the	HEKs	
































continued	 to	 be	 cultured	 before	 fixing	 and	 assessing	 the	 preliminary	 model	
histologically.	Haematoxylin	 and	 eosin	 (H&E)	 staining	 revealed	 a	 thick	 keratinocyte	
layer	that	was	dense	in	cell	nuclei	(see	Figure	6.13,	A).	The	dermal	layer	was	faintly	
stained,	with	few	identifiable	fibroblasts	(see	Figure	6.13,	B).	Despite	this,	a	distinct	
layer	 between	 the	 adhered	 keratinocytes	 and	 the	 fibroblast	 dermal	 layer	 was	
observed,	which	was	proposed	to	be	the	formation	of	the	basement	membrane	(see	












Figure	6.13	 Images	of	 a	 3-dimensional	human	epidermal	 keratinocyte	 (HEKs)	 and	
human	dermal	fibroblast	(HDFs)	in	vitro	co-culture	model.	
The	 co-culture	 skin	model	 was	 assessed	 histologically	 using	 the	 haematoxylin	 and	
eosin	 stain.	 The	 co-culture	 model	 contained	 an	 epidermal	 keratinocyte	 layer	 (A),	
fibroblast	 dermal	 layer	 (B)	 and	 basement	membrane	 (C).	 A	 yellow	 arrow	 indicates	















wound	 closure	 and	 cell	 viability.	 My	 study	 identified	 that	 P.	 aeruginosa	 BCM	
significantly	affected	HDF	scratch	closure	and	cell	viability,	whereas	other	treatment	
conditions	 such	 as	S.	 aureus	 PCM	and	BCM	and	P.	 aeruginosa	 PCM	had	 less	 of	 an	
effect.		
Methicillin-resistant	 S.	 aureus	 (MRSA)	 PCM	 and	 BCM	 has	 been	 shown	 to	 cause	 a	
significant	 reduction	 in	 the	 migration	 of	 human	 dermal	 fibroblasts	 (Kirker	 et	 al.	
2012).	 However	 S.	 aureus-conditioned	 medium	 had	 little	 effect	 on	 HDFs	 wound	
closure	 in	 this	 chapter.	A	possible	explanation	 could	be	due	 to	 the	 fact	 that	 the	S.	
aureus	 strains	 used	 in	 this	 chapter	were	methicillin-sensitive	 and	 therefore	 do	 not	
secrete	 the	 same	 soluble	 products	 that	 impede	 fibroblast	 migration.	 Indeed,	
differences	 between	 methicillin-sensitive	 S.	 aureus	 and	 MRSA,	 with	 regards	 to	





When	 repeating	 the	 scratch	 wound	 experiments	 using	 HEKs,	 it	 appeared	 that	 the	
HEKs	 were	 much	 more	 sensitive	 to	 bacterial-conditioned	 medium,	 to	 varying	
degrees,	when	compared	to	the	HDFs.	In	vitro	studies	by	Kirker	and	colleagues	have	
previously	 demonstrated	 the	 detrimental	 properties	 of	 the	 soluble	 products	 of	
chronic	 wound-associated	 bacterial	 PCM	 and	 BCM	 on	 human	 epidermal	
keratinocytes.	 In	 the	 latter	 study,	 they	 found	 that	 the	 presence	 of	 PCM	and	 BCM,	
from	a	single	chronic	wound-derived	S.	aureus	 isolate,	significantly	 reduced	normal	
human	 keratinocyte	 scratch	 closure	 and	 that	 S.	 aureus	 BCM	 significantly	 reduced	
keratinocyte	 viability	 and	 increased	 apoptosis	 when	 compared	 to	 S.	 aureus	 PCM	





in	 mind,	 an	 interesting	 finding	 in	 the	 work	 presented	 in	 this	 thesis	 was	 the	 large	




It	 has	 been	 proposed	 that	 bacterial	 biofilms	 within	 a	 wound	 are	 the	 reason	 for	
increases	 in	 host	 proteases	 and	 therefore	 this	 proteolytic	 activity	 is	 indicative	 of	 a	
biofilm	 (Wolcott	 et	 al.	 2008).	 The	mechanism	 behind	 a	 biofilm-related	 increase	 in	
host	 proteases	 is	 currently	 unknown.	 In	 this	 chapter,	 it	 has	 been	 shown	 that	 P.	
aeruginosa	BCM,	but	not	PCM,	elicits	 the	release	of	a	56kDa	metalloprotease	 from	
dermal	 fibroblasts.	 The	 soluble	 products	 of	 dermal	 fibroblasts	 treated	 with	MRSA	
PCM	and	BCM	was	assessed	for	MMPs,	growth	factors	and	cytokines	using	ELISA	and	




was	 that	 of	 the	 80kDa	 band	 detected	 in	 all	 controls	 and	 the	 P.	 aeruginosa	 PCM-
treated	 supernatants,	 but	 not	 the	 P.	 aeruginosa	 BCM-treated	 supernatants.	 As	
outlined	 previously	 in	 this	 chapter,	 the	 soluble	 products	 of	 P.	 aeruginosa	 can	
effectively	cleave	other	proteases	(Twining	et	al.	1993).	Therefore	it	 is	possible	that	
the	 soluble	 products	 present	 in	 P.	 aeruginosa	 BCM,	 but	 not	 PCM,	 cleaved	 or	
potentially	 degraded	 this	 protease.	 I	 propose	 that	 the	 detection	 of	 the	 56kDa	





EDTA-treated	 zymogram	 (see	 Figure	 6.4,	 B),	 however	 the	 bands	 appeared	 slightly	
faint	 when	 compared	 to	 P.	 aeruginosa	 BCM	 alone,	 which	 may	 indicate	 potential	
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interactions	between	 the	bacterial	protease	and	 the	 soluble	products	of	HDFs	 (see	
Figure	6.4,	A).		
An	 interesting	 finding	 in	 this	 chapter	 was	 the	 effect	 of	 the	 P.	 aeruginosa-derived	
partially	 purified	 proteases	 on	 HDFs	 and	 HEKs.	 This	 protease	 preparation	 using	




Figure	 5.8),	 it	 was	 used	 to	 investigate	 its	 effects	 on	 wound	 closure.	 It	 was	 clear	
throughout	 the	entirety	of	 this	 project	 that	 the	 fibroblasts	were	more	 robust	 than	
the	keratinocytes	in	culture,	therefore	it	is	not	entirely	surprising	that	the	HEKs	were	
more	 sensitive	 to	 the	 partially	 purified	 proteases	 than	 the	 HDFs.	 However	
considering	this,	I	hypothesise	that	these	proteases	released	by	the	biofilm	within	a	
chronic	wound	may	 reduce	 keratinocyte	 viability	 and	prevent	migration	 across	 the	




single	 cell	 type	 may	 regulate	 the	 secretion	 of	 MMPs	 in	 response	 to	 bacterial-
conditioned	medium,	they	simply	do	not	mimic	the	complexity	of	human	skin.	It	has	
been	shown	that	the	assessment	of	wound	healing	in	3-D	fibroblast-keratinocyte	skin	
equivalent	models	 is	 comparable	 to	 that	 of	 wound	 healing	 in	mice	 (Maione	 et	 al.	
2014).	It	was	therefore	an	important	aim	within	this	chapter	to	develop	a	3-D	human	
keratinocyte	 and	 fibroblast	 co-culture	 skin	 model	 that	 would	 serve	 as	 a	 more	
physiologically	relevant	model	compared	to	that	of	single	cell-type	monolayers.	The	
development	 of	 this	 model	 was	 based	 upon	 the	 model	 published	 previously,	
whereby	fibroblasts	were	cultured	in	a	3-D	fibrin	gel	matrix,	followed	by	the	culture	
of	keratinocytes	on	the	surface,	 to	effectively	reproduce	the	epidermal	and	dermal	
layer	 of	 the	 skin	 (Holland	et	 al.	 2008).	Using	 this	model,	 I	 had	planned	 to	 test	 the	




expression	of	MMPs	 in	 the	epidermal	and	dermal	 layers.	A	preliminary	experiment	
developing	 this	 model	 resulted	 in	 a	 particularly	 acellular	 dermal	 layer.	 Therefore,	
further	attempts	were	made	to	increase	the	seeding	density	of	fibroblasts	in	the	3-D	
fibrin	matrix,	which	 resulted	 in	 contraction	 of	 the	 fibrin	 gel	 in	 culture	 (images	 not	




been	 the	 preferred	 scaffold	 of	 choice	 in	 these	 skin	 equivalent	models,	 it	 has	 been	
known	 for	 some	 time	 that	 fibrin	 helps	 to	 promote	 keratinocyte	 migration	 and	
differentiation	 (Geer	 and	 Andreadis	 2003).	 Furthermore	 Holland	 and	 colleagues	
successfully	 cultured	 this	 fibrin-containing	 skin	 equivalent	 for	 subsequent	 testing;	






could	 be	 due	 to	 the	 fact	 that	 the	 PCM	 and	 BCM	 are	 produced	 in	 an	 isolated	
environment	 whereby	 factors	 affecting	 the	 bacterial	 growth	 include	 temperature,	
nutrient	 availability	 and	 oxygen.	 Such	 factors	 such	 as	 host	 cell-derived	 growth	
factors,	cytokines,	and	proteases	are	not	present	 in	this	artificial	 laboratory	setting.	
Therefore	 it	 is	 logical	 to	consider	that	these	factors	may	have	an	 impact	on	biofilm	
growth	 and	 maturity,	 and	 in	 particular,	 the	 release	 of	 soluble	 factors	 such	 as	
extracellular	 bacterial	 proteases	 and	 other	 virulence	 factors.	 It	 was	 indeed	 the	
intention	 of	 this	 particular	 study,	 to	 incorporate	 biofilms	 into	 the	 assay,	 however	
there	was	a	 lack	of	availability	 in	0.2μm	cell	culture	 inserts	 in	 the	UK,	and	shipping	






the	movement	 of	 the	 experiment	 to	 image	 cells	 and	 collect	medium,	 there	was	 a	
high	 rate	of	 contamination	of	 the	culture	medium,	which	caused	cell	death.	 It	was	
also	observed	that	the	biofilm,	once	suspended	on	the	surface	of	the	medium	in	the	
BD	 deep-well	 plate,	 became	 unstable,	 with	 bacteria	 contaminating	 the	 culture	
medium	in	the	well.	Therefore	it	was	decided	to	produce	BCM	without	the	presence	










the	 secreted	 active	 protease,	 is	 more	 appropriate.	 Therefore,	 future	 work	 should	
investigate	 the	 levels	 of	 active	 host-derived	 MMPs	 in	 response	 to	 bacterial-
conditioned	 medium	 in	 a	 more	 quantitative	 manner,	 possibly	 through	 the	 use	 of	




physiologically	 relevant	 to	 study	 bacterial-induced	 protease	 release	 from	
keratinocytes	 and	 fibroblasts	 taken	 from	 human	 chronic	 wounds	 (as	 done	 for	 the	
equine	studies	in	Chapter	4	of	this	thesis).	
An	 important	observation	 in	 the	 results	 obtained	 from	 the	work	performed	 in	 this	






presented	 as	 a	 mean	 of	 the	 biological	 replicates,	 it	 is	 easy	 to	 overlook	 these	
anomalies.	Questions	 do	 arise	 as	 to	why	 the	 secreted	 products	 of	 these	 particular	
strains	 of	 bacteria	 do	 not	 have	 the	 same	 effect	 on	 cells	 as	 the	 majority	 of	 the	
isolates.	Therefore	it	would	be	interesting	to	investigate	the	effect	of	factors	such	as	
the	 host	 wound	 environment	 in	 which	 the	 bacterial	 strain	 was	 isolated	 and	 the	
treatment	strategies	that	were	undertaken	at	the	time	of	isolation,	for	example	the	
use	of	antibiotics.	It	is	possible	that	these	factors	may	play	a	role	in	the	virulence	of	




The	major	 findings	 within	 this	 chapter	 include	 the	 significant	 reduction	 in	 scratch	
wound	 closure	 and	 cell	 viability	 of	 fibroblasts	 after	 treatment	 with	 the	 BCM	 of	
human	chronic	wound-derived	P.	aeruginosa.	Furthermore,	keratinocytes	appeared	
much	 more	 sensitive	 to	 bacterial-conditioned	 medium,	 with	 varying	 effects	 on	
scratch	 closure	 and	 keratinocyte	 viability.	 Zymography	 revealed	 the	 release	 of	 a	
56kDa	metalloprotease	 from	HDFs	 after	P.	 aeruginosa	 BCM	 treatment,	 which	was	
not	 detected	 in	 P.	 aeruginosa	 BCM	 or	 untreated	 fibroblast-conditioned	 medium	
alone.	The	expression	of	fibroblast	MMP-1	and	MMP-2	at	a	transcriptional	level	did	
not	significantly	alter	when	compared	to	the	untreated	control.	However	there	was	a	
significant	 decrease	 in	 the	 expression	 of	 collagen-I	 after	 treatment	 with	 P.	
aeruginosa	BCM.	The	partially	purified	P.	aeruginosa-derived	proteases	did	not	cause	
any	significant	reduction	in	fibroblast	scratch	closure,	however	100μg	of	the	partially	





































The	 cellular	 and	molecular	mechanisms	 of	 physiological	 wound	 healing	 have	 been	
well	 researched,	however	 there	 still	 remains	a	 clear	 lack	of	understanding	 into	 the	
pathological	 mechanisms	 behind	 hard-to-heal	 chronic	 wounds.	 Theories	 exploring	
chronic	wound	pathology	 include	the	 increased	secretion	of	host-derived	proteases	
and	 the	 presence	 of	 bacterial	 biofilms	 within	 the	 wound	 (Bjarnsholt	 et	 al.	 2008,	
Wysocki	et	al.	1993).	There	are	a	plethora	of	advanced	technology	wound	dressings	
and	 techniques	 such	 as	 debridement	 and	 antibiotic	 therapy	 that	 are	 used	 in	 the	
attempt	 to	 control	 wound	 exudate	 and	microbial	 bioburden.	 Despite	 this,	 chronic	
wounds	still	 remain	an	economic	burden	and	health	concern.	Wound	management	
appears	to	adopt	a	‘one-fits-all’	approach,	with	no	clear	strategy	employed	by	health	
organisations.	 One	 reason	 for	 this	 could	 be	 due	 to	 the	 lack	 of	 point-of-care	 tests	
available	 that	may	 help	 decide	 the	 course	 of	 treatment	 for	 individual	 patients.	 In	
order	 to	 address	 this	 issue,	 research	 must	 be	 focussed	 on	 understanding	 the	
dynamics	of	the	chronic	wound.	The	research	in	this	thesis	focuses	on	understanding	




hypothesised	 that	 bacteria	 within	 these	 wounds	 contribute	 to	 an	 exaggerated	
proteolytic	 environment	 through	 the	 secretion	 of	 extracellular	 bacterial	 proteases	
and	that	both	bacteria	(in	planktonic	and	biofilm	form)	and	bacterial	proteases	may	
affect	wound	closure.	Therefore	the	main	objective	of	this	thesis	was	to	evaluate	the	




The	 data	 presented	 in	 this	 thesis	 strongly	 supports	 the	 theory	 that	 bacteria,	





human	chronic	wounds	 (see	Figure	7.1).	 The	 reader	 is	directed	 to	Table	7.1	 for	an	
overview	of	all	bacterial-	and	fibroblast-derived	proteases	identified	in	this	thesis.		
The	 exaggerated	 protease-rich	 environment	 subsequently	 leads	 to	 the	 excessive	
degradation	 of	 extracellular	 matrix	 (ECM)	 components	 and	 potentially	 provides	
additional	 nutrients	 for	 a	 developing	 biofilm.	 Indeed,	 a	 proteomic	 analysis	 of	
catheter-associated	 biofilm	 has	 shown	 the	 release	 of	 P.	 aeruginosa-derived	
proteases,	 which	 are	 not	 only	 thought	 to	 play	 a	 role	 as	 virulence	 factors	 in	 the	
evasion	of	host	immune	responses	but	also	play	a	role	in	nutrient	acquisition	through	
amino	 acid	 metabolism	 (Lassek	 et	 al.	 2015).	 Interesting	 findings	 relating	 to	 this	
concept	 include	 the	 significant	 difference	 in	 protease	 activity	 between	 human-




expressed	 genes	 in	 planktonic	 and	 biofilm	 P.	 aeruginosa	 (Whiteley	 et	 al.	 2001).	 A	
laboratory	 strain	 of	 P.	 aeruginosa	 has	 been	 shown	 to	 secrete	 a	 25kDa	
metalloprotease	 named	Mep72,	which	 is	 only	 secreted	 from	 the	 biofilm	 form	 and	
not	 planktonic	 cells	 (Passmore	 et	 al.	 2015).	 Future	work	 would	 aim	 to	 investigate	
whether	 the	 secretion	 of	 these	 proteases	 are	 linked	 to	 the	 development	 of	 P.	
aeruginosa	 biofilms	 in	 chronic	wounds.	 If	 indeed	 they	are,	 it	may	be	 interesting	 to	
consider	this	mechanism	as	a	therapeutic	target,	possibly	for	the	development	of	a	
diagnostic	point-of-care	test	that	indicates	the	presence	of	a	biofilm	within	a	wound.	
Alternatively,	 this	 protease	 could	 be	 pharmacologically	 targeted	 to	 disrupt	 biofilm	
formation	in	chronic	wounds.		
The	 bacterial-derived	 extracellular	 proteases	 detected	 in	 human-derived	 P.	
aeruginosa	 BCM	 were	 partially	 purified,	 however	 the	 results	 in	 Chapter	 6	 of	 this	
thesis	 show	 that	 these	proteases	did	not	 significantly	 affect	 in-vitro	human	dermal	
fibroblast	 (HDF)	 wound	 closure.	 Although	 the	 bacterial-derived	 proteases	 did	
significantly	reduce	human	epidermal	keratinocyte	(HEK)	wound	closure,	which	may	
suggest	 a	 potential	 role	 for	 bacterial	 proteases	 in	 the	 prevention	 of	 re-
epithelialisation,	these	results	should	be	approached	with	caution.	In	vitro	culture	of	




the	 company	 from	which	 they	were	 purchased.	 Thus,	more	 research	 is	 needed	 to	
elucidate	 the	 effects	 of	 bacterial	 proteases	 on	 keratinocyte	 wound	 closure	 by	
assessing	other	available	keratinocytes	such	as	 that	of	a	neonatal	origin,	which	are	
considered	more	 robust	 in	culture.	 Investigating	 the	 role	of	 this	bacterial	protease,	









extracellular	 bacterial	 proteases.	 Furthermore	 the	 presence	 of	 a	 P.	 aeruginosa	
biofilm	within	the	wound	may	induce	the	release	of	matrix	metalloproteases	(MMPs)	
from	 resident	 dermal	 fibroblasts.	 It	 is	 unknown	 whether	 fibroblast-derived	MMPs	










Abbreviations	 include	 planktonic-conditioned	 medium	 (PCM),	 biofilm-conditioned	
medium	(BCM),	human	(h)	and	equine	(eq).	Error	bars	represent	standard	deviation.	






















































As	mentioned	 previously	within	 this	 thesis,	 the	 study	 of	 equine	 chronic	wounds	 is	
gaining	precedent	due	 to	 the	parallels	 that	 can	be	drawn	 to	human	skin	disorders,	
particularly	 fibroproliferative	 disorders.	 In	 the	 context	 of	 equine	 chronic	 wounds,	
whereby	 exuberant	 granulation	 tissue	 is	 present,	 it	 is	 unclear	 whether	 there	 is	 a	
protease-rich	environment	similar	to	that	diagnosed	in	human	chronic	wounds.	The	
available	 literature	 merely	 draws	 assumptions	 based	 on	 the	 clinical	 findings	 in	
human	 chronic	 wounds.	 Therefore	 it	 must	 be	 acknowledged	 that	 the	 clinical	



















When	 reflecting	 upon	 the	 equine	 and	 human	 data	 as	 a	 whole,	 the	 discovery	 that	
human-derived	 P.	 aeruginosa	 in	 planktonic	 form	 produce	 low	 levels	 of	 protease	
activity	 was	 indeed	 a	 surprise,	 considering	 the	 high	 levels	 secreted	 by	 planktonic	
equine-derived	P.	aeruginosa	(see	Figure	7.2).	Whilst	variations	in	proteolytic	activity	
between	varying	strains	 is	 to	be	expected,	 it	still	unearths	the	question	of	whether	
there	 is	 a	 relationship	between	 the	 environment	 from	which	 the	 isolate	originates	
and	 its	 protease	 activity.	 Horses	 are	 exposed	 to	 a	 plethora	 of	 environmental	
microbes,	 which	 may	 have	 an	 effect	 on	 the	 protease	 profile	 of	 these	 individual	
isolates.	 Very	 few	 studies	 have	 addressed	 this	 issue	 of	mixed	 species	 biofilms	 and	
how	the	bacterial	secretome	differs	within	this	environment.	One	study	by	Purschke	
and	 colleagues	 identified	 a	 uniquely	 expressed	 collection	 of	 proteins	 specific	 to	P.	
aeruginosa	 and	Candida	albicans	 in	 a	mixed	 species	biofilm	 (Purschke	et	 al.	 2012).	
More	specifically,	they	determined	that	the	bacterial	secretome	was	less	diverse	in	a	
mixed-species	 biofilm,	 however	 P.	 aeruginosa-derived	 proteins	 relating	 to	 iron-
acquisition	(a	process	that	is	thought	to	be	necessary	for	biofilm	formation),	such	as	
pyoverdine,	was	significantly	increased	in	mixed-species	biofilms.	Interestingly,	mass	
spectrometry	 results	also	 showed	a	decrease	 in	detected	P.	aeruginosa	AprA,	 LasA	
and	LasB	proteases	 in	mixed-species	biofilms	(Purschke	et	al.	2012).	 Indeed,	one	of	
the	 limitations	 of	 the	 research	 within	 this	 thesis	 is	 the	 determination	 of	 the	
proteolytic	 activity	 of	 the	 bacterial	 isolates	 in	 an	 artificial	 environment,	 whereby	






Similarities	 in	 the	proteases	detected	 in	equine-	and	human-derived	P.	aeruginosa-
conditioned	medium	and	the	medium	from	P.	aeruginosa-treated	fibroblasts	can	be	
seen	 (see	 Table	 7.1).	 Both	 equine-	 and	 human-derived	 P.	 aeruginosa	 secreted	 a	
62kDa	 and	 52kDa	 proteases	 (respectively	 with	 variation	 between	 biological	
replicates).	Furthermore	it	can	be	argued	that	equine	and	human	fibroblasts	secrete	
the	same	protease	in	response	to	the	P.	aeruginosa	biofilm,	with	proteases	of	57kDa	
and	 56kDa	 detected,	 respectively.	 A	 notable	 observation	 in	 the	 detection	 of	 both	
equine-	 and	 human-derived	 bacterial	 proteases	 was	 the	 resistance	 of	 these	
proteases	 to	 broad-spectrum	 inhibitors.	 Unfortunately	 due	 to	 this	 and	 a	 lack	 of	
conclusive	 mass	 spectrometry	 data	 (Chapter	 3),	 it	 was	 difficult	 to	 determine	 the	
identification	 of	 these	 proteases.	 Nevertheless,	 if	 the	 inhibition	 of	 extracellular	




To	 conclude,	 the	 role	of	P.	 aeruginosa	 biofilms	and	 their	 extracellular	proteases	 in	
equine	chronic	wound	pathology	remains	undetermined.	Whilst	this	is	the	first	study	
to	 demonstrate	 high	 levels	 of	 extracellular	 proteases	 in	 the	 planktonic	 and	biofilm	
forms	 of	 equine-derived	 P.	 aeruginosa,	 it	 is	 difficult	 to	 relate	 the	 clinical	
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Figure	 I	 A	 Protease	 activity	 of	 equine	 chronic	 wound-derived	 P.	 aeruginosa	 using	
milk-casein	agar.	P.	aeruginosa	planktonic-conditioned	medium	(PCM)	was	added	to	
milk-casein	agar	and	 incubated	at	37°C.	Zones	of	clearance	 in	milk-casein	agar	was	





































Since	 the	 identification	 of	 elevated	 proteases	 in	 chronic	 wounds	 (Wysocki	 et	 al.	
1993),	wound	care	has	been	directed	toward	the	management	of	excessive	chronic	
wound	fluid	 in	order	 to	control	 the	destructive	action	of	potential	 tissue-degrading	
MMPs.	 For	 instance,	 diagnostic	 tools	 such	 as	 WOUNDCHEK™	 Protease	 status	
(WOUNDCHEK™	 Laboratories,	 UK),	 a	 novel	 point	 of	 care	 test	 to	 detect	 elevated	
protease	 activity	 in	 hard-to-heal	 chronic	 wounds,	 has	 been	 developed	 to	 create	 a	
more	 targeted	 approach	 to	wound	management.	 	 Furthermore,	 a	 range	 of	wound	
dressings	 with	 high-absorption	 qualities	 are	 used	 to	 control	 MMP-rich	 wound	
exudate.	 As	 mentioned	 in	 Chapter	 1	 of	 this	 thesis,	 materials	 such	 as	 alginates,	
hydrofiber,	 foam,	 hydrogel	 and	 hydrocolloid,	 all	 possess	 absorptive	 properties	 and	
are	 commonly	 used	materials	 for	 wound	 dressings.	 Dressings	 incorporated	 with	 a	
substrate	 such	 as	 collagen,	 have	 also	 been	 designed	 to	 provide	 an	 additional	
substrate	for	excess	MMP’s,	as	well	as	for	bacterial	collagenases	that	have	also	been	
detected	within	wounds	(Metzmacher	et	al.	2007).	In	addition	there	has	been	much	
attention	 surrounding	 biofilms	 and	 chronic	 wound	 pathology	 and	 subsequently,	
wound	 care	 companies	 have	 developed	 wound	 care	 products	 with	 not	 only	 high	
absorptive	properties,	but	also	antimicrobial	 technology.	A	good	example	of	 this	 is	
wound	 dressings	 incorporated	 with	 silver,	 which	 have	 been	 shown	 to	 reduce	
bacterial	numbers	in	chronic	wound-associated	bacteria,	with	a	low	risk	of	microbial	
silver	 resistance	 (Percival	 et	 al.	 2007,	 Percival	 et	 al.	 2008).	 The	 use	 of	 silver	
nanoparticle	 technology	 is	 also	 being	 investigated	 and	 has	 been	 shown	 to	 reduce	
bacterial	 cell	 numbers	 in	 an	 in	 vitro	Pseudomonas	 aeruginosa	 biofilm	model,	 and,	
with	 human	 fibroblast	 biocompatibility,	 is	 thought	 to	 be	 able	 to	 reduce	microbial	





(MRSA)	 infected	 wounds	 that	 have	 been	 managed	 with	 Manuka	 honey	 dressings	
(Visavadia	et	al.	2008).	 Some	 research	groups	have	 focussed	on	developing	wound	
dressings	 that	 can	 control	 both	 elevated	 MMPs	 and	 control	 wound	 bioburden.	
Adhirajan	 and	 colleagues	 developed	 a	 novel	 biomaterial	 consisting	 of	 an	 MMP	
inhibitor,	2,3-dihydroxybenzoic	acid,	and	gelatin	microsphere	conjugate,	loaded	with	
the	antmicrobial	doxycycline	and	incorporated	into	a	collagen	scaffold	(Adhirajan	et	
al.	 2009).	 This	 novel	 biomaterial	 effectively	 reduced	MMP-2	 and	MMP-9	 released	




produced	 by	 Advanced	 Medical	 Solutions	 Plc	 (project	 funder)	 in	 comparison	 with	
commercially	 available	 wound	 dressings,	 including	 a	 collagen-substrate	 dressing.	
These	dressings	will	be	tested	for	their	efficacy	in	the	absorption	of	MMP-2,	shown	
to	be	upregulated	 in	human	chronic	wounds,	 in	 vitro,	which	will	be	assessed	using	
gelatin	 zymography.	 This	 chapter	 also	 aims	 to	 assess	 potential	 biofilm	 disrupting	
technologies	against	P.	aeruginosa,	S.	aureus	and	Candida	albicans	biofilms	 in	vitro,	







refer	 to	 Chapter	 2	 of	 this	 thesis	 (2.4	 Biofilm-disrupting	 technologies	 study,	 2.11	









present	 in	 the	 wound	 environment	 could	 prove	 advantageous	 in	 wound	
management	 by	 reducing	 protease-related	 local	 tissue	 degradation.	 Therefore,	 the	
ability	of	a	dressing	to	sequester	MMP-2	was	tested	in	several	commercially	available	
wound	 dressings,	 including	 a	 hydrofibre	 dressing,	 an	 alginate	 dressing,	 collagen	
substrate	 dressing	 and	 hydrocolloid	 dressing.	 In	 addition,	 a	 novel,	 natural	 fibre	
prototype	 wound	 dressing,	 manufactured	 by	 Advanced	 Medical	 Solutions	 Plc	 was	
also	tested.	
After	 1	 hour,	 the	 collagen-substrate	 dressing	 caused	 a	 significant	 reduction	 in	
detectable	pro-MMP-2	and	active	MMP-2	(P	<0.001	and	P	<0.05)	respectively,	with	
values	of	3.4%	±	2.3%	(standard	deviation)	and	32.1%	±	6.2%	when	compared	with	
the	MMP-2	 control	 (100%)	 (see	 Figure	 II-A).	 Furthermore,	 the	 novel	 natural	 fibre	
dressing	 caused	 a	 reduction	 in	 detectable	 pro-MMP-2	 to	 17.8%	 ±	 9.1%	 and	 active	
MMP-2	 to	 32.7%	 ±	 27.9%	 (P	 <0.01	 and	 P	 <0.05)	 and	 hydrofibre	 dressing	 caused	 a	
significant	reduction	in	pro-MMP-2	to	27.2%	±	10.6%	(P	<0.01)	but	not	active	MMP-
2.	 The	 alginate	 and	 hydrocolloid	 dressing	 did	 not	 significantly	 reduce	 detectable	




MMP-2	 and	 active	 MMP-2,	 with	 values	 of	 12.2%	 ±	 10.1%	 and	 17.3%	 ±	 13.5%	 (P	
<0.001	 and	 P	 <0.01)	 respectively.	 The	 hydrofibre	 and	 alginate	 dressings	 caused	 a	
significant	reduction	in	pro-MMP-2	to	8.7%	±	7.6%	and	26.0%	±	16.0%	(P	<0.001	and	
P	<0.01),	with	hydrofibre	reducing	active	MMP-2	to	5.2%	±	1.8%	(P	<0.001)	but	the	
alginate	 dressing	 having	 no	 significant	 effect	 on	 detectable	 active	MMP-2.	 After	 6	
hours,	 hydrofibre,	 the	 novel	 natural	 fibre	 dressing,	 the	 collagen-substrate	 dressing	




Similarly,	 the	 hydrofibre,	 the	 novel	 natural	 fibre	 dressing,	 the	 collagen-substrate	
dressing	 and	 the	 alginate	 dressing	 significantly	 reduced	 active	 MMP-2	 to	 4.4%	 ±	
2.6%,	 2.2%	±	 1.3%,	 4.8%	±	 4.1%	 (P	 <0.001)	 and	14.2%	±	 10.7%	 (P	 <0.01).	 After	 24	
hours,	 the	 efficacy	 of	 the	 hydrofibre	 and	 alginate	 dressings	 to	 reduce	 detectable	
MMP-2,	appeared	to	diminish,	however	percentage	values	still	showed	a	significant	





<0.001)	 and	 active	 MMP-2	 of	 14.3%	 ±	 4.1%	 (P	 <0.01).	 After	 48	 hours,	 sustained	
reductions,	to	varying	degrees,	in	pro-MMP-2	and	active	MMP-2	was	detected	in	the	
hydrofibre	dressing	[25.3%	±	11.7%	(P	<0.05)	and	4.6%	±	2.3%	(P	<0.01)],	the	alginate	
dressing	 [7.0%	±	4.7%	and	8.3%	±	8.7%	 (P	<0.01)],	 the	novel	natural	 fibre	dressing	
[2.2%	 ±	 0.1%	 (P	 <0.01)	 and	 22.8%	 ±	 8.6%	 (P	 <0.05)]	 and	 the	 collagen-substrate	
dressing	 [4.8%	 ±	 1.5%	 and	 0.6%	 ±	 0.1%	 (P	 <0.01)].	 The	 hydrocolloid	 dressing	 was	




















Purified	 equine	 fibroblast-derived	 MMP-2	 was	 incubated	 with	 0.1g	 of	 wound	
dressing	for	1,	3,	6,	24	or	48	hours	at	37°C,	before	washing	the	dressings	in	PBS	and	
testing	 the	 supernatant	 for	 MMP-2	 activity	 using	 gelatin	 zymography.	 Images	 of	
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gelatin	 zymograms	 showing	 MMP-2	 activity	 following	 incubation	 with	 wound	
dressing	 was	 taken	 using	 the	 Syngene	 gel	 doc	 (A)	 and	 pro-MMP-2	 (B)	 and	 active	




represent	 standard	 deviation.	 Statistical	 analysis	 was	 performed	 using	 a	 two-way	





Biofilm	 forming	 potential	 of	 Staphylococcus	 aureus	 ATCC	 9538,	 Pseudomonas	
aeruginosa	ATCC	9027	and	Candida	albicans	ATCC	10231		
The	 in	 vitro	 crystal	 violet	 assay	 was	 used	 to	 test	 the	 biofilm	 forming	 potential	 of	
Staphylococcus	aureus	ATCC	9538,	Pseudomonas	aeruginosa	ATCC	9027	and	Candida	
albicans	ATCC	10231	at	24,	48	and	72	hours.	Following	crystal	violet	staining,	it	was	
clear	 that	 both	 P.	 aeruginosa	 and	 S.	 aureus	 formed	 dense	 biofilms	 in	 vitro	 when	
compared	with	C.	albicans	whereby	 crystal	 violet	 staining	appeared	 very	 faint	 (see	
Figure	II-B).	Upon	solubilisation	of	crystal	violet-stained	biofilms	the	absorbance	was	
measured	and	it	was	determined	that	high	absorbance	values	were	represented	high	
biofilm	 forming	 potential,	 due	 to	 the	 greater	 amount	 of	 solubilised	 crystal	 violet.	
Equally,	 low	 absorbance	 values	 represent	 low	 biofilm	 forming	 potential.	 Results	
showed	significantly	higher	biofilm	forming	potential	for	S.	aureus	and	P.	aeruginosa	
when	compared	with	C.	albicans	at	24,	48	and	72	hours	 (P	<0.0001).	No	significant	





















Figure	 III-C	 Biofilm	 forming	 potential	 of	 S.	 aureus,	 P.	 aeruginosa	 and	 C.	 albicans	
biofilms	using	crystal	violet.		
Untreated	24-,	48-	and	72-hour	biofilms	were	stained	with	0.5%	crystal	violet	for	15	
minutes	 before	 biofilms	 were	 washed	 in	 tap	 water.	 Biofilms	 were	 air-dried	 and	
solubilised	 in	30%	acetic	acid.	The	absorbance	of	each	sample	was	 read	at	570nm.	
Statistical	analysis	was	performed	using	two-way	analysis	of	variants	(ANOVA)	with	a	





MIC	 and	 MBEC	 values	 of	 a	 chelating	 agent,	 surfactant	 A,	 surfactant	 B,	 polymer	
antimicrobial	and	commercial	pre-blended	antimicrobial	on	24	hour	biofilms	
In	 this	 section	 of	 the	 chapter,	 potential	 biofilm-disrupting	 technologies	 including	 a	
chelating	 agent,	 surfactants	 A	 and	 B,	 a	 polymer	 antimicrobial	 and	 a	 commercially-
available	 pre-blended	 antimicrobial,	 which	 is	 thought	 to	 contain	 a	 polymer	
antimicrobial,	Benzalkonium	chloride,	surfactants	and	silicone	siloxanes,	was	tested	
on	S.	aureus	ATCC	9538,	P.	aeruginosa	ATCC	9027	and	C.	albicans	ATCC	10231.	More	
specifically,	 the	 minimum	 biocidal	 concentration	 (MBC)	 and	 minimum	 biofilm	




































In	 this	 study,	 the	 pre-blended	 antimicrobial	 effectively	 inhibited	 the	 growth	 of	 P.	
aeruginosa,	 S.	 aureus	 and	 C.	 albicans	 at	 low	 concentrations,	 with	 MBC	 values	 of	
0.031%,	 0.0075%	 and	 0.0075%	 respectively	 (see	 Table	 II-A).	MBEC	 results	 showed	
that	 higher	 a	 concentration	 of	 the	 pre-blended	 antimicrobial	 was	 needed	 to	
eradicate	 biofilm	 growth,	 with	 values	 of	 0.063%,	 0.015%	 and	 0.015%	 for	 P.	
aeruginosa,	S.	aureus	and	C.	albicans.	 In	addition	to	this,	the	polymer	antimicrobial	
successfully	 eradicated	 planktonic	 cells	 and	 biofilm	 P.	 aeruginosa	 at	 the	 same	
concentration	as	 the	pre-blended	antimicrobial.	However,	higher	 concentrations	of	
polymer	 antimicrobial	 were	 needed	 to	 eradicated	 S.	 aureus	 and	 C.	 albicans	 when	
compared	 with	 the	 pre-blended	 antimicrobial,	 with	 MBC/MBEC	 values	 of	
0.031/0.031%	 and	 0.015/0.015%.	 Surfactants	 A	 and	 B	 both	 failed	 to	 eradicate	
planktonic	 and	 biofilm	 growth	 in	 all	 microorganisms	 at	 the	 highest	 concentration	
tested	 in	 the	 assay	 (2%-2.5%	 w/v).	 The	 chelating	 agent	 also	 failed	 to	 inhibit	 P.	
aeruginosa	and	S.	aureus	growth	at	the	highest	concentration	tested	in	the	assay	(2%	
w/v),	however	eradication	of	planktonic	C.	albicans	was	recorded,	with	a	MBC	value	
of	0.5%,	however	 the	highest	 concentration	of	 the	 chelating	agent	 failed	 to	 inhibit	
the	C.	albicans	biofilm	(see	Table	II-A).	
Checkerboard	 analysis	was	 used	 in	 order	 to	 test	whether	 polymer	 antimicrobial	 in	
combination	with	either	 the	 chelating	 agent,	 surfactant	A	or	 surfactant	B,	 reduced	
MBC	 and	MBEC	 values,	 potentially	 indicating	 synergy.	 Combinations	 the	 potential	
biofilm	 disruptor	 with	 polymer	 antimicrobial	 lead	 to	 the	 eradication	 of	 both	
planktonic	 cells	 and	 biofilms	 in	 all	 microorganisms	 (see	 Table	 II-B),	 however	 this	
appeared	 to	 be	 due	 to	 polymer	 antimicrobial	 and	 not	 the	 addition	 of	 potential	
biofilm-disruptor,	given	that	MBC	and	MBEC	values	for	polymer	antimicrobial	alone	
and	polymer	 antimicrobial	 in	 combination	with	 a	biofilm	disruptor	were	 the	 same.	
Nevertheless,	 the	 synergy	 of	 each	 combination,	 which	 can	 be	 determined	 by	




be	 determined.	 This	 was	 due	 to	 MBC	 and	 MBEC	 values	 of	 the	 chelating	 agent,	
surfactant	 A	 and	 surfactant	 B	 alone	 being	 greater	 than	 the	 concentration	 tested.	
Exceptions	 were	 found	 with	 the	 combination	 of	 chelating	 agent/	 polymer	
antimicrobial	and	surfactant	A/	polymer	antimicrobial,	which	revealed	‘indifference’	















Microorganism	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	
P.	aeruginosa	ATCC	9027	 0.031	 0.063	 0.031	 0.063	 >2	 >2	 >2	 >2	 >2.5	 >2.5	
S.	aureus	ATCC	6538	 0.0075	 0.015	 0.031	 0.031	 >2	 >2	 >2	 >2	 >2.5	 >2.5	
























	 SB/	polymer	antimicrobial		 CA/	polymer	antimicrobial	 SA/	polymer	antimicrobial		
Microorganism	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	
P.	aeruginosa	ATCC	9027	 0.031/	0.031	 0.063/	0.063	 0.125/	0.031	 2/	0.063	 0/	0.015	 0/	0.063	
S.	aureus	ATCC	6538	 0.015/	0.031	 0.063/	0.063	 0.031/	0.031	 0.031/	0.031	 0/	0.015	 2.5/	0.031	




	 SB	and	polymer	antimicrobial	 CA	and	polymer	antimicrobial	 SA	and	polymer	antimicrobial	
Microorganism	 FIC	 FBEC	 FIC	 FBEC	 FIC	 FBEC	
P.	aeruginosa	ATCC	9027	 ND	 ND	 ND	 ND	 ND	 ND	
S.	aureus	ATCC	6538	 ND	 ND	 ND	 ND	 ND	 ND	













It	 is	 thought	 that	 biofilms	 within	 a	 chronic	 wound	 are	 established	 structures	 and	
therefore,	the	efficacy	of	the	pre-blended	antimicrobial	and	polymer	antimicrobial	to	
eradicate	biofilms	grown	for	48	and	72	hours	was	tested.	In	this	portion	of	the	study,	
much	 lower	 concentrations	 of	 polymer	 antimicrobial	 and	 the	 pre-blended	
antimicrobial	were	tested.	Subsequently,	it	was	found	that	concentrations	as	low	as	
0.004%	 and	 0.0078%	 polymer	 antimicrobial	 respectively,	 were	 able	 to	 inhibit	 C.	
albicans	both	 in	 dispersed,	 planktonic	 and	 biofilm	 form	 after	 24,	 48	 and	 72-hours	
(see	Table	II-D).	The	MBC	value	for	S.	aureus	treated	with	polymer	antimicrobial	was	
higher	 in	 48-hour	 biofilms,	 however	 this	 value	 dropped	 in	 72-hour	 biofilms.	
Interestingly,	 MBEC	 values	 for	 S.	 aureus	 treated	 with	 polymer	 antimicrobial	 were	
lower	in	48-	and	72hour	biofilms,	when	compared	to	24-hour	biofilms.	P.	aeruginosa	
biofilms	treated	with	polymer	antimicrobial	resulted	in	higher	MBC	and	MBEC	values	
than	S.	aureus	and	C.	albicans,	with	MBC	values	 remaining	consistent	 (0.0156%)	 in	
24-,	 48-	 and	 72-hour	 biofilms.	 MBEC	 values	 for	 polymer	 antimicrobial-treated	 P.	
aeruginosa	were	 higher	 than	MBC	 values,	 however	 these	 values	 reduced	with	 the	
maturity	of	the	biofilm	(0.125%,	0.0625%	and	0.156%,	respectively).	
Treatment	of	C.	albicans	with	the	pre-blended	antimicrobial	resulted	in	low	MBC	and	




biofilms	 (0.002%).	 The	 pre-blended	 antimicrobial-treated	P.	 aeruginosa	 resulted	 in	
higher	MBC	and	MBEC	values	when	compared	with	S.	aureus	and	C.	albicans,	with	






	 24	 48	 72	 24	 48	 72	
	Microorganism	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	 MBC	 MBEC	
P.	 aeruginosa	 ATCC	
9027	
0.015	 0.031	 0.0075	 0.063	 0.00375	 0.031	 0.0156	 0.125	 0.0156	 0.0625	 0.0156	 0.0156	
S.	aureus	ATCC	6538	 0.002	 0.002	 0.00375	 0.002	 0.0075	 0.002	 0.0078	 0.03125	 0.03125	 0.0078	 0.0078	 0.0078	
C.	 albicans	 ATCC	
10231	








This	 chapter	 highlights	 the	 potential	 effectiveness	 of	 a	 novel	 natural	 fibre	 wound	
dressing	to	aid	the	absorption	of	excessively	produced	proteases	in	chronic	wounds.	
However,	 although	 there	 is	 a	 plethora	 of	 advanced	 wound	 dressing	 technologies	
available,	 the	management	of	chronic	wounds	still	 remains	a	major	health	concern	
and	 economic	 burden	 in	 healthcare	 settings	worldwide.	One	 reason	 for	 this	 is	 the	
complex	array	of	factors	affecting	the	status	of	a	wound,	not	only	involving	increased	
proteolytic	 activity,	 but	 ischemia,	 age,	 mechanical	 stress	 and	 infection.	 It	 is	
inappropriate	to	adopt	a	‘one-fits-all’	approach	in	wound	management	as	all	chronic	
wounds,	whether	they	are	venous	leg	ulcers,	pressure	ulcers	or	diabetic	foot	ulcers,	
are	 indeed,	 complex	 and	 differ	 greatly	 from	 each	 other.	 Therefore,	 although	 this	
novel	 natural	 fibre	 dressing	 showed	 the	 sequestration	 of	 MMPs,	 and	 may	 help	
control	 protease-rich	 exudate	within	 chronic	wounds,	 other	wound	 care	 strategies	
may	also	need	to	be	adopted.	
This	 study	 also	 showed	 the	 effectiveness	 of	 the	 polymer	 antimicrobial	 in	 the	
eradication	 of	 biofilms.	 The	 polymer	 antimicrobial	 used	 in	 this	 study	 became	 a	
popular	area	of	research	in	the	treatment	of	infection,	because	of	its	increasing	use	
as	an	antiseptic	worldwide,	and	thus,	there	is	a	plethora	of	in	vitro	and	in	vivo	studies	
demonstrating	 its	 efficacy	 in	 the	 control	 of	 wound	 bioburden.	 With	 a	 chemical	
structure	similar	to	that	of	chlorhexidine,	another	commonly	used	antiseptic	in	oral	
cavity	 care	 and	 skin	 disinfection,	 the	 polymer	 antimicrobial	 used	 in	 this	 study	 has	
been	effectively	used	in	the	decontamination	of	wounds	and	decolonisation	of	skin.	
As	this	study	used	a	commercially-available	pre-blended	antimicrobial,	it	was	an	aim	
to	 determine	 whether	 synergy	 occurred	 between	 the	 polymer	 antimicrobial	 and	









effect	 on	 biofilm	 eradication.	 Furthermore,	 the	 potential	 use	 of	 chelating	 agent-
incorporated	 wound	 dressings	 for	 infected	 wounds	 may	 encourage	 biofilm	
development	rather	than	disrupt	the	biofilm.	There	is	 little	literature	on	the	effects	
of	 surfactants	 on	 biofilms.	 One	 study,	 in	 the	 context	 of	 biofouling	 and	 marine	
bacterial	 cultures,	 showed	 that	 the	 treatment	 of	 a	 polystyrene	 surface	 with	 a	
surfactant	 resulted	 in	 a	decreased	attachment	 and	 colonisation	of	marine	 cultures	
(Blainey	and	Marshall	1991).	Although	in	this	chapter,	the	surfactants	had	no	effect	
on	already	established	biofilms,	it	may	prevent	the	colonisation	of	wound	dressings	





MMP.	 There	 are	 other	 well-documented	MMPs	 in	 the	 context	 of	 chronic	 wounds	
and	 therefore	 the	 assessment	 of	 the	 efficacy	 of	 these	 dressings	 on	 those	 MMPs	
would	be	beneficial.	Other	 studies	 into	 the	efficacy	of	 antimicrobial	 substances	on	






48-	and	72-hours	and	 it	may	 therefore	mean	 that	 increased	bacterial	 cell	numbers	




The	 assessment	 of	 MMP-2	 sequestration	 in	 a	 variety	 of	 commercially	 available	
wound	 dressings	 and	 a	 novel	 natural	 fibre	 dressing,	 resulted	 in	 the	 significant	
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sequestration	 of	 MMP-2	 by	 the	 collagen-substrate	 dressing.	 There	 were	 no	
significant	 differences	 in	 the	 efficacy	 of	 MMP-2	 sequestration	 between	 the	 novel	
natural	 fibre	dressing	and	the	collagen-substrate	dressing,	which	 indicates	that	this	
dressing	may	help	reduce	elevated	MMP	activity	within	chronic	wounds.	
Some	 of	 the	 potential	 biofilm-disruptor	 technologies	 examined	 in	 this	 study,	
including	the	chelating	agent	and	surfactants	A	and	B,	failed	to	show	biocidal	activity	
against	 P.	 aeruginosa,	 S.	 aureus	 and	 C.	 albicans	 in	 planktonic	 and	 biofilm	 form.	
However	 the	polymer	antimicrobial	 showed	 low	MBC	and	MBEC	values	along	with	
the	 commercially	 available	 pre-blended	 antimicrobial.	 Furthermore,	 no	 synergy	
between	 the	 polymer	 antimicrobial	 and	 the	 chelating	 agent,	 surfactant	 A	 or	
surfactant	 B	 on	 the	 eradication	 of	 24-hour	 biofilms	 was	 determined.	 Higher	
concentrations	 of	 the	 pre-blended	 antimicrobial	 and	 polymer	 antimicrobial	 alone	
were	 needed	 to	 eradicate	 48-	 and	 72-hour	P.	 aeruginosa	biofilms,	 however	 these	
concentrations	were	still	considered	low	level.	
	
	
	
	
	
	
